var title_f8_60_9152="Testicular appendages";
var content_f8_60_9152=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F67439&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F67439&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Anatomy of the testicular appendages",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 381px; height: 491px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_60_9152=[""].join("\n");
var outline_f8_60_9152=null;
var title_f8_60_9153="Balloon extraction of common bile duct stones";
var content_f8_60_9153=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F60642&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F60642&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 498px\">",
"   <div class=\"ttl\">",
"    Balloon extraction of common bile duct stones",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 478px; height: 341px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Left panel shows a balloon catheter being threaded over a guidewire within the common bile duct (thin arrows). At least two gallstones are visible in the distal common bile duct (arrow heads), which is dilated. In the right panel, the balloon has been inflated above a gallstone (arrow), which permits the balloon to drag the gallstone out of the duct.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Isaac Raijman, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_60_9153=[""].join("\n");
var outline_f8_60_9153=null;
var title_f8_60_9154="Sulfonamide structures";
var content_f8_60_9154=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ALLRG%2F59357&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ALLRG%2F59357&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 612px\">",
"   <div class=\"ttl\">",
"    Structures of sulfonamide medications",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 592px; height: 516px; background-image: url(data:image/gif;base64,R0lGODlhUAIEAuYAAP///wAAAIiIiCIiIru7u0RERBEREd3d3TMzM2ZmZszMzJmZme7u7sDAwEBAQP8AAFVVVYCAgHd3dxAQEPDw8Kqqqj8/P39/f7+/v6CgoCAgINDQ0ODg4DAwMO/v7w8PD2BgYN/f3x8fH3BwcP9/f7CwsP+IiP8REVBQUJ+fn/8/P5CQkP+/v19fX//MzP9AQM/Pz//AwP/v7/8iIi8vL/8PD//f3/+AgI+Pj09PT29vb/9ERP/u7v9VVa+vr//d3f+Zmf+7u/8zM//w8P8fH/8QEP9fX/9mZv+fn/8gIP+qqv/Pz/8vL/9PT//g4P+goP+Pj/93d/+vr/9vb/9gYP+QkP/Q0P9wcP+wsP8wMP9QUO9QUG8AAIBwcKBgYN9QUF8gIJ9AQKBwcN8gIM8QED8wMO9PTwAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAACH5BAAAAAAALAAAAABQAgQCAAf/gACCg4SFhoeIiYqLjI2Oj5CRkpOUlZaXmJmam5ydnp+goaKjpKWmp6ipqqusra6vsLGys7S1tre4ubq7vL2+v8DBwsPExcbHyMnKy8zNzs/Q0dLT1NXW19jZ2tvc3d7f4OHi4+Tl5ufo6err7O3u7/Dx8vP09fb3+Pn6+/ycCwEBBEASEBDAv4KlIASoAAxBAAWOFEJUBORBFEQ9Hrhw8aBHtRMnkJl4cKTfrQQAB0hgoCAAAkoKGZIyMEASQYE0QzmcKCgmJoISADAIYGDR0KKSdhJSakiiIh4nhCTKuLEjpoxKEEV5YOIVSElbu86iapKWhIIHCiho+XKSz1FD/9sODBgX1VtLQEsxZeQ00cisGDVy9HgJq66vyDiWLCtLYYGVggwAXOgw5s6WRRUUmEwQIIIKASAAUCgANILTADoXVOAQIE8AZwHinMxg0ALJRAFczn0TdwAGtwGKPrrZAETfok07LNBZoFOURBem5kyoJfWzBSRDsA6QgYGi2CUnUGgcwHehCgFWOAvBgATWAAsc0B0a4ILRD7kXlMhgs2xCO4QkyEgPPDBDVlQNRggPGRWohAtCFLjDDwBE2KAJBD4g1QkFWjWSCTw8cMIOIrpASIYHVthRgWIJwlGHXW3VwwlRcGjiCTMA8FWDD0wY4ogGmjCDh1z9SOIJJrpAYv+PFA6ixJAcSmXhAw9GyOSPAIzkUYRWAgbADAIyBosCA0yGwAFsCdIaZfnlNkB5PUkHmmikgeZZXmUe4NB9heS1WQVpDnLUfGq2WdRNaaYJ1FHTiTZImQSAVgAAmy1wQAA1SUQQnQvhGQCh1eV21mwK5GUeeAVJdsA/CZyKn0CCxBaABG8yQIBL9CngXVF9AYAZfgqc1aohM+RYyEg7AJCgVYNk1CKYPAShoYpBSBuSYYQMGcSHWGp5CLLUWnsIRyFtVWAUW0VRUVeICeJstyR9+cAP3IqYpVXQVrSYIENWJWWHT54QrYbwbqnRD+1mxIOYsjAgwWYCBMrUbsbhOoj/T3O+mjF+ky10kEu1xcnQWe9ZPAh0oeX6K6K45mUaoxnLulDGMTEq0aj4VZDeZDIBcMDOv+G8k6nn4SwZAxmfd/QgOKc51G9KHS3Rzx0zIBGZAMHJr7EAKLHktMsSJgiHCwPAkVQhPsBDhC5gia25DtYbkhLMCuJ1h/+2be8gP/CodlguGhjgwl8J2WEU8F7Ettxdd/Qi3oOQa/a0bE+OdoEFq3ij2u5yzrArEMCK0gIt1ZRroYC6qbVC95mmccrTDVvInoP4uVCghXj3qUOpHxpQoi3PCnNoBE0aE80L2fyQ7RUQJDshpJkXdEFDBzBs0an+ljSvCMGGUK23vrTT/62ZPhS91A8xbT2AYXIYxNnKClZ3/M8KLG3ebj8AxL3JYsU43WLT0QPeRzmNYKlZXBEgDwDXuXjpCEn2GgniImgRzf0PXydoUiFAMrC88ct+BBMRD7zFNmlxDUyfe4UA0mMAWKWnAkyxU3F85Z/fKEAyL9nMABxSGthNZzI3nMzzvEcUgeDOV5NpIQBkyJvfWSw46xseBBjgEAPwDnkVUB5EisO7H7pmEEFEwNGE9hAqdgd7s0Fays5jNZ7hzFetkQ99UgKRq+EQfQrYmRwH8ZcBFYhL8atKABkEMAhJiEJsw5ILorQ2EUVICRcMIIEAmci9uShKZGNg4zQytmv90f8iibNgkewFQLN9LYBAiFIBTWQ2K00IAOYikcE4NANWKiaFuMwlI6AilW7QLVmuGMm+IlE5QpBFl8hM5iAqchFukMhLqYDbDsomiWL6cZjKzKY2t8nNbnrzm+AMpzjHSc5ymvOc6EynOtfJzna6853wjKc850nPetrznvjMpz73yc9++vOfAA2oSQSAmykKtBubEsQAYHVQfYDmPnpyVEOzQVAD3GehE9UHBIIiiJaELKPWEMBCDcAAjIL0Hib12adOGtIBeCcBKWXpPDYKxt/IlBoi/SFDb/qNhAIgpof4B0QRIFGe+gJiKiXAInL60+4ZVRoEaA0CXpOa71x0p4T/KAEIBEFQ4Xz0nG0EiARuRagETEoZXQ3NVymVp0sp1RAUyAAKUmO6f2D1qbxA2V0PcQADDKsALiWESAla0p3GFQQT6EAE5Hma2kSVrIIw6y3SkhI+LeKhPiNqIQpgVvkE4K2C4MAKUBAAFKzAn/DBlACY+tO9EoNWECGAEpcqF/P0jK4vxWhcSduBFXBgnh4lBGQBIFmhUNUVjZ3OcZvCUSR+lbO3IohSRduB0maAAuaMqmeWy4i+DmuFrAWqMQzQMwHUFhHFVahl6apTAFj3t/UkgOkGcauOTeo2NAFVK4Lbk+YmIqWX0i9nOUaAC0wABCXA7jm9KwjArrUR5u3T/3xNiiZjuNU2801EhAdBXsGarkwCUfA9W6Lf4Ur2ALVhDiz+QYgEDPEQNO2oTQcx4Et9NgTs3HBkbusIAQxRNf+RwHfOSowOc/W8fF0fW7/KVLtCIgIdUOdp5vPYlRL3rAQoAJFdwd/R+BcRQs1sUSk1LJSAVhEdGAEAHKBmbab3p+vtcYbZq1AjRoa7vYBpbGebCOxq1yV4pgSb00lZoozVysU9gEjP3Iod1oYgga5dQR88CQ5MoAEUmEAJtKlj20qir44C74RhZd4vC0OvgthAItosCks3wJ66opRrU1HoAfBJxJpIQSMyMAEKlKDX2bzUX12Ka0f8GQGrHbUgCP8gUkobYwKqNsSvS/HrYsNTyAbYsi06YG0AsDoSi20ECBzgbXJn89gQCUBv4bsJpXon0sLgdbQHkelNl2LciUjtQk2s7Xb4VLyTqLAuQMDtQjRgApQINyMooIEVUECxiVhAmVzCbGWnIgY3yLjGN67xKgzjsBPQwAjmbYjTPkKM7nFGXKFNCAeA4OEKX0QEItAAc0OC4SYvBINTAwF+y6OiV70GwUWc6Qxs4NKOcEADZv6IDQRgA04n+SAwS9xkP2rWoBhCEqZAgq57/etdr0EMjFGCEWjgwPYWBAVQoIFIKEC/yhg6IkZgc0bMvOaTiLohOg0An8djsCQFeDMevlX/REA86UuPOSNWoAEKMN7aMa6dxU9xAxU0AglJSMYGoGzdX79cHARHxATYbXea170RFPit2R3AetanZoj1ncxZBc6OZvtV8IPvQOENEeVHKJ3pkBjBqzvQgda7vgBxBjJC3k4KJxRhCYuwgSCY4PGBz7URHJBrADJQDjX3J2sCSXsj7n56RrCZ4TRvgPpfzdplI3pS2O73J57Qofrbv0Bjv0VOm7Nm4/uf9cBmDBSwVamFAPdBeuaXeHkXACWwfuo3Gj+mbChnap2gBUYAAFIABYlQAywAACxQBEOQC9UWCQGADhLQFgsgfzJnek/GbShwfTpnAKHWc+/nK3c2CkNQ/wQduAhQkAW4wFQgBgAYMIREWIQYcAG9lwwIwFE+Jgm/p3io13CHABqiY3V11nd9hxSgEAM1IAMyQARSkAhQQASC0ARXgAv1BgklWILUEANPEAknCHdPxoKOcHAb8HiIcGwC4HelRgpXYHmNQARvaAtN5lSJIALcZwtPkH8np4KIB3yQ8IIahhsFUHFXFyu2JgpZoIEkAIiJwAQkAAA28ABWcAuDpobuNQ0x8AJEQAQv4ASPwAAJgENxNn50uHATYHRIdwkV52ya4AQPYAMyoIGI0ARI4IEg6Asds4wBYAFCGICy8ARJwAQ1cAUh6AgKAB1q4YQKCAm81m2RsABv1v8JT0CGoyh9isACNSB9JPACtoCHqMiGz7CKNaCBMjAFRVB9kPAPvogI5Jd0L3d4luBuWvMJLxCKnZgIUtCFAKACZ6gMFvBtriCNRNCBNqACScCIj5AASJaAkNgIR/dqvJiFJ3JCLTIIBWIiFZEIOdiBKhCKjDAFTQAAX4gF+SZVEOUfmWgIX8Ri4TVrRyd1jbCG8/gCNUACXkgCGrgETPACpbgIoSMIt9GPhzACt6gIUDaA5TcJEygKXCgD56gIKjAFovgAsJgMIRAACKgKFHmMNmAEHbiQVHCNimCAkeWIidAB3Yh6AlkJffUdtyUkgzADJykIBpIjK4kIlYeBRCD/A40gAxwIAJiXCEvIVa2SXJDGkwNQEz45ebwHhUOZisxAj0gpAyRQAyqwgwBAAg9wA0s1cQOgVEKpCEqXfYxgh9+oCcwnCklwjC8ZfTUAfe14CyigA5JwAVtpCm0pikbwAEaAjjLQBEVgk4ogK2cCAOCICCX4gI6Ab7q5VoLJL4UJAFxxAiaQmIYAjMIIho+ABI3ZkK55CAiwZV0WeYMQEC3UmZdYlUlIgqKZDKSZlKipmoPAlFnwlPQWAQh3CCwHkiE3cotQdK72C1XABIzpmIuQkJCpkbHQAB/gAZLgAR8gkqiwnG/pnOhICAupBXQZWohleNlZCBmgbr7lCCMY/woZwiIuUjb68yEPgAgvQJYJCQm/+YEtCkbaqAAsdjLDEmvutQA3UYLKBysb4IAzupaOUIJ6iQxWYJSleZqpqQisGZ8UoKBKhwjyxggzmgENYHYiN5trtlVpNgrS0iRHAEwAkkA/MECI0JJfGIaBqIGTiQjfV0SRRR2GgFRu5XeGhwOUkAJtdwpYkARE4JbN+ZyJEJ3T6aIBAAJYCgBytwiI1QBalVg1mgiWJn6fEJ5f0hVCABJBQJ5AwAND8qNOEAO4iqtP0IVhCQlLEIwAYARf4IDceTJTNWNephvfoVQBsAAlBRB01lqCQHfGNwErsHmSUIJnegw30AQCGqaMYP+gXTAB25oIaZoICkqiALABbgqhg8ABDkABI9CfoFCngnCnhrADQ/IDexqrh0AFMzmkjaCOjkl9iHCCUgl/A7BndwVYn7KoNYgIKyAClkADOUcKB8mcKNoIC7kFINCpnzoIoXoIa9cBpFeq69YKrEqYABCrJuAR+gMAFfGjT/ACNnuzOuiBkzAFlkcEYfB/usEnkuVoyoWFK/SkBgGtP4kITvdrqsoI2qquxHADJLAEA/oIjkkCXCC15qoIIKABcMquGvCmg/BrIbsJ9goA+FoIO3CnE8KnhmAF69irjtAEF2ikhxCHhGBkqYFknKVlEFtWKphpGGAJGACNo/ACLID/BBvrCF5oBmBwtoSwe3BVfOCIsqeKCivbIj3QFTErL4rpiZIgA0jQgwdrJvNRa+sVlc2qUFLqmYXAeLwmuYUQtchAtQAAfZAABUawBJmHCfAao6nWrk5bCtJSf8DEr4LQttIyEkEwBLmaqxn7m5AAmR3YBFtArK8mi7R4YVJpOgdAKNAVEJ8Ve/ExdzmACTlAuaKguGAZCcYIBVSQCVrVCKUaK0JElaAQBXjqCL1ZCRuKCQ+jCS84r6hYrsVABcQYCV3HAu6oCmIrkaGQtvhaI+YJAG0bPwPUpTdrszmLlJIABRaKBGQAtITAj3wbYdgmEAOWHgTgd8wYAD7gATQA/6KSoAMpgAHyOApJoLuRkJokEJ+qUAEGMB+sIYekwL+SgAXvubNaIMB4GQk4N6dZumZcKwyKOwkN/MCP8G9YNwsUnCwmEgQhkcF7CreFsJiVYARfOIiFEJUGQVJ6loV2JltkplLlG7GGEAHOaAEXIAkwEAAhYAGg+Qk/OglALMSOoKifRQlEzGioQC5REQkZKwm/epaVgBlWpAlNq2mQgMDEkMWSsMWRAHTSygthzEcekcFqi8aEoHWASgnDeQgilRJvhWq1IxoDRlx5LLiIwHA+kJY4Bgl+fLjCuwmHLAmJHAkOG76NTAnmZaiqsBEuoEGOYAXA+sOKnMlrgcSUIP+7o+d7VxwMogy/pfvEAzFShWUMT2LNjFCOGCoJNiB2mFABA+DN3igCHqAD6fsIPqDPiHgKyRwJ69gE+rjIneW9lnBDPLYLVzCTkCAFSXCktFDA9HoI1BUADkC7u5AFBPoIy5zOufXFutDOklDJkmAE83sJ9ozPkeAAFyCihesIIpACSHgKQzDQkPCjKsChjDC+0gXNCVAbNwTJutCSkCCIujDFEqx2K1BdKJBgI2CtxqDTIM0CQVzKNcF/xAASIOHOiyC3KfoIeHsJ3/EdLu0IG/ABIYADFNsIF2ABIjrOnxADorvTDenTi9DCAGHUjfBnhtgLFfoIs6wLnayuu2X/XbjWAMQHp7xg1Y4Q0l38YYH9Cz9AzZJABReozZmAJmuhCSDQAgBAA466CCHwARjQAuw7CnZNCTyt14pQY33dDf+rAvdXfyQwz7C91NqHAtf1DJAdiEtgBAcNYXVV2dSA1O35u7ZAuBjwoYvQAi0AA+F8Cq0tzzUAAESAoAh9qH5dDV/JCCotDDpAoxxdDD+K1ZHw2vSgxo9ZA9R5C3wMADlgnInw3B5AyBdneVAQywNrecH9Di9w2/eXjLrQkyXoA+cNRq2xUEtbCzFgoUzJBD7MCOxND//LmgT+AJZX2Lxgw4fgx5B6zJ1wA2S5kN7qCCwA4HjlXpuZtAHnV1wV/zqwCwv0CKinCcKMYHk9XQ9YwJDRZ5bIEAIt4AEi8LSjII0UTpNGUAPHGK5kGeAghZ8CsKSlfF4PTnussIpFcANPUAQpfpEV2Qg2QAS7nYd6vA0v0ARg1+ad+JC3wMgE4AFGaIQ6kJygII1J8AQ38AAwyQJEoAJjnQgsIOWI8OD11KxROglNKFjLKBDx1wov0OXXOARaUAOACgU1MAXxbAgnutKQwKjb4AQcV+oaR9Gz0MxuBQP/53+O7QlJsOeDYAVZsOT3WI/pqAL5aBM1Hk/N+qw7PNkSdokTUZCocAMUPalhrgJjXgifjsmhnubx9Lee9d2r4MaEcANF8OeBPv/oHqjryM7ovQ5PrXsQMT6DD96HmPC56DkIJrQwa9unV4DrAKDpZCkIz14J5hsAUaxOQP3MnZDKx8IsLJsITsCKHXjrT/7tlF4JU3pPrdtUlKCHD96L674/MmvVJlQS8Z4IMZAEgi6KYZjvAynt8MTXAM8JAn8iILE/Ba8IVVAEnO6B0LfiDY8X497ih0CQ8GbhGN/ugiAtFREEHc+S866BJM+LJv9Osp3yaDsv99q/A0KYAvPyinDwY27z4f4TOa/zs/MdFCgJ9ycIPMBKdaqvRa8IH88ED0AF0K70vkxPu2xmn3C8HZK8TSIkUHEEVr8IMc8EN58JiO71i7CbFy//CCuZSifgEXX6IlK/CENQBW9P+KeQyhbcFYJJION59VWA6pSP3j//oz9AOC5gr0fQI5/fC6k8xiERnkOy+alvDeyezC6QI/a6p48f+7Ww8i+bJcayLro/Dj+QIsGfDCZd/Ocw/NCE/MRw/MxfDjPS8s/f1V4N1tPfDWW/Edc/DJet/dv//eAf/uI//uRf/uZ//uif/uq//uzf/u4vULfSYPwu+P1uCU6PVpNyAEH4OY0MCAIBAQCFhoeIiYgBBIqOhgUCj5OUlZaXmJeMAIKEmZ+bn6KjpKUADAWDBpKJBIQVBgymroUCBaaVobi7nwoIgwgLirYAEre8lbTIy8sL/waDBQqKjAy6pKHWkZXazN3NzwHR0wTVjd6H1ufq3hIIhQvHiLTEs5706unrzAgStQnDtyCw0kewoKVqFU5BEJaIkQJPprCZy8TNoEVFCBUyXETgYcF8F0NWanfgUIJjAxa4OjAowIIBgwZICwAzQAJghSAAY1BzgIABMBHI6oRAgauECBKw3HkzJidgMxvpDCBU5CgE8Qr5BMDygK0FLZdSZeAKpoGp/Q78sskpksuW/2ranAd0LICpVa3uqjYQANhCCf4xqhm4pbACNREHMFCyk8ymAViuPSwAbFgCzwxQfkpTml59fA/9BRAYwOBBCSyz/QlsbUKiRgMg/QfbtP/UnZ9zF2KQ4Fkw0ihVErqntV8ASQkGHGBJQEBVBAKU/TzAQPNDaScBwIKQlWVCrimvA7ftXBZ03ZcUNBW3tSuxilxlu2o04NZfCP8OGFDwc6LfALIAgFlsnChX3QLlAXAeeqTAgxoDo5XGiDKGJOBOAfZt4pMC+xUDgW2FHFcgABUV8M8qfsUSCYfSSPAhg944aBOEnkhIAIXvADgdS8hFEwB2t2x3i3jZMZLggjB+BhZvwc1zC29wgUgPI5DNZU9wLxVCwACAAQiAAqkMIgyHwmQpIJdUtsRWkpZYCEB7kb0nCZiGKaMNLXK5RM8Ca0Xml0wCDhdclf+wOQoD/ET/KNiN9oDD5Z2eRKIaTSCCmKU2iObnp2kHSKoml4Z2g6gEitqmDJ9hTdnIV6Bu2aUsZrqaZpShGiTQO7H8JKBmTv5n3qJthdhcXoEOFZx43GlX3y1uVrMAh+Yge4uRxNaayG/jmfiUV7do06xLdkpCC36H0DNAPxVE9lJJgQb7JoLVWksJAeIgGl1kai1Ki3fFPCpupAKwiM53m1wqgL2GoCiAigF3KO8u9Epj70r5murJudrFecwmtkirLIZf/njXtMMG+DBBrNHUyAFB8SooV2sNAKyqdxmGKE3mCgObKwrwlABmNLkU5iCcFQXiVC6dXIgELSFQkitUaUyiuM/A/yRcIZDCnOoxjkWmZgG9vluzmEo7cgDSL6ZiQFIWYx2Tv+1OzRlbTTH359SdDHJjZpvlXWjZmZzdUtqLsT2hPTFJLeUtO//oc9FRjZ004JRXbvnlmGeu+eacd+7556CHLvropJdu+umop6766qy37vrrsMcu++y012777bjnrvvuvPfu++/ABy/88MQXb/zxyCev/PLMN+/889BHL/301Fdv/fXYZ6/99tx37/334Icv/vjkl2/++einr/767Lcfet4QdFqo3e7Xbz/zEgDaKb3zg3T//wDsnQG+A4n+RctkAUygAmm3KUioiRH6McAAF0jBCrZOM4jQVnwaIQ0BvP/IgiAMoejytzKwadBuDICAcqy3gMBsRIQw9B1klHLCUNiiL9H7yQLg8cEY+tB4y+FED6HHIXZVxz8JZNqDfji6QUhjNMxwhgFWOD0z5aQfC4RFSXzBLiaCjiZcgiIzGOAZ6lmRNH9LICyQ6MUvLqwyEKHEBtCHGZNthYLOWQwO28g5PR0njpNwwOWu8IBCGvKQh4wB5vgxlAEgkIIcIqAXrRCDSlrykpa0wsNcwhOihaABoAylKBuwAg1QoHJWeIANKgGFLGCuU0BxWgUFkABZQCsEJfDiEIqggl768pe+LIIT5JU0ywAgBRZIpjKXaYEAZMByLyDBJYhQhcwx4JH/CiRAnyQBAw1MAAQZOCUMqdAESxiBCsRkCEws0QIQVA4LRJDBIZYABRKQQAqrNAQLijAEys3RERxY3RBeQNCCGtSg1cwcB1bggAA4YAUBtaAVapDPR0gBADKogSIBh4ELePSjIMWABz7QAMolAQmGQAIRiNAEe6rgAU1YgiGacAXAbWACj5jAPw3xrEIooIycu4IKWEDUohqVqEjgJ+cokAEUTKADI9hpAqMJgCmgVBE2qIFMSeBKjoL0qxfAAAAu0AHA3UAFhZBBE4hwVUPIgAQPuKoNHjDMk2VgAs90RAacaQiWxAKNnnOCKs2Jzs+VAAQa0AAIpGo/eMpgCRR9/wQJmFAIIjwhdCLI68OcUAQWFEIFTJCnIiB7VRK8wK4TyOUkGjCBERRCMshJo+aoKtrRXjSrmnxYCSYQUUtswAERAOAQTgoAFUhzEkSAAgD22c/PYWAC4pQXFYxQiMnWdrSDzehGawUCnVqCAx1AwQYdWRrOxaAGMshoRRHBAvQCwLQPo0BqMUGBDUQguP87KwBUWon2ylMFN6hVCT7gAVFYAL/WOq88M+pZSpCgnPtNgrVA0IHeVoIC4u1KAmgpW8wRdwpofUQTqCsDy8oLBe7ERAOAi+Dp7eAIhfjBA4KAiCA8YAY8AMARdvAIzi6BwZYYMQDmWldF+AIYwuhUTP9eaAgn/mdEWtnjITSQglGEIAAW3oUJHtCDQszABAB4ABAKAYQHXIKq+w0xJWTwANEyIcBGXstvlEwTJodIZH/RVZQnQYEOdCC6gcPXAMi1uSpQdgmDfQSQpZCE5hqqlICuxIoj4NrqvTjGM67xjWG840dMt6oQrgSQp6CFR/DDHwqqiiCAGiKgPFnPb5JyISJggVLoQLzLMMEJTjDmL4d5zAAosyWeQARDGEG5lhhqIZiriFNz4h8IULXIFuHqPIMq1o8ALwgijYmukMYAHa7cLj1rXFZStrhwZhMHJlDSTKy4BIK0NIwBIGMaH8LGZQ5CpxWhYMiulxJQoKx2HYH/lUM8xGQQwCI63mhtQ9wxEfIVKylG2m5emODLJ+CBr8VMZjMjwgmYjEESLvrZBldiCscFgBG2MMqSFtwQBzdEwhvC8OFc++GIuGmKSeFt/YRbHxwPtscPseUuA8DXjiDnfuNpCSZIcwnCfIQSZyQgObM6UI7MlgEf0YEWX2LFK7beDhBpbxcUwsY/2MEM9p0IqpY7E04HABQkbOT1KECM5S2jHwUxt0HIGgQtwAUONJBrHJ/gCBtHZCF4YHYAPOGgLyiCTEt+CXsaggRjcIDmN/8lu+O9UD0LEYL+2HcRAaChD6y0Kbp4TZEEXdiI0DWvjw5mRUzUBhkleX8je05H/2jxS07zOdayfoiy/CM7NWTjrMsqCrDHm3qXpveMf7BrHKPdBYXk8RNuwH3uU6HY/P1Ee1fJBC/c9/yaBUxRvHTFCGadkzWBMrYbcP7zfyAEHggBKfRPgxUg4+IAsGUPAGavZ2ZAsGtGlwj6VQhN0FaUoAIkN1e59QgWEnNXpCAS1AjwRzSwhnOHcF+nV3GXU4CJcHG6pnG113bSBGKZYATlNHCJsEbl4g4JI0mBAhYEgHxblwg3xVhf5wBhJ2+YRmNmtwMmgHY69gDa133cdwXu9W+XYARGkFFiUH8R8EzYkh0DIG3SIA3aUEwceHOSQH/1NwIEhgO1JgoYcH8H9v9/M+BlA/hrHUdvOXYCjYcIw3VVUEBdohZZAEBTBMcQWsiFAiJEplEmYehwsgaCQKg5iORxjFcIF8cDh4d0iOBYiAaFkwBkXOUIeYQi2eFwwkBGWhIZiIF8D9QIHGCFikUKzid281ZvhjADLoCEMsZjiqAFU1AKMmAD8KUIUydLdJYShwAok7NOHShrKKADHiACVfYJFnABKWBKbthxBAhssAcALvCGjuBYQ5Zok4AEIcZswNg0JTGML3Qrx2hziugIjCiCmUAIIKgXJHiAJ9BlACiAYAZ5RSBNRpBymBB+D1AGm6d56RdJznEIAyRFH7ISDxEOJLJ1q2iF7IYC6Wf/Ca/oPTsQBZkgWJp4CUS2CwWgcKXAAQEQAj4gAgWGCSmgkiKgWiLxAzOgBJOAZi64ZjXQYEyQULhgDLvwjtcAAPNoFST4A3XoAgB4dHEYck/gXqSgAkhgWi3HAbRkSwZAACxRKIjBANQBAPuxEqQBkcmnV6nlXSoGhM+3PRspCgs4CoCICyOJDLQGANGICc3oAxeQlhchkzQ5CbeHUUzAh4ogA4FZCEhAdz2ZFaUAlKMgj153ESRYCNsYgNxYZimICGg2CjaQVdtVfNukJVYHc1wClizRLTuoCCAAXH92lkG4PbJ3AhyJCbuke5lAjqWwMBJEkqQgXz4AA/d3CRdg/wEh8AE+aBA9sGuz52l8uARM0ARQyAJEwIcwaAoPIUE0uJjB1YiNKZSPqRt82ZHgKAq9hwssY4O72XUOsHOShpbe4wLumWOZQGyjsJO88FOhtwsZIAIA0AI5YAlXFgLt9BmM556UMG5pNQUwBQUsIAWTVQNtNQWnVZ8/1UWkwJii4Jhs8p2fIFSkYJs8NwDmWQo3tVsXmW0Z0Jr3k5mXMHfy4gAXMFISNwk5oAPPxW21cgPnVgg2sIe9NAW0GZKG0lQhGJTwxibHuWvAdgkGKgoAtgsQIEEYxAt3tVvF6Qgoaj8KhgnTGSoNcIY0QAlr6AE00J3WQlzJlm5sEnbaef+hAHClujGgd4gJ8vkJh8kLZPRTzJCaEbCalsBQCfRpy3VURyVPpHYygAcAIoADk5Co01g5WUoJHpokagqPmEAIbqo5WYBsl5BRWBBf6KmeitAA3aUB/hdAPlZcwARMSwCknJMCNEBx0MQEqZqqNXBZtTKpQXmlLbRhsAJzV8cmj2oJv/gwI4pXirABI5BYUUVBbTkJTeo5IQADeXk5QxBy1tqZ67CrB+MXvhqqgrSmoNCmackdO2Qi3gZYD6OLQ2ZP7Nqulseql4OsylqlwpUEj3ivSmUtZSEL2aEDzMRMfJU85AoPSrEp5YUIYbeso1BSrXlGy2GwP5ckgrWq7lr/sX9YU5ezit4EApTKR2VjfOMBAy0nSisAXcjjsOd6sIdwqc3XAQ0wRyobH4FhIaD3qwxyVoIqqEnlaJXzTTDpsZfjCjgYipQAXMgTs1kZGGzzJZ7hAB0wAQUZtRrwQFT7QFDrWkh7HOX6DxIgQUMEI0OgBZA3trb6MILwIh4ItJizEqeomACFZceTtZVBsMXgtW06sqJEr5RAHPHBLqUhMYxhPbgpDGmrtpbjkNBwPXybsv8AuBTaDfoxihUgAIxbC85WPT+xMDwha4YLOGB5E24bPZF7CpNbuZxwueqgTbGElRCrJT+BTdDzuuBWuJ3ruX5SmpkAP/LzWv4zO6q7/4Ws67eF0hzEBxomw3qysDKBi7lc0gmcW7umkz/SsD9jyTut91qG0HrK+7h6gQC5qbigAhPPC72kM0GHUL33OTzeawC6mRvpy7w5Mr7kKzoN5DZqgpVQGqK+877z278XxGRj2UFf678EXMCJQEJcYUJbl0JUZMAO/MBdghq7u0G1AB8QfMEYfAhB5EEZ3MEdLEUN7MEi7MCkOMImfMIonMIqvMIsfDJ2ApEQA0jZwzFEUxB8azwvHLqlgCMtPHW11Aqv8Fc77Ak8TAkWrDvOAA2/Sg2bcMTdcMO4gwqqIGW0AAuwm7tZETYr/HtcBMTuMsSlCD0ZkUJ2ZhseYRFQfP877fAOoavFy1DEKiyDFdIkXiMmPTEThIETYyMUPeEKv9AhdzwpnSIJUZM0W0I2sRMaPFUji0IYkSDFi7Eri7EALNMP7QAlYiIW4MI3wXLIk2M7JGESdCwWLxETMzEZduMKqGALPnELnvwyBbAW+SHLHfyJPaIVV8O3GCMiyfGwJaMg91KKjaBBxVFAciMiuoJBsDA7MlJLpXI4WHMvJoMizsCVZxHCbmK51SEJ1UwMymwAUdwbVCEMoZgSbvwmxiEJCwNYpRHLjXELKNIrILMS5KIfNuvAkVTOufwkM7Q4wkIoyqAMgYHJbJEp0WwpyvFA3Ps6o/LMjHLQTLMK5+r/J2DxHQvjFKQhFBPNLZpcv7ezJPrcKwQNLCuBGd7GDbbgbfIsCV2RJ2VMwFX5JVepK5ixz76iIDOzMb9cisnLyEuC0whz0AXDJVHqu/UCHRRjOA8tNz4VGQoTC/qhQg+bEPkzHoXw1AzgzS89O7eSIlk9mi4TLD+t1P2CNQiQNqzgzeoMyywdGYTWwdrUEizdMjatFjGR08IiOQtwMwMg0EoRMxt2v1/YCFniydf2OoIzCISzNvoCMFDDFkCjGSwjCRAgFGECFI99HJGtM67cE7iTMn0NHlQR1sRg1zQhGDFhDuliDiidIVETLNrQFabt0S1c29qTDmls27r9P9ag/x/6u9vAHdzCPdzEXdzGfdzIndzKvdzM3dzO/dzQHd3SPd3UXd3Wfd3Ynd3avd3c3d3e/d3gHd7iPd7kXd7EYxnyWwjpMsDIIEGnoDYW8RDXWT068ds50r7BoxP3TDmCELGh0xTnQkZUQQr1bRBTVAkFvt7r4N6CkN6joOAwN+DnIAj4nTHs/Qv7XTkF/gjVMd8wQuG+FwDsfRH6/QkQniQlfjpMw9LRIN8ELhsFUQ0erggJLuILDs5MY9/d4OITHgAV3job7okwbigg/jApzjkP4d+eoxMjGSDgIBu/UN8YXp1fMjR5gwAKrhMCkC7R5g55Myd9AlRTJwlPbjJHFv8OXtE0XP4L0uZ3xSDi7HsIUwcBWS4iEpQ3EgDJIPrmBfAMH5I3ex7lfpcKQvEQH6IAZjHgdILmiYDnek7V4eDnDzkI1TE4IfMhgi4i+r3mdtEJz0CSiw4gZ14A1LEYqeATMPEhXP4MT3LZkE7mP8I0fW7jYbkYsgHJpoc14Lw0kU7rY87nfq4QMWGDju7qwC7ikw4gT37oNp7pfZHskiDrwa6Qlr7m3isyB67fgI4UIj7oY2HoCtLtIrLopK7BavMMDMA0TyoBo14SUx7JbD4IBDQAu246iG6OPN4nFfDu4EzvZVTjH6Ll6QIMIA4Tdm1nIJ4KFcDjDhcLflwzCZH/Lt1yHAUfGVOncFxuCHVO5uBc4PXNE7Gw4l45bU9xC7/AKFxyE89i4zDxUwNO7zSSAAPv42crc7cO8yL/DPzh44gAEx3R7IfT8T8i8SRyHA/RvDzf8GUE835cDeDc328SGQp+Ex508yFv57GO9Tsf8LLBNOHmarwO6zvfDwqf8z9S3yxx2DWfE1af7lpf5A7nEEDPKPVucJFs9r/q8zPPDz4OFpRN8oJg8oeT8i4B7ifvCv0eC2CRRlo+8m4/CPnj8APO7+GuABFk81ccOumeCgEj4RheCPzO8BBv4TWz5bSONPKuGsRS4EzD7hLe1O5QDQAC8G9e9WpSASJ/CLhu//pcz/Gjj+7hjvsiguEVMDTu8O7usOKG7vQhs35q4uFBDvy/IPySgOFFPnWyYfiOE8mbbuMrXvNwz/AuLvvMD+LEb+MULv1dr/Uij+EiX9/3vhhABfa1X/ms7+Pt/yNPTuk2DwgVAIMGAQwACAEVEgECiAEKAgESg4wBlxUKARCPCgwBBoODBxCXlwyMjokKogCWmBWbg5oDBQaHpQoVBaYInZq+qZqcq58GmqYBvqKFrIWojQDAAJ+Gq5qhqwDPg6WHreDh4uPk5ebn4xCOAAkBC7SD2o+ZoAADx6KlCwCxvqUCsTgBkJRAXKJ9gyRR4kVvmah7DAgoA6CPn6xUBP9bpRoXa0A/itEMhColiCQDiBtXFSIw7dpEYbJERpx478A4SQJBVjh5KyWkjJIK6BzWyRhIXRcbSfSlsNU9VoMgLjXadFVAALwEmEQ5aRskn5G6MhTFqKAoW2SjrWrKEGzFcDjzKeIJTdXPAAWDDpVVrJ5cR8/AitJL8mq3S2ZzrWwJaRpMYpCM1hQ3NnA0e7eWzsPWSeKAh6HQiR5NujTcUqDWoa4gL1YAXqEU8DqloJAvXgMSAZSVMFltU2bTppY2sZWCRK9t/kZwdaMkUwo2tnquTBBu3dtGKqI2m7krtXeVTXQZrBFR14l8yTaVc7ApCQy6CwLLAHl9UInoQfb/VC9X82iWJEKJKOvRhlwBB1DVlVWgIMbdJd4dMMBrzQgGW36oJTfddt/ZxYolBjhCX4ahuXcJfPJ1WJR9iRiQH1F9lSiNbZZ5KMp9LipimEWQHBaWeL6Q1yGMkdVTIG+zpFdjkpcgyCNsjxQyAFSaBGfalVhmqeWWXHbp5ZdghikmZe58ueOY4zDgIppstklOLEK5aY5nWMojF1Ry5qnnnnz26eefj5wI5pl7LtAVoIiWNtafrimDZ2l2DoRXopRWaumlmGaq6aacdurpp6CGKuqopJZq6qmopqrqqqy26uqrsMYq66y01mrrrbjmquuuvPbq66/ABivssMQWa+yx/8gmq+yyzDbr7LPQRivttJUWYNYBARBA7bbcemrtKNkCQAByCDzabajfAoCttud2KUAhm3yz5wGzDYBQu7amu+4BBphVwADy4uvtteEKPMi4EJrLUZkHINCeae1css45CCBwiCQKG+yqvtkK4NA2gmiMTsSXyTmbKewKzK+/AJ8DwYDEBUyaBFOKG+I5msj7ssiynnwJAQnEGdW9PI9DMysE3GwywSnj63ErBoRczgATY2vTlVEP9vE4hraSgJVFs8oxAU8zI3XY4WSd0NZojq1x0E4RnQ7MOV+5rigLfGZO3d3AjPaqY2PLssx/q1swAHnn6bbBZRNyNtcMO5yl2v8DsS1Obhf3WDjgTItLbsaFU9745mwKPsi/hIvz7iUQpC5aAjUnPXE59F5iL+m49wo70krnjibCjgKQAZ8kr0MBORz4vuzq8Z5bvJ5ZGd502AEML04JeXZwvDgdKN+r9Rs0IP74x8eyT8MPe3/lvwEccDeaeUNItt72zD5rBtWHQ8EE2WsfTgTdU5+laheA24VpAhsAwAgcwMAGJnBnszCEALNkrQIg6HBhMt8gEiAAAdCPareiAP6sJwoHgCBPFOiA/0TRAAROsFIVyxzospQBF44DhOC62gsVlQCJSGJ6X4LgYD5oP1lpD3/YG8QKNECBBbopAykMIAA8oAEccGD/Ag3Y4Z/4RhG/eWkFE0BBAx3YRQJJkFsNcAAAHJBF0jQgeab5FmqA6KUCyI06EpuFDmEFghWGYwJwRNMGJkBCcHRgBFr8U9dE8TUxRcAB4Ruf+I5nqPNJrltpXGMb0cEBFHxgAhHY3mi+hS0MggkCYPPgQ1QhEi+6CgRqvJ6cBjkOKSaST1wUopeumEByMK9158okG9FBgQhMoAUegIEFNFDIc6SrHXTsUizWwUFVRsUR2koarZK3AHgVYIZiSl58LnGzXt6yT5iTFDivhAJE5q6FGsDiOUqgAQvAAAA+8AE+RTBMczSzhJskRwY0AIJAIi8h3pzfKithwFl9QhAM/4CA3OQkgWUsQGjn7BMBG+qlFoqycMWcgAMy4ABQfrQVG3CACFIAAGWKQJ+DuMAHCjqOgcbyfyINaCsGykwQBICm4uAACPhHmgXAjVafKOKeKrrHjJIqAxGIqlSnKlUNrIB0Ie0nANJo0lY0MQAX8IAHdPCBsILDAy3oqihsqlNwZDWgPCWhUH9qUKGqVTTZlJGsLooY181zBCdFBwMSYJuJOrVTGyjrBRbL2MYuNgAGjVaZEBcAhLLuEG8VB1dDCQAw5iAEAMDBBz5LDmUyU3ga0Ko53hrXoPq0oHblLGn4JZLHIRUBrjwHBxzwAQtM4KpYMhQDTnoJVnTNmvU7LP+fHHABdFzgptKabNc0iD4A5NQcXO2ACDAAAAzQgAbcPYcPRHDd0oT0tOWY611N4wlaUYACBPgmNRCgVHJ81awYEIEG2iqOCFBkHd1kACFbUcDPHJeIysUSGzOJjhKIwAPmuKcHPpDE6CKka0LMWWTLkQEaACAEOfgADkQTApZWNkscCOw4UryskGaAFOwZBHo5PAELgBYHFhiEaB2wYVHQM8cetJ228tuBNjYiRAdeaIJNs2Do2lcDLNUBTMMRggCANgUa8NNGDdupZFwiuTl0Y44/oAMIiwYDOT4xt5CLw1ZE732iyOw40jhjcDRAu9z17nZFMdYAABYcKV2pOUT/iwIAuEMSkpBUMuq75HI0GR0RyDEMPgDaceggxwCwgH/5FEN1jkq6lc3wGUXTgBybeTRoNvS52FxE9rnvcHLGrgPqLFQRfzjEI6ayb61HARCU9dTlQKuhF3CSL7O60Wy64j0t0FxyeOCl3Z2AitGUy9xyCtSUtWT6sIvp0qRazds6NjgqeEFtxZrUsx6eMZHpAZkisxxENiZpS1MmQ1VW3MgWEwhaAIAUiEC8DwZAC06op0VuEGyewvZA4AVMMV/p26v28jrai5UeNiJcaeQvumt8z/HaUzSi1QGWJjuhgSBYgIsThWcOcdQ0zaZ3mv2AWD8QXnNYQOQh+IA5xVFc/8qaXMk4G7UufVXqh6d51QhGgEi0JceffamyLmWpaHQAg8Xme32da4VnCtJycVR0EBd1dHN1kAMSB+Cezy1HgX2O73OkE2PCKrppIN6lDVD17lJ91bG1pZWKG86UWqrsYoF9DgtgwOpX5yG4picRQwENo+Fg6jky8O9JV9q5phbBP0VxZAEk+Zqj2bKMR7BzXcnd20fvUgda4NjWX0DzrsK3OvzODsBnCdykMTziEz9KL7MLKhKh1wC6Ho7BFnYc+9Mns0sjaB8wcRyHvriiTcFoUo8gniAowbRldXrS0H1LK/j3OTAgbVtJAPJjwv1odN/sK11g04cNnEgAFnxkxP9pgWN0J94kiP8GdsDD/jZ3MgcANNABY+QA7uQOxXZvJ8clG7ACHRAAKJABPQYr3Ydqqacl+1Nz41BpFqB/snJ+eaJ+osF+WfJ+CeY2rFAAAhB8tRcnkTQ+DwRgtwAAMSg+JUBpH3YlOdACVVYCktQAvVRvxtaAu5QBKBAAHVCBrXKBZ5aBWTICZXd45CBoVcaEqoINa9ImJIgOJoglKKhcKTclLogt6DcdE1JA0QQA+5YlIQBiIAgOJMeAQBcmKaRxTZhjF+CDGKhqWsIBVkaAuSYOGDCAaTcrCpCITSUmXVh4h9d+phGGvFcA1tYlG5gl5Ld9X7JEmmhnGVcrRYf/Vr+GDiXmh1nCXKHlYeWQAyI3YXgoWVjyhe4Hf1dHiW4SAap4JTQAXG2yAQFQeuYQVaoVKw1gay1lAYJ2DmgVAHXmRjI3YRwoDjnHXViGL41oc494grSIbO/SSm0CZVeCA1lmieXQAdt4DsL4iqxyZ3u2T4ZXDoTGAa1VGuDYAvx2DhegijRwjtNyjeUgi5HIj0uWiBSHJsVIeMr4Aeo4GoU2DiNgS6IRVSMgkLBSQzYWU6N1eaJAZHClAeP4S66Di901gOggAiOWiedyYhrphdkIhhTJe6LxaOeAiqShAw3JJRRgVZoFSKYxVblSTAFQZlPUAmAlCiD2WzVlEdom/w6XSAODOH4DOHAp2VJBiZDkAJClIYkweSUyaQ6AuJLlcIVf0kKRlZO8SBo+qSudZIwhwG/t5medKGqE04Y4kIuiYY8fpnPdEgAQBmLGeA4wMFYWYJXnEAL7uJWnKD5ORg4jgGkY8JiQGZkYAGGaFiZO1AoocJOlkZa7wo7h5W+QhA5tZjUH6ABWBo2lgZo2uS0DNQHJqGfRKI05EEZlRRp9JluIKSeXaAG82Zu+aU8+UH5gkpNeFgBXhYXjwJm8YpHLVGEuQzeGEIQNoAH6dE+mgQP/VpnS0loD9Y791ltgOQjtNlPHk0bQdg7xmJt8QnkluXk4CWi/OAHOCWl59/8rFBAAuIkOlaQulwQOlEeY6JACzteJxjKPgxBSfPiWQtkK4xWaO1VP1kmINLBf6pkloicaE1CcGrqYbLJENYSc4KCcveKPN8FwrkOTV/Js7oksBgoOtdZsfglTpuWeQCkpAgFCSFmhWdJpcDd5z5cpmfmQaFmfv0KiWZJY4elcHKosHbCiLKRSMIUBIXCbnZg83bgPIESgOkoO1XYOOTmflmKWhzQaIsorRpolbWgaOQeMyWJ7AgWhofUBKACiQ/QuJ1F9W3oOBscOCPc/S1opvlgC8ikaHMABURUsZ4oll1gaUoksEfUehraGyGdM+rWQ4OBBagI7eJqn5dCl6QX/WZ7ioTwZkS8pMJHmbcJ5LJ02LpF6JfJ4Jar0HJvKqeTwdppDDggIKkEKkeRQAg5QqgIDjqNxmMjCRYPgpmhiTRMyq7QqDhfKKmIah+BQAkPVAStAp6HiguyAfm8WLq+QABdjolqSgxAGA5IpmVc2jshCAPTDeZLarK+CrJgSqIMKaCMwARpAerGircSHFRPyagRQAQagHAhwANTVnwo2dr/5myngisqiCU0lr/B6Ko8qKBJ7KR5KQhtwffnKpq3Cr9waNOUmsE0jl38YiOZwiMpSMTbBqhcLJm03sVyyqr7wspaSmQDAAdc3ASDgsa8iEckQJ+5zOhb3Q5UzHKPZ/z7UsE6MqaEaiq2+QkAGQAk26yUxK7NZYqytKio5iX1gSisg6woi4QhNh0G1UQFy2U0GsG1Y60tG2LZYwq7hULWA+rW2Era843elRDbgOiMEsJ/VlSDbwLRwO315VLhZq7QE9q63FLYJwQnPlC3AcxkgSSDtirg38baYSxos6zlbq54VMACLaBoSYlubi4Z1eLqh93JUy7hLFrqjWxqlq7pum7q0e7vZIRKxKxoQIBIGwGW4G7zCKwoHQJBbwgDGO7zKu7zM27zO+7zQG73SO73UW73We73Ym73au73c273e+72sQreIKb6+IhH01jQCcIaikb5dQr5bikfMuiXmu/+4PEMdA+C65cC+6DC/7lqkF3aN/CsaGKS/o6G/BCwuJBrAn3u6yIUo7sss1lQAbFvA6osOD7wqCjcOCnwOA1zBNxEnB3x7+NusDQxCVpO+kkBABYC8yMEJz1EzBYQYEILA/IkyIKEMfgUt1kRf2zo0ngEKqEEJDYMYpYQXJLMPBYAcBWG+Q+x0qGExuYJtIKQmFcCupjAQLNg+s7HCNxwK4lEm7Js0oIDE6Su6yCEBRcxBAzAhFmO+9jYpaYgXTIwc4fLEOcypeJRcJ3y/JscA9dFBDlEbH8IJ0QA7AGu+EBAnHQPFPBxxtuMIR2UvEqEtteBzqKQuxxDCCXAbQhH/fIisyGTDyPGrKsWJOAb2GTdjvh7EdwDzxx6kQ9EQq0JxMwGWxDYBAZxQG2QDwqKrJgsQwMJ1MMfwyccayofQyHBbwo5wwnHSSAORADCGAAvwxgXUqvoruZVlQNlCMpOCdBFUAZH8yyfGgjQcx4cGwvDyGeRsNearzUCTDH0qK9imJuOyAFZDw/rrzALwNVYSLomTvvdsaPSyDgZkRwYcJ5JcWQtAxzaRN0iTzQixzfCMuA38LSlswK3cZh4kyPR7zQSAyLm8yHccLdakCQqVNOJ8OtgUalbyNNgyH+q8zO0D0sRhzGb6v2sTGjeTaBjtx1Tzyv37z7PsCHZKzhQR/9KhnBAIndIDQAmxcAB5czU0bdIeM9K02sBAmwgHQMBbzADUsQ/UURDh4tHmqwBsXMemALw6vGjqwsa/O7/kPMemULyFEDS2E9OGcwBlfdbakiFqHa84TQ2XYW+JgMVn0SSH8HKtKtQ2M8ZYsQ5NTAm/wUFLrcq20z5Bu9fi0ddpDb6enStJY9WfPdq8h1ukfdqondqqvdqs3dqu/dqwHduyPdu0Xdu2fdu4ndu6vdu83du+/dvMknLAPdzOItzEfdzJYtzIvdzE4jMXzNzQDSvKHd3UvSvTXd1b+jwVet3YnUiVew5HYzOj3N3kXSkHO8FQIzWjU96+AzzlgrUmS/87h5M47N0tz0o7/XI6LTOxSbu7ZqM19d0tPHqrvvQxlNOs8V0OuyPeW8pg2OupCo5RHDUmjvs3gIuwCk59eerg17unzpy/Bm66YFLhf1O5Pgu1MMnh1gvh5GA6/iraWULivmND4fCnOqri1murhOvehCu/XubBf1NDwAhAWIvj1XuhWsonMp47IkTjNviLRW7j2etHrXCWSq64/Yo7VN4KV2S3FWrk3NtHJ0VLf7LkuNNH45CrEwvmYU7l5rg/ThoqFdsVGZytiaolBPetDLDlAS4yKURw4oCzq0KzwwZ2d94nx/HIG8wmAkuwB4DifU4tfz4OP3rlLZPloqG1dZ7/KSvzuIuOJiRbuN06wtHba9JALvtgqeAwTsNhGlvXw3F7uYbmZYOAvJmy3p+erC0y3onnanAGvqb9zFjydYgD5BrsDtts7FyquJyH02orupeyz+CQ6zUFrDhz4LRKbr/+vQig7OYgeTGuxcPn7ePQuS6L04Jr1JXSwDSMbiLQnKaxz4egyzJrLT703M2rABEjX1difMrw18devE2iJVJLtYEdX+QuJ/wiEFpB7aLwooMAmj4rDpPL67VYEHOU2pvMJcFcGi7YDglvoauMKe7dgpWFhwgKbG/5Z+UA5v0UF8m16WJYEHs72tK8QSGfDzQI4yqntGaIJaouDYlt8X3C/7Mb9mMRCg5HaeUPP1QCaUwndKUxH9iNFrmkHr3D8woFCwBJjoZChijGNBoSIBI5/ye9BkqiEGhSt5GT2QreRaFxBvWaaOoeZKcgJPNo0/WtTQEoQFTh0AETP63jgAJdL5BdTwEOAPiz1eOXcmcaQK2jOEV1GQA0YAEBIAJmFfEfwGMAQE8Oig6Y2i93T+ubk1LrlSVFxr0boAGEn5wDtlpDNfhwn16JT+mBPwgtBAJ6ryorEAB8OAgw8O5T1l0hNmV91gHNeA6xmkd4rzH3hWaPLxobwKuDUEPW3ry9z/R2xrPbN/0OsH1g9JKCyvLh0Puleq9eTivgNmlPyaAfsP/2mcbnyq83y1roPoc2nnV5Eu9PaA8IAIKDghsdHRyEiouMjY6PkJGSk5SVlpeYkxQoGhuSFA6djBkTEZGGiIwjEyWQhg4UjByHiZm2t7iCAYMeHymPMAEwgxYOmAIDggsBAgABC8q7udPU1bYNGjQYix4XHyCxixQgEw2Rq63W6uvs7e6R2CjhkysBK4Tj5ZSrGYSzqZHymSNUYsKIdwhvSQPQokWkCxaIGUtIsaJFfw58PQrRopSiV/MgFTx4saTJk9UiTLh3aYMGeQBcwrLUYALMkZZImRKEDqXPQdI8BAgh6cMwAMV+Kl0aMEIAHR4GwbiQw4IOHEQFYaChYeD/Co+V/tViSrZsRVAdPGXapMEpy0tsUbDC9KpEBwdjzVaU5iOipBYXBCXVSxglKQtZAWAQIUJHCgxUA7SIKijFBwec1F7iV7iz5wIJBB0IQEARgQADGABIUABATXC5MgTQDBeAgw4haU4IoM9zQmkXAktKkUPwxEwOBvpe7ijAtkHecCwKkUPEUQAecsy8tpC5d5SgRZM2jTo0awAa+lHrUILC20oTOEygfakB3uTf2wEXHgmD38HIKZffd93hYJQjBlIGwAU7ZbJLdwNGiFB4AIxWGiGnLUPAeeqsAE4AeUliFza42GebgBLmApwOk+DgEFLHYYJfiswtFIIwkLTg/9eCDWLyII1AslNAAEQSeaECgpx2QAEDcGiNfACg8J4kIKwwAknXGDNjkAppRcMkLUgH4y1bcknYQoBF0stRDHYJoZlwXkKhhQcYYEBqSipAZGvrdJBBBjFKMp8ot5hYZpyVLHQgJL1kBaCMKCK61EJDSaIDizy6KemmlMw5HpIFCKDkagHw2aE8AeT2SAmdTJCLoZFy+shCEEWiw46PXnKorChJs9Uk/gnSpi0/8mrsIp5eCMAACow6mqlPpoqCelReCcKrWsZ6rCILeUDDi41YlliulGzAwa7bWuTrjpDAIIKwPV5SbLr0IivBRX5mgAIl87GH7Yn1NtIdDB9Mxv+IN9eNaUk+JaAb8DvrTuIuvJo+HHAB9160AqqqMoINlP86XG82z2FngQgXHBUCDiLQcF0IFkwAFj0TgMCBSiiEaLE70kwsSV8UE+vMzvQKYKcBGVPEgbTUPnKlh9PASjQhX+WQGAYtiEDkBzn8IogHOgQQAQUNdNAVPBp00ACrDpRATrxTq6Nowo60gOmwDg4d97EK9K2aRfnuG0knfkad7d6CUDBCABco2IiBORNCCl6NcCBXBudOQG3ZZyNuDZrgOhLCB1nh7aPeZkmAwN9yJu25SRtTkKorGsjecUsHjUBf3Bs4IILXiyymNiMUOIXlIhwsPvbrCNn4gQ+Q5AD/runyok6IAEVCsGRoFY6nCAMQFHnvM9Esgj0EggzQTJ0HKDMAkQgQgMwg6i/CgAHKMq8/0axaUDIA1FkJJM7lCJvobH+fI4Rl/qeIFtBAQdSzhDHeJAFmVagABEjWIhCwOgAQAAHOgAYAlmE+O0GjfgnIWAXItxoBzC99zViEBLiHwBo+TCUtCEE3AjCC21FCWzbMxdLEVJkPNE4RW3ngIGCmAQc48YlQjKIUnxiAJ5LEABVQhAYJoSfW6UKEJFQEMozGgPoNIIsAgIDrAPDCZcVQERUwQBDfcZrUrKY1DcijHvXIxgCgz424MBqRIOBF5o3jA5c54CPOB0NJKAAB/0RS36juOEdFkAIEHRBByagTgBwERwc0MCIvLsDDPZrylKhEpVoC0D5CDKlI3kOSB5PBLVhKgwGyRMb9ElA/VgqiACIcBPZgGUMFtLJ7g5BlJalRR/O0ZopOZKMJAWmLFULjAAj4Yw3zeIxp1g8SdeKeACAwSSfNUSCCqFpiQpCC4FzgfykQgQN2Vw0DBPOX3KOTnVKjp2N+sXwLsBP65jfMZvgyjTQURBvrhwA7ZWw0FdpnIZeZiQyRxpyMGKMByvhGTKgxmQGYKEUXqb6NfnORIMTQQTFaQ5DgY3FHbIR/NJAOd1SwNEvKYD4/BYBQAYCD7ftgCMt3ANUYQAEvfP9fM84oiBXGMAEupCUgS0MAOQIgjoIAVUdHigklMYmlYkyNAXi5VUucdDT+5CpJd3lSRwggoR60JZ8OoEyunksjiuDIzBCSgCIlYHviUZYFl0QkpA11hAtRQDJeuIxmpFCYBtiT/KT6zQqKcIaEsKBaK8pKPZUKEgQlUlkr8dGshnSzkQgtM1Ir1SSttDUSsBO0uIoNbUDnGz70CcYscQCmNoJ9lljAee6nrN2itqu+7OtszUdLpd5iGdfM5nFB29zVgtMAfxxnOVsjy6O6YwHvC0D8FlpWIiGJhOQdYWRLhSTCouaegwCf+A4bRkngMJ4i+4lxKdFbNDpCdSJtBFX/5bjf/U63Es76LEmjMdpKCNKPAT4wG2nZWEl8EH6ieq1CEbBGa1hTEFBNL7cGkAz0UlYADAhAFsEHDQ6qBnt1FYSLPQhCFtb3EyBIT2eM5lBKQOBo8LVFnezkX4UercMSTvIcJxthXJRWmCdeBDMMIAAT0w/F1jUt656sZW6B8U1c6psCmvw9MatjzIwQM5mVzGbEleZ+Ma4GMMVoy2K28hnYw14fiTnCVyaAATdOAPdkSYDW6sKWgsBlmxfNaAk31LDtgABc0/vo8S2gjESa8JUJwQAOd3EQahwyPw8KlC+rF7uNTrWqKWrMdzgVxFHd9ICHuoxdkDeDSOr0UjsI/2MAaPWnCAhqjU1dVAB4d9XITrayr7deDIrYsod9n6ZheIDwDVI0rxzAPQf7SsPaOLGGXra4x01u4S6XGgaWRH/Jze52J3vW60h3JNbt7nrbW8lDxuI6eAxpSfx4mvcOuMC5imZ2qJkSuOzbwBfO8IY7/OEQj7jEJ07xilv84hjPuMYt5lOF5C/g3tu4yD2zQrg25+OT6PgkTsMtlOuvr/C7UMg523JkPxJ+QbbEzH85WpWP3CIFKMBGJbHzlDeYEkV/Off6GudqJL3NHFaoyXXu8kb4/OcJGY1iRTjMADQrvMItUm8jqYBaE+kAVQ2APXu6VLI7I7wwByHLsVmk0v9Yu4PMEzSox0eA0cCPATBHzZ4R0CwV/zQBc4ekkdL490UjAFoWGmEymLSn9xmgfeFlVuBHA17WGFTxCzB72IkEjQIofupYPwYIBcDdkK8dqzsfQNLCQ2X1MsDnsneGYwdwAAuxHAJ8Io0AOoiAo+9M7wptTchHg8beLkBPSDpPHIEf1zQGX37EN/5mFQDzAhhzPODtaWs0RM308V0Xf/Tpao3GdkUkAIRBj2taU4+J8J49/OKBZeQB71cAdDo0aKULS4JigRca48F6ukAALKdtCRh4AYB6RIN8acR3CvBK5KMAa4d/hQZip7WAInRRsASBEvZ+kRd+PsVybMd/RGL/gDJ3IepHVazUcQ82eetDavSHXH+DMXqiLGsHFFm0DKqBAH9WfINQe2QUKkB4eM5QGgi4hL+HPjs4fGt2fEvnSxcFQin2fPhjWkhCfRUwAPH3hL4mfHjHaAggQudBPkzSfiiIhKclhM6ARt7zggBQQT11L8xXhzTYPfN3g5SQANoUUHvmdYUWSaTCSorXJF1HGmm3dqFCd+WxhGx0fSynWOI1HtbGQq8TeISXgGn3PgtggbYGP4U3Zk1Sie8DSXZXJDk3XRJQJME2eHvYhgIAiU1yiJHXfkUyAKVRa6EYSXsYgH44jMRIIFVXjMiYjBLydMrYjM74jNAYjdI4jdRY/43WeI3YmI3auI3c2I3e+I3gGI7iOI7kWI7muD/uxYDnuI4/92CEJAkz1mvsOI8Y92HYpE2O8GmCwGX02I8R92T66AiBJoL+WJD3dlY2mGantY9IZpAOaW8AuZCPMAC85nUPeZECB10VIl3zlm2tiJEgKW7uqBpNowhwE5IouXCawwgbAGYp+ZL2tgEriQ8aMCUweZPutgEy2TQgoCXHg5NAuWykQE8AsAK4EZRIKW6kIDBEmZROuWj9cHuF1Qwl+ZRW2WiqowzndpVcyWaq04ddGZZKBniRdYZieZaMloRouZaoBQExFFAMkFuN0AAoAERseZeSsgkTFkml0RuSYP85H6ADiYSXhMkpNSE4i6ATTTEBOYQDO9RDhRmZXKISVUkILtUI/TMVBSMIAWSTI5WOHymZ0IgWTTkI6PQRvvMYLcNAW9E5ahWPFimaFhN42meYNSOXkmMQpglTMGABeMUIlkE5IxWQ/IiTFyZeTYcoIykJFYQkVVWbiMIZliAWVTMVT+E4jPCYuOk5A5mU4fRLdiQr9siRkKBvGyYhIkYI5oVYUQIQmLA42mAZiEEJ1BEoNkScDZmSw0cI5skpEUlmuSh56BllI1Ziu1CZEoQBOqBJlRAcGGCfNkSRLxabQWlO6sgpCAmW/Olf+xkh6QkURlNlLqkrGICdkuCgEFr/Q6DplB0qCP25Kf8ZCbzknLXnoXWWVX+DZ8wwogmKCSgqm54zGtzDJFOYIhp5j5NAmylCaXZSGs+AaTxaCSBARA36TikKpA9znJ1oLMuJoK4RJ+nFhOhDPrVGDRHAH1X6oBy3WgGKpUQzk4pAARoApgSaRgYlQtI2DWfqo1bKce/Te8y4LeAVc9I0SH+jpD21U8f4kDu5CCCAmLwiAVtppmhKCT/6MKARdG36CBFgClH6HR/WQuOJPs3pQbW3RQjUhKilk3AKAAVRPEfJKZKKEHt6CZd6MYi3o4tKCJ1qPUDCj//Zn/uJqnszqOIlP5M6R0PZCC1ZmkCiJ3aSUuxQ/6uWcKtcYh/Q9EQsEh7WtquD0Kuf6h1zlllvhFYhZ4K25K3pEqohlqyQsAu9ajFLyQg1aSxipqG5QK1peqUR4gA6gAEAG7ACiwHDEB5+p64AAK5wImmKEKwcCn+K6jn8qKrVE6/yKgivuIIMwK8jtad08xB9aiYZ8C6SQCF9hbAKayav1kJHKl0zaqrNQKxTM67C5K6zkrAnWS9x1D6PhK9ctac0wKCTYK00IqfQ8w4payYPhkGFCmEcKFr4FFgSO2k22xw4GzdxhLA/iynymRiR4AOEAiQRwC4pYAGwZAHAYwtJK44r265CY7FEM3xqB50UVRA5hB2kBBWM0hHk4P+lzLE0R+EuaEsZHlC21nELayuOS4usb5uzFoOBRVYSFJAB28kch3RE1PEBVKoIkJMIr1G5eoECmEIwmzsIBnIULQCp9uWpVwmvjpsub6UaGKi16pABGiACOgYnvfM7XiK0gyA8AgIKYfsdDfABUTE6absI4oIdH2CXMAm66nm1QLIBnhkJrXCcq/W67GAfIgA9PiBPzpof/fMclvEindkI9VC9kFBHqgFW7NABYmI3tvIiONABywS3B+aXSAcK2usZh8QVNSUJq9AIdwG9tnC5hNANuBUnOEQUHqBDpASZjuASKGCi6xuJ7lu7JHsjFqwIQpEVIlCZ62lljRRQe5L/nEGCv5aAqDIrK4qZKBPwAWlBF6Hgt+6gTgCAX+ErFo1wmj3FpoyoYZbQwIygV/37HZdbuOD7CSigupFgURtStbhAARNAvsUhCV2jFROgKqhhoNPmRim2YhAQmjSiwpRQqs+ZqFKbLpcJCbVVohEMuvkQAbZ7KOxLSS0sCW8MAD7gwN4AG41ACj85CmBBeYCqgEI8CeMLCTMVwEHSOx9AU5awDUNSg8foVU0ixbcwAjsSHEPLHxYwyFMmol+sPilGt2V8xI0grBC7xunCMI9wV2l7vpHwFZEjCCoByHF1i+eRx7GMApo7CC1gRMfbEXDjw65wF4mqqUHcShmMmrw7/wnBqUgS0gAGPAiGvKmuYQ55sie/UTKefKL8gQG29CALkGejyGe/+IBFOiBmrG7nOnnp+jA4IQ4wZcGtCUTYMDyKwAFv41oa0ssRqwlOobeE0JvR3MiD0MaTcBCgcRrYg8iwVLVOEVOUsEOqbCyZWgCRNwJORCTKPCrKlRBjCx2V6gjhjBRw86ThVcod1Wn5KbYZvQisrMbdQ7twwsODcBheywid288O0KqLYB80hcm9PM+SYLsW8LGD8L22lcPg+8KYwK1Gsl2S4ABHiwk+wLHp8tC6mrB5FBIJpskHXMWVccWRkMWKscVSBg1lemve539ESAnnkl9KUdfXbA4vm//GvrwtPVE2vhsCt/IBAUADao0dYbM8iiM222m73fxZfU0IvpPVj+ANVoO3key8kGCwVZ3Ij+AADFQJaro3VB2oJzGynBkAHUwINwLCIoyntnZi1ZY9lFA8T/HH14wQxcOYOSBAlKAST2tdkX0sBZERVBo2LdDHisEyh8uZMaMSwqkJIg3ZA/2uHgADq53ALcA4URFBlmCyzQxiVQvatjDaccPZpn0S8CsIDREJ7b0g9qsOcsnTnGnMZaHUR5HPAXEb4fs6S6Mg3kIDPS0IOBAAaRs2ms0IY23T2swIu+A/9GkBEeHdJ0HemWDeM1uFOE0RxXu8vwmcpMO8CW4J+kv/CIAd2gr9E7tL2UUU3UN9m2rVHTmgRI3gAzgiLOHaPEgR2oySKUxh4ZiA4RSHAi9Cuo+zKC1wLesg1YIAmKWrQINpEkncCGDD2IvQE5u1ED5gvJCAA1+C45Oy4z460+8A5Jcg5FyFAp3qxO0gH4HLGClAuPHU3DAQH21OCwCw2wbDme10AThwHdp5EUT8NRiQAo+hIDADpzqd5YNAA8nbCN0L5krx4Dz+EGTuDmY+yVxtQzVBxdSsDiU9CGV7tmlrAZeeuI2wChGgAUv9u77pSVTxAZHOmb2tvtawyFqRAwFgATkw45JxNSKgNvV8XNLAwSf6IqQU5hBuq5e+CHZ9/9WVLgloTjT8TAkOkAEgoOQJYbSTALbXjOro+zyEIJiOqQjlSwiLMeLX8OHeYNEAREppayBzcWARI+1+key28OyRQOljngv6DgmZLtqbni6zUwm2uzSfbg2orSYhjAng7jHsAkpMjR3fQggWoO6Z0AAR39yLQDCl7sioVe/9ce853gj/frPLXq3Nrggn7wgBTwnTbjEugQk0BQInKV9EMj6whBz/OrA+rwMDvwgPP9Q7ggGLQuXRjBQYjwka39Qh7gjBcB0Xn2Qiz8gkTyZL7+Bizuz+nvXOHu39EfTGoi+YACgyqSozJlSamPHZGkX9zQhDrwhNLxhPjkQkq/QIMf/3AJD0KI0rXq8/PXP3kEAckh4gKrL1Kt/1/g72jCz2vDICza6XDhAvAflPvhH3Ju4XBDMJsz717zD3PsMoT+/59D4IvvsIaFv4kKIiHpDyDbryikO5HWDrk9ABjP8IMf8wLS/0E/BEEr6BtQS1vtbOFIH5gzD3OIDWkKADwkH67TD3F4Apae01zk/s0MEuMsXlC1LyjLD73e8ft59XIUDhImETK/ASurkWKBAApw/zIsDmFlPwmEABHVCXeQSw/eRlg5BvkQsIAIKDhIWGh4iJABERAAGKhA0WghcXkIMpOYIWDZeeipKCOTiflZudn6mqq6ytrI+CHiKkibK0ABf/sK4OGa6DGxoYOjCpHjoBPheNqhwoExnOJQAcHR0chgELggu6vxooFBkTFiGpIRbPvurr7IbAvhQdIIcICAcABAiO2oMKAAIQ2glk5OhTKFyWPPmYBICTwEQHLfgoldDhw4sYMw7qBuPDrUIhaLQglEudjg/LWq0IoIEGhlQpPuSAkatXqhUTRogDR2jEBGmEsm3rtijAikEURgS44AGSsQARKGicShVABgcANoC4lgrYvEMHCgQIYEDCPkIMIAy4V1UVQaIQGV4Y6clUQ1RUD9q9pKMi3raAAx+akKOcIBgiJBIKceGDDkIxA/wVDIACCg0bAOAsDAkDDREYUohw/8A1lYarGoAWKpFTqiChALghddAhcyEODj6kSBSTNGXBSaOuAjbBQQkQE4Rf2jDhqy8BBQT8xngQ8Scau++2PZjpE+hT08O3pQDiA9NYOEQEsGBBfY6XgjBYSC3ON+UG31xXVnreUIgcHsmXmkqtJYJbba+NpaAgDTSnnyH4uVSIZxpMJl5Gm6FjkycrHRVBcyU4kI4izG3YygH3AHRhOwcBIEJ2imDwQVPaVXWQBwEYFuMHg1i04o8PbeDAi4thYORiLSSHVAQBjCCIAAaMBQEDTyoIQVgJCHJAAASk8qGJg+CmGyEeNNZCCEmmBEkCCkoHQIWefHlWbI/4MCIkm/+V898ERwGZUQMdfAcABiJ0YGEhlmGGlFIRlKCBoYg0CCYrCxhgwFp+ailWAAPwA0mLotGYCA0J1ZgXQwDogOqopfqY6auuOGoBfIaU+QEIDwqCGwAVCHUAAgFJMIA/YRFQQJYAbNnlJRTQZlukLb0kiwU03VoaJML6Q4AB0uUKygRzyubDs8yW10KT3sLqSjMeAeDBTILg8AEK10aSnyHN8ImTfYNkEMCkrTDgD6z1UClAAAODsmoONIhqSAs0EOKqRi16IJIiEEt8qLocX/JhCw4D4MNo5B4CgVmCKBAAAwZUUMixWnJ5SYO4ckhYCD4QCmkqLQ8igD6rSAWbbK3/aFVyx6xQ8KEONJYZAMjuHqPcIB/2GakDpzE5gmvibIy0KipTKcjJM4ug47sSFgIDDQ0PEoIIqk1VQtuChMQZSBbQ7S4NXn/td5jlJQTDfAAbMoCbyQawJVuDbKrgsgqI/aCcqSQVAA13fqLsIAsM8PfniMhKDEgtmFe3hoI0i+AlGWjACwidiHM06J8QLUgCyCpieX8AyEuqkRdYYPogjaFgFFXiBAqjB+e2kIKRKZzL9CDy8kT79YM0MGSa6ZqMMgBhG+CpIDAnTsABlvaMIDXWtMLBCt1D0vOTQGP/t5AiTJSIfPnHV6g4NfuE0prDAeTMzn6KCNsgyOYJMS0v/wWqsoAOUiCqkTmgE8Cw3kPIM4FOyIpWjGGPBUahI531DYFfy8BWVMENbfwqWAPoUrHKtzl/qOhDPnFSeBIwLHxwyxVj8YftUBgk84QMEaKhVrw+YDVVkIclByQiIgaAAIMhTBURotUhBncaQiTqhKrYQAccMLkJnEkR58icFNd4CShJSWxsGksCsBSzLqUFUwDAT9ymE8cAIO4VA/DcENmojlCUyilmasrEmBE/QhIiLGPpFIHuRibuHUIcavIFTjKZusAdwmlbc6QopwKdPzrSj9wa5ChXEQq4oNF5plol0shjROrNq16FEOM/AhAQABwOEQfr5S8vE8U8Dkl/gv/oDS5lyUxWoOgfvRxlNg52sGayopWuWKQ1X4W/5xUKjJX5h6W08ctDQEl8vpSOBhXROmpRCJzbjGchKnUpxokyGwwYwFjkaZBJuNIT2uQnkBylxjYezgD5lI4DFsrQfxw0oUH7EJ8ESlFPCKyZQuHGPyvKIH9mE54cBQ4rBDAAlvFQOg1IqUodatJyroIDjQypTGUJG33OFEIebUVAb/o5ku7Sj3lUaUod+lNT8vSoSE3qIbCpU5AqFUg+9SVQGdrQqOrTqE/NqlYrylRW7HSrmYoqN7BKVDqRFaxoTasju7qKr6r1rXCNq1wFwlZVuHWueM2rXvda11Tcda+ADaz/YJXaV6fgwAN/HaxiF8tYa2YgYoe8REzIwbfGWvaymF3lhwKFzM58JjSjWWZmR0va0r5KdZlp5+gQgSbzcHGPpo2tbGcbGJrpZ4BQM4SZ0JScmNL2t8ANbip8ArACDk8QI5tV9UQr3OY697m6qgZzjdk/0XhzZ9DNrnaFi4GcfEK1MMjBRLdL3vLKFgew1d2H0GXe9rr3rUNzZefGgoBlsYID032vfvcb0vgaolf8SMBZ+UvgAqPVv4VgoIEXzGD4KmifALgoAAowvgZb+MJI9S891wKB3GH4wyCuqH8PQKXo9MpNAg6xile8SgQbqwBPilIACmBfFtv4xoQ8AElr/4zjHvuYiJGb8IB/TOQiq0sCloKxkZfM5I4dIGFNjrKUp0zlKlv5yuaFziFkBkQeb5cAG2VFdBQ7ZjBz+RNgxvJvFoCASEpHy9jwMiLSHBQ5x1YBbeaUUemsDi2PWa14pm+FyScdBAz5EHxORKLV7Aowu0nLcC7EmV9h59KiD1kqKsSi1fHntCIAZQLwcOOkY4BKKzrMjH5Ihw0BnUoZTB8ByDM5pbO4UmbjEb96HAAgQF+xlfZnhuB1rBmQ5lwHIEvGDsimCsAAKKFIfH7Os6ifigAl1zE2notOHDuloCwFmpdb6nWaNXpsqcoxzSTVZxV/2sNUT1E6ZvacliUpSf+gQimdidNxDPHxCAgomUs/o5KhYxvqQgQcAIZO86rRpwB/+6ykDBi4BOrxZhgXICAqg/JTFRDHAihgc50TsiNqzI1m128QW6pAoksuiG0pAN1rYdkCFGAAf0ggmu5OcO5CDukCVMBzI+f3AX5ZayWnWZIj72O5TRvVQSg9AUd/cOc8hbsnIYuKT7K4m2CT1gTYQ2YhHzPY86y4A/AaATN33ALGTfZ7dE5bj4Bzp8jNqZwfolegljeMWTbwoAtrwlk6mI6N3m+MA3zds0VfLwFy8Jb328MOfxLEfymBAvzSz9LplT2pHWAYC8XyIpfZAMyi+Yd7PcLZODrpFdc5tqCXW8mdornG7T7PPF9eyUgWm4L2beY2D97x4FO3zITN9dLmg77SIf7acd32ZE94LMwmqcCmafE2oVUCCrLHTxGQbenI7GCcUhz4Ux8lfS6f3Yp7MI3jDnttjH/atIdEp+NP/5z3ytf1z7/+98///vv//wAYgAI4gARYgAZ4gAiYgAq4gAzYgA74gBAYgRI4gRRYgRZ4gdsVCAA7);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Modified with permission from: Tilles, SA, Slatore, CG. Hypersensitivity reactions to non-beta-lactam antibiotics. Clin Rev Allergy Immunol 2003; 24:221. Copyright &copy;2003 Humana Press.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_60_9154=[""].join("\n");
var outline_f8_60_9154=null;
var title_f8_60_9155="Uterus didelphys normal vagina";
var content_f8_60_9155=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F77029%7EOBGYN%2F75163&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F77029%7EOBGYN%2F75163&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Uterus didelphys, bicollis, with normal vagina",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 348px; height: 284px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Pediatric and Adolescent Gynecology, 6th ed, Emans SJ, Laufer MR (Eds), Lippincott Williams &amp; Wilkins, Philadelphia 2012. Copyright &copy; 2012 Lippincott Williams &amp; Wilkins.",
"    </div>",
"    <div class=\"contractual\">",
"     <br/>",
"     <a href=\"file://www.lww.com\">",
"      file://www.lww.com",
"     </a>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Septate uterus: complete with associated vaginal septum",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 354px; height: 291px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Pediatric and Adolescent Gynecology, 6th ed, Emans SJ, Laufer MR (Eds), Lippincott Williams &amp; Wilkins, Philadelphia 2012. Copyright &copy; 2012 Lippincott Williams &amp; Wilkins.",
"    </div>",
"    <div class=\"contractual\">",
"     <br/>",
"     <a href=\"file://www.lww.com\">",
"      file://www.lww.com",
"     </a>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_60_9155=[""].join("\n");
var outline_f8_60_9155=null;
var title_f8_60_9156="Naphazoline and pheniramine: Patient drug information";
var content_f8_60_9156=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Naphazoline and pheniramine: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?31/31/32243?source=see_link\">",
"     see \"Naphazoline and pheniramine: Drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F199791\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Naphcon-A&reg; [OTC];",
"     </li>",
"     <li>",
"      Opcon-A&reg; [OTC];",
"     </li>",
"     <li>",
"      Visine-A&reg; [OTC]",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F199792\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Naphcon-A&reg;;",
"     </li>",
"     <li>",
"      Visine&reg; Advanced Allergy",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10016907\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691589",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to ease allergy signs.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10016906\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2702573",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to naphazoline, pheniramine, or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10016911\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697225",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have glaucoma, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697258",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have heart disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697265",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have high blood pressure, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697349",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have trouble passing urine, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10016912\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698045",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Eye irritation.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10016914\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699086",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sudden change in eyesight, eye pain, or irritation.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10016909\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694913",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       For the eye only.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695783",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take out contact lenses before using this drug. Lenses may be put back in 15 minutes after this drug is given. Do not put contacts back in if your eyes are irritated or infected.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694779",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not touch the container tip to the eye, lid, or other skin.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696124",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tilt your head back and drop drug into the eye.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694401",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       After use, keep your eyes closed. Put pressure on the inside corner of the eye. Do this for 1 to 2 minutes. This keeps the drug in your eye.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695618",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Space each eye drug by 5 minutes.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10016910\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696583",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Use a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696485",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not use 2 doses or extra doses.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696540",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Many times this drug is taken on an as needed basis.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10016915\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699264",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Protect from light.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10016916\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 10891 Version 34.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-203.80.222.8-D1AB04EF24-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_60_9156=[""].join("\n");
var outline_f8_60_9156=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F199791\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F199792\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10016907\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10016906\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10016911\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10016912\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10016914\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10016909\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10016910\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10016915\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10016916\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?31/31/32243?source=related_link\">",
"      Naphazoline and pheniramine: Drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f8_60_9157="Birth control; which method is right for me?";
var content_f8_60_9157=[" <h1 id=\"patTopicTitle\">",
"  Patient information: Birth control; which method is right for me? (Beyond the Basics)",
" </h1>",
" <div id=\"patTopicContributors\">",
"  <div class=\"rcTop\">",
"   <div>",
"   </div>",
"  </div>",
"  <div class=\"rcContent\">",
"   <table>",
"    <tr>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"UTD.htm?8/60/9157/contributors\">",
"       Author",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"UTD.htm?8/60/9157/contributors\" id=\"au7462\">",
"       Mimi Zieman, MD",
"      </a>",
"     </td>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"UTD.htm?8/60/9157/contributors\">",
"       Section Editor",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"UTD.htm?8/60/9157/contributors\" id=\"se4464\">",
"       Robert L Barbieri, MD",
"      </a>",
"     </td>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"UTD.htm?8/60/9157/contributors\">",
"       Deputy Editor",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"UTD.htm?8/60/9157/contributors\" id=\"de4555\">",
"       Vanessa A Barss, MD",
"      </a>",
"     </td>",
"    </tr>",
"   </table>",
"  </div>",
"  <div class=\"rcBottom\">",
"   <div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"patTopicTool\" id=\"patTopicToolTop\">",
"  <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"   Find",
"  </a>",
"  <a class=\"toolbutton printicon\" href=\"UTD.htm?8/60/9157?view=print\" title=\"Print This Topic\">",
"   Print",
"  </a>",
"  <script src=\"file://w.sharethis.com/button/sharethis.js#publisher=357881b8-c7e3-4c31-b7d2-242aeb1528e1&amp;type=website&amp;post_services=care2%2Cfacebook%2Ctwitter%2Cmyspace%2Cdigg%2Cdelicious%2Cfaves%2Creddit%2Cxanga%2Cstumbleupon%2Cblinklist%2Csimpy%2Cyigg%2Ctechnorati%2Cmeneame%2Corkut%2Cmixx%2Cfunp%2Cfresqui%2Cmister_wong%2Cfriendster%2Cfriendfeed%2Clinkedin%2Coknotizie%2Cgoogle_bmarks%2Cyahoo_bmarks%2Cfark%2Cnewsvine%2Clivejournal%2Ctypepad%2Cbus_exchange%2Cpropeller%2Cwordpress%2Cblogger%2Cblogmarks%2Cwindows_live%2Cfurl%2Cybuzz%2Cdiigo\" type=\"text/javascript\">",
"  </script>",
" </div>",
" <div id=\"patTopicMiddle\">",
"  <div id=\"topicContent\">",
"   <div id=\"topicText\">",
"    <p class=\"headingAnchor\" id=\"H1\">",
"     <span class=\"h1\">",
"      INTRODUCTION",
"     </span>",
"    </p>",
"    <p>",
"     There are a number of methods available to help prevent pregnancy, with some of the most popular including condoms and birth control pills. Deciding which method is right can be tough because there are many issues to consider, including costs, future pregnancy plans, side effects, and others.",
"    </p>",
"    <p>",
"     This article reviews all methods of birth control. More detailed discussions of hormonal, long-term, and barrier birth control methods are available separately. (See",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?4/16/4355?source=see_link\">",
"      \"Patient information: Long-term methods of birth control (Beyond the Basics)\"",
"     </a>",
"     and",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?22/2/22563?source=see_link\">",
"      \"Patient information: Barrier methods of birth control (Beyond the Basics)\"",
"     </a>",
"     and",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?21/32/22021?source=see_link\">",
"      \"Patient information: Hormonal methods of birth control (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H2\">",
"     <span class=\"h1\">",
"      EFFECTIVENESS OF BIRTH CONTROL",
"     </span>",
"    </p>",
"    <p>",
"     Most birth control methods are quite effective if used properly (",
"     <a class=\"graphic graphic_table graphicRef70218 \" href=\"UTD.htm?12/56/13197\">",
"      table 1",
"     </a>",
"     ). However, contraceptives can fail for a number of reasons, including incorrect use and failure of the medication, device, or method itself.",
"    </p>",
"    <p>",
"     Certain birth control methods, such as intrauterine devices (IUDs) and injectable or implanted methods, have a low risk of failure (pregnancy). This is because they are the easiest to use properly. You should consider these methods if you want the lowest chance of a mistake or failure, which could lead to pregnancy. (See",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?4/16/4355?source=see_link\">",
"      \"Patient information: Long-term methods of birth control (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p>",
"     Overall, birth control methods that are designed for use at or near the time of sex (eg, the condom, diaphragm) are generally less effective than other birth control methods (eg, IUD, birth control pill).",
"    </p>",
"    <p>",
"     If you forget to use birth control or if your method fails, there is an option to reduce your risk of becoming pregnant for up to 5 days after you have sex. This is called the morning after pill, or emergency contraception. (See",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?23/32/24068?source=see_link\">",
"      \"Patient information: Emergency contraception (morning after pill) (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H3\">",
"     <span class=\"h1\">",
"      CHOOSING A BIRTH CONTROL METHOD",
"     </span>",
"    </p>",
"    <p>",
"     It can be difficult to decide which birth control method is best because of the wide variety of options available. The best method is one that you will use consistently, is acceptable to you and your partner, and does not cause bothersome side effects. Other factors to consider include:",
"    </p>",
"    <p>",
"     <ul class=\"bulletCompact-block\">",
"      <li>",
"       How effective is the method?",
"      </li>",
"      <li>",
"       Is it convenient? Will I remember to use it?",
"      </li>",
"      <li>",
"       Do I have to",
"       <span class=\"nowrap\">",
"        use/take",
"       </span>",
"       it every day?",
"      </li>",
"      <li>",
"       Is this method reversible? Can I get pregnant immediately after stopping it?",
"      </li>",
"      <li>",
"       Will this method cause me to bleed more or less?",
"      </li>",
"      <li>",
"       Are there side effects or potential complications?",
"      </li>",
"      <li>",
"       Is this method affordable?",
"      </li>",
"      <li>",
"       Does this method protect against sexually transmitted diseases?",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     No method of birth control is perfect. You must balance the advantages and disadvantages of each method and then choose the method that you will be able to use consistently and correctly.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H4\">",
"     <span class=\"h1\">",
"      EMERGENCY CONTRACEPTION",
"     </span>",
"    </p>",
"    <p>",
"     Emergency contraception, sometimes called the morning after pill, refers to the use of medication to prevent pregnancy. You can use the morning after pill if you forget to take your birth control pill, if a condom breaks during sex, or if you have unprotected sex for other reasons (including victims of sexual assault). Morning after pills may be hormonal (eg, PlanB Obe-Step&reg;) or nonhormonal (eg, Ella&reg;). An IUD can also be inserted for use as emergency contraception, and is more effective at preventing a pregnancy than pills. Detailed information on emergency contraception is available separately. &nbsp;(See",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?23/32/24068?source=see_link\">",
"      \"Patient information: Emergency contraception (morning after pill) (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H5\">",
"     <span class=\"h1\">",
"      BIRTH CONTROL PILLS",
"     </span>",
"    </p>",
"    <p>",
"     Most birth control pills, also referred to as \"the pill,\" contain a combination of two female hormones. A full discussion of birth control pills is available separately. (See",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?21/32/22021?source=see_link\">",
"      \"Patient information: Hormonal methods of birth control (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H6\">",
"     <span class=\"h2\">",
"      How well do they work?",
"     </span>",
"     &nbsp;&mdash;&nbsp;When taken properly, birth control pills are very effective. In general, if you miss one pill, you should take it as soon as possible, If you miss two or more pills, continue to take one pill per day and use a back-up method of birth control (eg, a condom) for seven days. If you miss two or more pills, you should also consider taking the morning after (emergency contraception) pill. (See",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?23/32/24068?source=see_link\">",
"      \"Patient information: Emergency contraception (morning after pill) (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H7\">",
"     <span class=\"h2\">",
"      Side effects",
"     </span>",
"     &nbsp;&mdash;&nbsp;Side effects of the pill include:",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       Nausea, breast tenderness, bloating, and mood changes, which typically improve after two to three months.",
"      </li>",
"      <li>",
"       Irregular vaginal spotting or bleeding. This is particularly common during the first few months. Forgetting a pill can also cause irregular bleeding.",
"      </li>",
"     </ul>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H8\">",
"     <span class=\"h2\">",
"      Progestin-only pills",
"     </span>",
"     &nbsp;&mdash;&nbsp;Unlike traditional birth control pills, the progestin-only pill, also called the mini pill, does not contain estrogen. It does contain progestin, a hormone that is similar to the female hormone, progesterone. This type of pill is useful for women who cannot or should not take estrogen.",
"    </p>",
"    <p>",
"     Progestin-only pills are as effective as combination pills if they are taken at the same time every day. However, progestin only pills have a slightly higher failure rate if you are more than three hours late in taking it.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H9\">",
"     <span class=\"h1\">",
"      INJECTABLE BIRTH CONTROL",
"     </span>",
"    </p>",
"    <p>",
"     The only injectable method of birth control currently available in the United States is medroxyprogesterone acetate or DMPA (Depo-Provera&reg;). This is a progestin hormone, which is long-lasting. DMPA is injected deep into a muscle, such as the buttock or upper arm, once every three months. A version that is given under the skin is also available.",
"    </p>",
"    <p>",
"     DMPA is very effective, with a failure (pregnancy) rate of less than one percent. A full discussion is available separately. (See",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?21/32/22021?source=see_link\">",
"      \"Patient information: Hormonal methods of birth control (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H10\">",
"     <span class=\"h2\">",
"      Side effects",
"     </span>",
"     &nbsp;&mdash;&nbsp;The most common side effects of DMPA are irregular or prolonged vaginal bleeding and spotting, particularly during the first three to six months. Up to 50 percent of women completely stop having menstrual periods after using DMPA for one year. Menstrual periods generally return within six months of the last DMPA injection.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H11\">",
"     <span class=\"h1\">",
"      SKIN PATCHES",
"     </span>",
"    </p>",
"    <p>",
"     Birth control skin patches contain two hormones, estrogen and progestin, similar to birth control pills. The patch is as effective as birth control pills, and may be preferred by some women because you do not have to take it every day.",
"    </p>",
"    <p>",
"     Ortho Evra is the only skin patch birth control available in the United States. You wear the patch for one week on the upper arm, shoulder, upper back, or hip. After one week, you remove the old patch and apply a new patch; you repeat this for three weeks. During the fourth week, you do not wear a patch and your menstrual period occurs during this week.",
"    </p>",
"    <p>",
"     The risks and side effects of the patch are similar to those of a birth control pill, although there may be a slightly higher risk of developing a blood clot.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H12\">",
"     <span class=\"h1\">",
"      VAGINAL RING",
"     </span>",
"    </p>",
"    <p>",
"     A flexible plastic vaginal ring (Nuvaring&reg;) contains estrogen and a progestin. You wear the ring in the vagina, where there hormones are slowly absorbed into the body. This prevents pregnancy, similar to a birth control pill. You wear the ring inside the vagina for three weeks, followed by one week when you do not wear the ring; your menstrual period occurs during the fourth week.",
"    </p>",
"    <p>",
"     The ring is not noticeable, and it is easy for most women to insert and remove. You may take the ring out of the vagina for up to three hours if desired, such as during intercourse. Risks and side effects of the vaginal ring are similar to those of birth control pills.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H13\">",
"     <span class=\"h1\">",
"      BIRTH CONTROL IMPLANT",
"     </span>",
"    </p>",
"    <p>",
"     A single-rod progestin implant, Implanon&reg;, is available in the US and elsewhere. It is inserted by a healthcare provider into your arm. It prevents pregnancy for up to 3 years as the hormone is slowly absorbed into the body. It is effective within 24 hours of insertion. Irregular bleeding is the most bothersome side effect. Most women can become pregnant quickly after the rod is removed. (See",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?21/32/22021?source=see_link\">",
"      \"Patient information: Hormonal methods of birth control (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H14\">",
"     <span class=\"h1\">",
"      BARRIER METHODS",
"     </span>",
"    </p>",
"    <p>",
"     Barrier contraceptives prevent sperm from entering the uterus. Barrier contraceptives include the condom, diaphragm, and cervical cap. A full discussion of barrier methods of birth control is available separately. (See",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?22/2/22563?source=see_link\">",
"      \"Patient information: Barrier methods of birth control (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H15\">",
"     <span class=\"h2\">",
"      Male condom",
"     </span>",
"     &nbsp;&mdash;&nbsp;The male condom is a thin, flexible sheath placed over the penis. To be effective, men who use condoms must carefully follow instructions for their use. Condoms are most effective when used with a vaginal spermicide (see",
"     <a class=\"local\" href=\"#H18\">",
"      'Spermicide'",
"     </a>",
"     below). Using the male condom and a vaginal spermicide is as effective as a hormonal method of birth control, and is more effective than a condom alone.",
"    </p>",
"    <p>",
"     Many people who choose another method of birth control (eg, pills) also use condoms to decrease their risk of getting sexually transmitted diseases.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H16\">",
"     <span class=\"h2\">",
"      Female condom",
"     </span>",
"     &nbsp;&mdash;&nbsp;The female condom is worn by a woman to prevent semen from entering the vagina. It is a sheath made of polyurethane, and is prelubricated. You wear it inside the vagina.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H17\">",
"     <span class=\"h2\">",
"      Diaphragm/cervical cap",
"     </span>",
"     &nbsp;&mdash;&nbsp;The diaphragm and cervical cap fit over the cervix, preventing sperm from entering the uterus. These devices are available in latex (the Prentif cap) or silicone rubber (FemCap) in multiple sizes, and require fitting by a clinician. These devices must be used with a spermicide and left in place for six to eight hours after sex. The diaphragm must be removed after this period. However, the cervical cap can remain in place for up to 24 hours.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H18\">",
"     <span class=\"h2\">",
"      Spermicide",
"     </span>",
"     &nbsp;&mdash;&nbsp;Spermicides are chemical substances that destroy sperm. They are available in most pharmacies without a prescription. Spermicides are available in a variety of forms including gel, foam, cream, film, suppository, and tablet.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H19\">",
"     <span class=\"h1\">",
"      INTRAUTERINE DEVICES (IUD)",
"     </span>",
"    </p>",
"    <p>",
"     IUDs are placed by a healthcare provider through the vagina and cervix, into the uterus. The currently available IUDs are safe and effective. These devices include:",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       Copper-containing IUDs. Copper-containing IUDs remain effective for at least 10 years, but can be removed at any time. Copper IUDs do not contain any hormones. Some women have a heavier menstrual period or more cramps during their period while using a copper IUD.",
"      </li>",
"      <li>",
"       Levonorgestrel-releasing IUDs release a hormone, levonorgestrel, which thickens the cervical mucus and thins the endometrium (the lining of the uterus). This IUD also decreases the amount you bleed during your period and decreases pain associated with periods. It can be left in place for up to five years, but can be removed at any time, and is highly effective in preventing pregnancy. Some women stop having menstrual periods entirely; this effect is reversed when the IUD is removed.",
"      </li>",
"     </ul>",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H20\">",
"     <span class=\"h1\">",
"      STERILIZATION",
"     </span>",
"    </p>",
"    <p>",
"     Sterilization is a procedure that permanently prevents you from becoming pregnant or having children. Tubal ligation (for women) and vasectomy (for men) are the two most common sterilization procedures. Sterilization is permanent, and should only be considered after you discuss all available options with a healthcare provider. (See",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?7/28/7620?source=see_link\">",
"      \"Patient information: Permanent sterilization procedures for women (Beyond the Basics)\"",
"     </a>",
"     and",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?29/2/29730?source=see_link\">",
"      \"Patient information: Vasectomy (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H21\">",
"     <span class=\"h2\">",
"      Tubal ligation",
"     </span>",
"     &nbsp;&mdash;&nbsp;Tubal ligation is a sterilization procedure for women that surgically cuts, blocks, or seals the fallopian tubes to prevent pregnancy. The procedure is usually done in an operating room as a day surgery. Women who have recently delivered a baby can undergo tubal ligation before going home. The procedure may be done at another time as well. A separate article discusses tubal ligation. (See",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?7/28/7620?source=see_link\">",
"      \"Patient information: Permanent sterilization procedures for women (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H22\">",
"     <span class=\"h3\">",
"      Essure&reg;",
"     </span>",
"     &nbsp;&mdash;&nbsp;Essure&reg; is a permanent birth control method in which a tiny coil is placed into a woman's fallopian tubes. The tissue within the fallopian tubes grows into the coil, blocking them three months after placement in most women. The coil is placed after you are given local anesthesia (medicine is injected into the cervix to prevent pain). A back up method of birth control (eg, pills, condoms) is needed until you have a test confirming that the fallopian tubes are completed blocked; this is usually performed three months after coil placement.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H23\">",
"     <span class=\"h2\">",
"      Vasectomy",
"     </span>",
"     &nbsp;&mdash;&nbsp;Vasectomy is a sterilization procedure for men that cuts or blocks the vas deferens, the tubes that carry sperm from the testes. It is a safe, highly effective procedure that can be performed in a doctor's office under local anesthesia. Following vasectomy, you must use another method of birth control (eg, condoms) for approximately three months, until testing confirms that no sperm are present in the semen. A separate article discusses vasectomy. (See",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?29/2/29730?source=see_link\">",
"      \"Patient information: Vasectomy (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H24\">",
"     <span class=\"h1\">",
"      OTHER BIRTH CONTROL METHODS",
"     </span>",
"    </p>",
"    <p>",
"     Some women and their partners cannot or choose not to use the birth control methods mentioned above due to religious or cultural reasons. Fertility-awareness based methods for preventing pregnancy are based upon the physiological changes during the menstrual cycle. These methods, also called \"natural family planning,\" involve identifying the fertile days of the menstrual cycle using a combination of cycle length and physical manifestations of ovulation (change in cervical secretions, basal body temperature) and then avoiding sexual intercourse or using barrier methods on those days. &nbsp;",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H31\">",
"     <span class=\"h1\">",
"      WHERE TO GET MORE INFORMATION",
"     </span>",
"    </p>",
"    <p>",
"     Your healthcare provider is the best source of information for questions and concerns related to your medical problem.",
"    </p>",
"    <p>",
"     This article will be updated as needed on our web site (",
"     <a class=\"external\" href=\"file://www.uptodate.com/patients\">",
"      www.uptodate.com/patients",
"     </a>",
"     ). Related topics for patients, as well as selected articles written for healthcare professionals, are also available. Some of the most relevant are listed below.",
"     <br/>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H311\">",
"     <span class=\"h2\">",
"      Patient level information",
"     </span>",
"     &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H14514083\">",
"     <span class=\"h3\">",
"      The Basics",
"     </span>",
"     &nbsp;&mdash;&nbsp;The Basics patient education pieces answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials.",
"    </p>",
"    <p>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?13/56/14211?source=see_link\">",
"      Patient information: Choosing birth control (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?1/22/1378?source=see_link\">",
"      Patient information: Long-acting methods of birth control (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?18/17/18707?source=see_link\">",
"      Patient information: Hormonal birth control (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?22/51/23346?source=see_link\">",
"      Patient information: Sterilization for women (The Basics)",
"     </a>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H14514098\">",
"     <span class=\"h3\">",
"      Beyond the Basics",
"     </span>",
"     &nbsp;&mdash;&nbsp;Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are best for patients who want in-depth information and are comfortable with some medical jargon.",
"    </p>",
"    <p>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?4/16/4355?source=see_link\">",
"      Patient information: Long-term methods of birth control (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?22/2/22563?source=see_link\">",
"      Patient information: Barrier methods of birth control (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?21/32/22021?source=see_link\">",
"      Patient information: Hormonal methods of birth control (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?23/32/24068?source=see_link\">",
"      Patient information: Emergency contraception (morning after pill) (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?7/28/7620?source=see_link\">",
"      Patient information: Permanent sterilization procedures for women (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?29/2/29730?source=see_link\">",
"      Patient information: Vasectomy (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?30/54/31588?source=see_link\">",
"      Patient information: Maternal health and nutrition during breastfeeding (Beyond the Basics)",
"     </a>",
"     <br/>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H33\">",
"     <span class=\"h2\">",
"      Professional level information",
"     </span>",
"     &nbsp;&mdash;&nbsp;Professional level articles are designed to keep doctors and other health professionals up-to-date on the latest medical findings. These articles are thorough, long, and complex, and they contain multiple references to the research on which they are based. Professional level articles are best for people who are comfortable with a lot of medical terminology and who want to read the same materials their doctors are reading.",
"    </p>",
"    <p>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/19/32058?source=see_link\">",
"      Overview of intrauterine contraception",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/8/4233?source=see_link\">",
"      Contraception counseling for obese women",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/8/26759?source=see_link\">",
"      Contraception for women with inherited thrombophilias",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/13/42201?source=see_link\">",
"      Contraception: Overview of issues specific to adolescents",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/0/32777?source=see_link\">",
"      Counseling women considering combined hormonal contraception",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/45/34522?source=see_link\">",
"      Depot medroxyprogesterone acetate for contraception",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/5/31833?source=see_link\">",
"      Emergency contraception",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/13/5334?source=see_link\">",
"      Female condoms",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/58/37800?source=see_link\">",
"      Fertility awareness-based methods of pregnancy prevention",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/47/3832?source=see_link\">",
"      Hormonal contraception for suppression of menstruation",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/38/20070?source=see_link\">",
"      Barrier contraception: Diaphragm",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/23/12665?source=see_link\">",
"      Hysteroscopic sterilization",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/27/3512?source=see_link\">",
"      Etonogestrel contraceptive implant",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/62/30696?source=see_link\">",
"      Male condoms",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/27/19898?source=see_link\">",
"      Management of problems related to intrauterine contraception",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/10/22698?source=see_link\">",
"      Management of unscheduled bleeding in women using contraception",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/24/39306?source=see_link\">",
"      Overview of contraception",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/5/18522?source=see_link\">",
"      Overview of the use of estrogen-progestin contraceptives",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/61/39893?source=see_link\">",
"      Overview of vasectomy",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/8/24713?source=see_link\">",
"      Postpartum and postabortion contraception",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/52/9031?source=see_link\">",
"      Progestin-only pills (minipills) for contraception",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/7/39034?source=see_link\">",
"      Risks and side effects associated with estrogen-progestin contraceptives",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/42/15018?source=see_link\">",
"      Surgical sterilization of women",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/10/41127?source=see_link\">",
"      Transdermal contraceptive patch",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?43/42/44712?source=see_link\">",
"      Vasectomy and other vasal occlusion techniques for male contraception",
"     </a>",
"     <br/>",
"     <br/>",
"     The following organizations also provide reliable health information.",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       National Library of Medicine",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://www.nlm.nih.gov/medlineplus/birthcontrol.html\">",
"      www.nlm.nih.gov/medlineplus/birthcontrol.html",
"     </a>",
"     , available in Spanish)",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       National Institute of Child Health and Human Development (NICHD)",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;Toll-free: (800) 370-2943",
"     <br/>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://www.nichd.nih.gov/health/topics/contraception.cfm\">",
"      www.nichd.nih.gov/health/topics/contraception.cfm",
"     </a>",
"     )",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       National Women's Health Resource Center (NWHRC)",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;Toll-free: (877) 986-9472",
"     <br/>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://www.healthywomen.org/healthcenter/birth-control\">",
"      file://www.healthywomen.org/healthcenter/birth-control",
"     </a>",
"     )",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       Planned Parenthood Federation of America",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;Phone: (212) 541-7800",
"     <br/>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://www.plannedparenthood.org/health-topics/birth-control-4211.htm\">",
"      www.plannedparenthood.org/health-topics/birth-control-4211.htm",
"     </a>",
"     )",
"    </p>",
"    <p>",
"     [",
"     <a class=\"abstract\" href=\"UTD.htm?8/60/9157/abstract/1-3\">",
"      1-3",
"     </a>",
"     ]",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Aug 2, 2012.",
"  </div>",
"  <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"   <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"    Find",
"   </a>",
"   <a class=\"toolbutton printicon\" href=\"UTD.htm?8/60/9157?view=print\" title=\"Print This Topic\">",
"    Print",
"   </a>",
"  </div>",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <div id=\"patTopicRefHeader\">",
"    <div id=\"patTopicRefHeaderHeader\">",
"     References",
"    </div>",
"    <div id=\"patTopicRefHeaderTop\">",
"     <a href=\"#top\">",
"      <img alt=\"\" src=\"./../images/top_arrow.myextg\">",
"       Top",
"      </img>",
"     </a>",
"    </div>",
"   </div>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/60/9157/abstract/1\">",
"      Kost K, Singh S, Vaughan B, et al. Estimates of contraceptive failure from the 2002 National Survey of Family Growth. Contraception 2008; 77:10.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/60/9157/abstract/2\">",
"      Moreau C, Cleland K, Trussell J. Contraceptive discontinuation attributed to method dissatisfaction in the United States. Contraception 2007; 76:267.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/60/9157/abstract/3\">",
"      Trussell J, Wynn LL. Reducing unintended pregnancy in the United States. Contraception 2008; 77:1.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
" </div>",
" <!-- patTopicMiddle -->",
"</div>"].join("\n");
var script_f8_60_9157=[""].join("\n");
var outline_f8_60_9157=[" <div class=\"patTopicFancyTop\">",
"  <div class=\"rcTop\">",
"   <div>",
"   </div>",
"  </div>",
"  <div class=\"rcContent\">",
"   <p>",
"    Contents of this article",
"   </p>",
"  </div>",
" </div>",
" <div class=\"patTopicFancySpacer\">",
" </div>",
" <div class=\"patTopicOutline\">",
"  <div class=\"rcbBottom\">",
"   <div class=\"rcbLeft\">",
"    <div class=\"rcbRight\">",
"     <div class=\"rcbBottomLeft\">",
"      <div class=\"rcbBottomRight rcbBottomRightBottomOnly\">",
"       <div id=\"outline\">",
"        <ul>",
"         <li class=\"plainItem\">",
"          <a href=\"#H1\">",
"           INTRODUCTION",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H2\">",
"           EFFECTIVENESS OF BIRTH CONTROL",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H3\">",
"           CHOOSING A BIRTH CONTROL METHOD",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H4\">",
"           EMERGENCY CONTRACEPTION",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H5\">",
"           BIRTH CONTROL PILLS",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H9\">",
"           INJECTABLE BIRTH CONTROL",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H11\">",
"           SKIN PATCHES",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H12\">",
"           VAGINAL RING",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H13\">",
"           BIRTH CONTROL IMPLANT",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H14\">",
"           BARRIER METHODS",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H19\">",
"           INTRAUTERINE DEVICES (IUD)",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H20\">",
"           STERILIZATION",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H24\">",
"           OTHER BIRTH CONTROL METHODS",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H31\">",
"           WHERE TO GET MORE INFORMATION",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#references\">",
"           REFERENCES",
"          </a>",
"         </li>",
"        </ul>",
"       </div>",
"       <h1>",
"        GRAPHICS",
"       </h1>",
"       <div id=\"relatedGraphics\">",
"        <ul>",
"         <li class=\"plainItem\">",
"          TABLES",
"         </li>",
"         <li class=\"bulletItem\">",
"          <a class=\"graphic graphic_table\" href=\"UTD.htm?12/56/13197\" title=\"table 1\">",
"           Pregnancy rate during first year of contraception",
"          </a>",
"         </li>",
"        </ul>",
"       </div>",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"  </div>",
" </div>"].join("\n");
var title_f8_60_9158="Norethindrone: Pediatric drug information";
var content_f8_60_9158=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Norethindrone: Pediatric drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_general\" href=\"UTD.htm?15/52/16199?source=see_link\">",
"    see \"Norethindrone: Drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_patient\" href=\"UTD.htm?40/56/41860?source=see_link\">",
"    see \"Norethindrone: Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F202477\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Aygestin&reg;;",
"     </li>",
"     <li>",
"      Camila&reg;;",
"     </li>",
"     <li>",
"      Errin&reg;;",
"     </li>",
"     <li>",
"      Heather;",
"     </li>",
"     <li>",
"      Jolivette&reg;;",
"     </li>",
"     <li>",
"      Nor-QD&reg;;",
"     </li>",
"     <li>",
"      Nora-BE&reg;;",
"     </li>",
"     <li>",
"      Ortho Micronor&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F202478\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Micronor&reg;;",
"     </li>",
"     <li>",
"      Norlutate&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list_set htclist drugH1Div drugBrandNames\" id=\"F1060617\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Therapeutic Category",
"    </span>",
"    <ul>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Contraceptive, Oral",
"      </span>",
"     </li>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Contraceptive, Progestin Only",
"      </span>",
"     </li>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Progestin",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block dos drugH1Div\" id=\"F1060611\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Usual",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_general\" href=\"UTD.htm?15/52/16199?source=see_link\">",
"      see \"Norethindrone: Drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Adolescents and Adults: Female: Oral: Not indicated for use before menarche",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Amenorrhea and abnormal uterine bleeding: Norethindrone acetate 2.5-10 mg/day for 5-10 days beginning during the latter half of the menstrual cycle",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Endometriosis: Norethindrone acetate 5 mg/day for 14 days; increase at increments of 2.5 mg/day every 2 weeks up to 15 mg/day",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Contraception: Progesterone only: Norethindrone 0.35 mg every day of the year starting on first day of menstrual period or the day after a miscarriage or abortion. If switching from a combined oral contraceptive, begin the day after finishing the last active combined tablet. If dose is missed, take as soon as remembered. An additional method of contraception should be used for 48 hours if dose is taken &gt;3 hours late.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F202457\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Tablet, oral: 0.35 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Camila&reg;: 0.35 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Errin&reg;: 0.35 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Heather: 0.35 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Jolivette&reg;: 0.35 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Nor-QD&reg;: 0.35 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Nora-BE&reg;: 0.35 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Ortho Micronor&reg;: 0.35 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Tablet, oral, as acetate: 5 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Aygestin&reg;: 5 mg [scored]",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F202444\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Yes",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F1060621\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Oral: Administer at the same time each day; may administer with food",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F1060620\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Treatment of amenorrhea, abnormal uterine bleeding, endometriosis, oral contraceptive",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F202514\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       Micronor&reg; may be confused with miconazole, Micronase",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block arm drugH1Div\" id=\"F202513\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Cardiovascular: Cerebral embolism, cerebral thrombosis, DVT, edema",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Central nervous system: Depression, dizziness, headache, insomnia, migraine, mood swings",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Dermatologic: Acne, chloasma, hirsutism, melasma, pruritus, rash, urticaria",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Endocrine &amp; metabolic: Amenorrhea, breakthrough bleeding, breast enlargement/tenderness, menstrual flow changes, spotting",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Gastrointestinal: Nausea, weight gain/loss",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Genitourinary: Cervical erosion changes, cervical secretion changes",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Hepatic: Cholestatic jaundice, liver function test abnormalities",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Ocular: Optic neuritis (with or without vision loss), retinal vascular thrombosis",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Respiratory: Pulmonary embolism",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Miscellaneous: Anaphylactic/anaphylactoid reactions",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F1060624\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to norethindrone or any component; thromboembolic disorders, severe hepatic disease, breast cancer, cerebral hemorrhage, undiagnosed vaginal bleeding; known or suspected pregnancy; as a diagnostic test for pregnancy",
"    </p>",
"   </div>",
"   <div class=\"block pre drugH1Div\" id=\"F1060610\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Precautions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Use with caution in patients with asthma, diabetes mellitus, seizure disorder, migraine, cardiac or renal dysfunction, psychic depression; may affect lipid and carbohydrate metabolism; women with diabetes mellitus or hyperlipidemias should be monitored closely",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F1060609\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Discontinue if sudden partial or complete loss of vision, proptosis, diplopia, or migraine occur;",
"     <b>",
"      there is a higher rate of failure with progestin only contraceptives",
"     </b>",
"     ; progestin-induced withdrawal bleeding occurs within 3-7 days after discontinuation of drug",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F202506\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Substrate",
"     </b>",
"     of CYP3A4 (major);",
"     <b>",
"      Note:",
"     </b>",
"     Assignment of Major/Minor substrate status based on clinically relevant drug interaction potential;",
"     <b>",
"      Induces",
"     </b>",
"     CYP2C19 (weak/moderate)",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F202452\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Acitretin: May diminish the therapeutic effect of Contraceptives (Progestins). Contraceptive failure is possible. Management: Given the potential for progestin-only preparations to fail to prevent pregnancy during acitretin therapy, such products should not be relied upon. Alternative, nonhormonal forms of contraception must be employed during acitretin therapy.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Aminoglutethimide: May increase the metabolism of Progestins. Management: Progestin-containing contraceptives are not recommended; consider the use of alternative, nonhormonal contraceptives.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Aprepitant: May decrease the serum concentration of Contraceptives (Progestins). Management: Alternative or additional methods of contraception should be used both during treatment with aprepitant or fosaprepitant and for at least one month following the last aprepitant/fosaprepitant dose.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Artemether: May decrease the serum concentration of Contraceptives (Progestins). Management: Consider the use of an alternative (i.e., non-hormonal) means of contraception in all women of childbearing potential who are using artemether.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Atazanavir: May increase the serum concentration of Contraceptives (Progestins).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Barbiturates: May diminish the therapeutic effect of Contraceptives (Progestins). Contraceptive failure is possible. Management: Use of alternative, nonhormonal contraceptives is recommended.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Benzodiazepines (metabolized by oxidation): Contraceptives (Progestins) may increase the serum concentration of Benzodiazepines (metabolized by oxidation).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Bexarotene (Systemic): May decrease the serum concentration of Contraceptives (Progestins). Management: Women of childbearing potential receiving bexarotene should use two reliable forms of contraception (including at least one nonhormonal form).",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Bile Acid Sequestrants: May decrease the serum concentration of Contraceptives (Progestins). Management: Administer oral progestin-containing contraceptives at least 1-4 hours prior to or 4-6 hours after administration of a bile acid sequestrant.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Boceprevir: May increase the serum concentration of Contraceptives (Progestins). This has been seen specifically with drospirenone. Boceprevir may increase the serum concentration of Contraceptives (Progestins). This has been seen specifically with norethindrone. Management: Patients receiving boceprevir, ribavirin, and peginterferon alfa should use two reliable forms of contraception.  Norethindrone/ethinyl estradiol may be used for one of these when norethindrone dose is at least 1 mg/day. Avoid drospirenone.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Bosentan: May decrease the serum concentration of Contraceptives (Progestins). Management: Use an alternative (i.e., non-hormonal) means of contraception for all women of childbearing potential who are using bosentan, and do not rely on hormonal contraceptives alone.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CarBAMazepine: May diminish the therapeutic effect of Contraceptives (Progestins). Contraceptive failure is possible. Management: Use of alternative, nonhormonal contraceptives is recommended.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CloBAZam: May decrease the serum concentration of Contraceptives (Progestins).",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Cobicistat: May increase the serum concentration of Contraceptives (Progestins). Management: Consider the use of an alternative, non-hormone-based contraceptive, in patients who are being treated with the elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate combination product.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Colesevelam: May decrease the serum concentration of Norethindrone.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP3A4 Inducers (Strong): May increase the metabolism of CYP3A4 Substrates. Management: Consider an alternative for one of the interacting drugs. Some combinations may be specifically contraindicated. Consult appropriate manufacturer labeling.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Darunavir: May decrease the serum concentration of Norethindrone.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Deferasirox: May decrease the serum concentration of CYP3A4 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Exenatide: May decrease the serum concentration of Oral Contraceptive (Progestins). Management: Administer oral contraceptives at least one hour prior to exenatide.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Felbamate: May decrease the serum concentration of Contraceptives (Progestins). Management: Contraceptive failure is possible.  Use of an alternative, nonhormonal method of contraception is recommended.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Fosaprepitant: May decrease the serum concentration of Contraceptives (Progestins). The active metabolite aprepitant is likely responsible for this effect. Management: Alternative or additional methods of contraception should be used both during treatment with aprepitant or fosaprepitant and for at least one month following the last aprepitant/fosaprepitant dose.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Fosphenytoin: May diminish the therapeutic effect of Contraceptives (Progestins). Contraceptive failure is possible. Management: Contraceptive failure is possible.  Use of an alternative, nonhormonal contraceptive is recommended.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Griseofulvin: May diminish the therapeutic effect of Contraceptives (Progestins). Contraceptive failure is possible.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Herbs (Progestogenic Properties) (eg, Bloodroot, Yucca): May enhance the adverse/toxic effect of Progestins.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     LamoTRIgine: May decrease the serum concentration of Contraceptives (Progestins). Management: Women using progestin-only &ldquo;minipill&rdquo; products may be at risk for contraceptive failure; it is unclear if other progestin-containing products would be significantly impacted.  Alternative, non-hormonal, means of contraception are recommended.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Mifepristone: May diminish the therapeutic effect of Contraceptives (Progestins). Mifepristone may increase the serum concentration of Contraceptives (Progestins). Management: Women of childbearing potential should use an effective, nonhormonal means of contraception during and 4 weeks following mifepristone treatment.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Mycophenolate: May decrease the serum concentration of Contraceptives (Progestins). Management: Use of an additional or alternative (nonhormonal) method of contraception should be considered.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Nevirapine: May decrease the serum concentration of Contraceptives (Progestins). Management: Instruct patients receiving nevirapine to use an alternative or additional nonhormonal contraceptive. Nevirapine product labeling however suggests that depo-medroxyprogesterone acetate may be used as a sole method of contraception.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     OXcarbazepine: May decrease the serum concentration of Contraceptives (Progestins). Management: Contraceptive failure is possible.  Use of an additional or alternative, nonhormonal method of contraception is recommended.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Perampanel: May decrease the serum concentration of Contraceptives (Progestins). Management: Patients should use an alternative, non-hormonal based form of contraception for the duration of concurrent perampanel.  Both oral and non-oral progestin-based contraceptives are likely to be impacted by this interaction.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Phenytoin: May diminish the therapeutic effect of Contraceptives (Progestins). Contraceptive failure is possible. Management: Contraceptive failure is possible.  Use of an alternative, nonhormonal contraceptive is recommended.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Prucalopride: May decrease the serum concentration of Contraceptives (Progestins).",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Retinoic Acid Derivatives: May diminish the therapeutic effect of Contraceptives (Progestins). Retinoic Acid Derivatives may decrease the serum concentration of Contraceptives (Progestins). Management: Two forms of effective contraception should be used in patients receiving retinoic acid derivatives.  Particularly, microdosed progesterone-only preparations may be inadequately effective.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Rifamycin Derivatives: May decrease the serum concentration of Contraceptives (Progestins). Contraceptive failure is possible. Management: Contraceptive failure is possible.  Use of an alternative, nonhormonal contraceptive is recommended.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Rufinamide: May decrease the serum concentration of Norethindrone.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Selegiline: Contraceptives (Progestins) may increase the serum concentration of Selegiline.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     St Johns Wort: May diminish the therapeutic effect of Contraceptives (Progestins). Contraceptive failure is possible. Management: Consider using a product other than St John's wort.  Contraceptive failure is possible.  Use of an alternative, nonhormonal contraceptive is recommended.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Telaprevir: May decrease the serum concentration of Contraceptives (Progestins). Management: Two different nonhormonal forms of contraception are required for women of childbearing potential taking telaprevir.  Hormonal contraceptives may be less effective during concurrent telaprevir and for up to 2 weeks after telaprevir discontinuation.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tocilizumab: May decrease the serum concentration of CYP3A4 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Topiramate: May decrease the serum concentration of Contraceptives (Progestins). Management: Caution patients that this combination may be associated with reduced contraceptive effectiveness.  Consider adding an additional (non-hormonal) contraceptive method.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tranexamic Acid: Contraceptives (Progestins) may enhance the thrombogenic effect of Tranexamic Acid.  Management: Ensure that the potential benefits of concurrent therapy outweigh the increased risk of potential thrombosis that accompanies use of tranexamic acid with hormonal contraceptives.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Vitamin K Antagonists (eg, warfarin): Contraceptives (Progestins) may diminish the anticoagulant effect of Vitamin K Antagonists. In contrast, enhanced anticoagulant effects have also been noted with some products.  Management: When possible, concomitant hormonal contraceptives and coumarin derivatives should be avoided in order to eliminate the risk of thromboembolic disorders.  Consider using an alternative, nonhormonal contraceptive.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Voriconazole: May increase the serum concentration of Contraceptives (Progestins). Contraceptives (Progestins) may increase the serum concentration of Voriconazole.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block foi drugH1Div\" id=\"F1060625\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Food Interactions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Avoid bloodroot, chasteberry, damiana, oregano, and yucca; may enhance the adverse/toxic effect of progestins. Avoid St John&rsquo;s wort; may diminish the therapeutic effect of progestin contraceptives; contraceptive failure is possible.",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F202453\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     X (",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F5120967\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     First trimester exposure may cause genital abnormalities including hypospadias in male infants and mild virilization of external female genitalia. Significant adverse events related to growth and development have not been observed (limited studies). Use is contraindicated during pregnancy. May be started immediately postpartum if not breast-feeding.",
"    </p>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F1060608\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Inhibits secretion of pituitary gonadotropin (LH) which prevents follicular maturation and ovulation; in the presence of adequate endogenous estrogen, transforms a proliferative endometrium to a secretory one",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F1060623\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacokinetics (Adult data unless noted)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Absorption: Oral: Rapidly absorbed",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Distribution: V",
"     <sub>",
"      d",
"     </sub>",
"     : 4 L/kg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Protein binding: 61% to albumin and 36% to sex hormone-binding globulin (SHBG)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Metabolism: Hepatic via reduction and conjugation; first-pass effect",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Bioavailability: &sim;65%",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Half-life: &sim;8 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Time to peak serum concentration: 1 hour (range: 0.5-2 hours)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Elimination: Urine (&gt;50% as metabolites); feces (20% to 40% as metabolites)",
"    </p>",
"   </div>",
"   <div class=\"block pai drugH1Div\" id=\"F1060616\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Patient Information",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?40/56/41860?source=see_link\">",
"      see \"Norethindrone: Patient drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Progestin-induced withdrawal bleeding occurs within 3-7 days after discontinuation of the drug; for contraception, take at the same time every day; use an additional method of contraception for the next 48 hours if dose is taken &gt;3 hours late",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      American College of Obstetricians and Gynecologists, &ldquo;ACOG Committee Opinion. Number 310, April 2005. Endometriosis in Adolescents,&rdquo;",
"      <i>",
"       Obstet Gynecol",
"      </i>",
"      , 2005, 105(4):921-7.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?8/60/9158/abstract-text/15802438/pubmed\" id=\"15802438\" target=\"_blank\">",
"        15802438",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      ACOG Committee on Practice Bulletins-Gynecology, &ldquo;ACOG Practice Bulletin. No. 73: Use of Hormonal Contraception in Women With Coexisting Medical Conditions,&rdquo;",
"      <i>",
"       Obstet Gynecol",
"      </i>",
"      , 2006, 107(6):1453-72.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?8/60/9158/abstract-text/16738183/pubmed\" id=\"16738183\" target=\"_blank\">",
"        16738183",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 12652 Version 36.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1103-89.32.226.102-36135ECCB4-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_60_9158=[""].join("\n");
var outline_f8_60_9158=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F202477\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F202478\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1060617\">",
"      Therapeutic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1060611\">",
"      Dosing: Usual",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F202457\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F202444\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1060621\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1060620\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F202514\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F202513\">",
"      Adverse Reactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1060624\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1060610\">",
"      Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1060609\">",
"      Warnings",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F202506\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F202452\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1060625\">",
"      Food Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F202453\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5120967\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1060608\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1060623\">",
"      Pharmacokinetics (Adult data unless noted)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1060616\">",
"      Patient Information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_PED/12652\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_PED/12652|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?15/52/16199?source=related_link\">",
"      Norethindrone: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?40/56/41860?source=related_link\">",
"      Norethindrone: Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f8_60_9159="Genetic factors in the pathogenesis of essential hypertension";
var content_f8_60_9159=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Genetic factors in the pathogenesis of essential hypertension",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?8/60/9159/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?8/60/9159/contributors\">",
"     Norman M Kaplan, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?8/60/9159/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?8/60/9159/contributors\">",
"     George L Bakris, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?8/60/9159/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?8/60/9159/contributors\">",
"     John P Forman, MD, MSc",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?8/60/9159/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Apr 10, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although a number of individual genes and genetic factors have been linked to the development of essential hypertension, it is likely that multiple genes contribute to the development of the disease in any given individual. It is extremely difficult to accurately determine the relative contributions of each of these genes [",
"    <a class=\"abstract\" href=\"UTD.htm?8/60/9159/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Certain rare mutations can cause hypertension even in the absence of other risk factors (ie, &ldquo;monogenic&rdquo; hypertension, for example, Liddle&rsquo;s syndrome). However, more common genetic variants (polymorphisms) appear to have very small effects on blood pressure. As an example, a set of 200 polymorphisms that were associated with hypertension explained less than 1.3 percent of the variability in systolic blood pressure in a large population, after accounting for age, sex, and body mass index [",
"    <a class=\"abstract\" href=\"UTD.htm?8/60/9159/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Thus, other than for a very small number of hypertensive patients who have been found to have a monogenetic mechanism, primary hypertension is a condition that represents \"the extreme of a physiologic state whose variability is described by a continuous unimodal frequency distribution\" [",
"    <a class=\"abstract\" href=\"UTD.htm?8/60/9159/abstract/3\">",
"     3",
"    </a>",
"    ]. The search for a single or even multiple genes as the \"cause\" of hypertension is therefore fruitless.",
"   </p>",
"   <p>",
"    In addition to genes that are associated with hypertension, there are genes that protect against the development of hypertension. One example is Gitelman's syndrome in which loss-of-function mutations in the thiazide-sensitive Na-Cl cotransporter in the distal tubule are associated with lower blood pressures than in individuals without this defect. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/43/23226?source=see_link\">",
"     \"Bartter and Gitelman syndromes\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Genetic associations with hypertension do not prove causality. However, genetic factors probably play a role in the alterations of various physiologic parameters that have been identified in hypertensive patients. This topic will review genetic factors in the predisposition to essential hypertension.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     GENETIC FACTORS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hypertension is about twice as common in subjects who have one or two hypertensive parents, and multiple epidemiological studies using ambulatory blood pressure readings suggest that genetic factors account for approximately 30 percent of the variation in blood pressure in various populations [",
"    <a class=\"abstract\" href=\"UTD.htm?8/60/9159/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Importance of the kidney",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cross-transplantation studies in experimental models of genetic hypertension have shown that the inherited tendency to hypertension resides primarily in the kidney [",
"    <a class=\"abstract\" href=\"UTD.htm?8/60/9159/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A similar relationship may exist in humans. In one report, for example, transplantation of a kidney from normotensive donors with a negative family history of hypertension led to prolonged normotension in six recipients with a prior history of end-stage renal disease due to benign nephrosclerosis and resistant hypertension while on dialysis [",
"    <a class=\"abstract\" href=\"UTD.htm?8/60/9159/abstract/6\">",
"     6",
"    </a>",
"    ]. A larger study of 85 patients found that a transplanted kidney from a hypertensive donor raises the blood pressure and increases antihypertensive drug requirements only in recipients coming from \"normotensive\" families; a family history of hypertension blunts the effect of a \"hypertensive\" kidney [",
"    <a class=\"abstract\" href=\"UTD.htm?8/60/9159/abstract/7\">",
"     7",
"    </a>",
"    ]. Beyond these general associations, a number of single gene mutations have been recognized to cause hypertension, almost all of which involve renal sodium retention [",
"    <a class=\"abstract\" href=\"UTD.htm?8/60/9159/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    There also may be an important role for extrarenal vasculature in blood pressure regulation. In elegant cross-transplantation studies, the blood pressure effects of deleting the type 1A angiotensin receptor in the kidney alone and extrarenal tissues alone were evaluated [",
"    <a class=\"abstract\" href=\"UTD.htm?8/60/9159/abstract/9\">",
"     9",
"    </a>",
"    ]. Results were consistent with the view that the renin-angiotensin system also regulates blood pressure via the extrarenal vasculature, independently of the kidney [",
"    <a class=\"abstract\" href=\"UTD.htm?8/60/9159/abstract/9\">",
"     9",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Identified prohypertensive genetic mutations",
"    </span>",
"    &nbsp;&mdash;&nbsp;Specific genetic mutations have been found in a few, very rare forms of hypertension including [",
"    <a class=\"abstract\" href=\"UTD.htm?8/60/9159/abstract/8\">",
"     8",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Liddle's syndrome, a disorder that is associated with hypertension, low plasma renin and aldosterone levels, and hypokalemia, all of which respond to",
"      <a class=\"drug drug_general\" href=\"UTD.htm?37/12/38085?source=see_link\">",
"       amiloride",
"      </a>",
"      , an inhibitor of the distal renal epithelial sodium channel. The primary defect is a gain-of-function mutation in the sodium channel gene, that is associated with a marked increase in sodium transport and loss of inhibition of channel activity by elevated levels of intracellular sodium [",
"      <a class=\"abstract\" href=\"UTD.htm?8/60/9159/abstract/10\">",
"       10",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?24/51/25399?source=see_link&amp;anchor=H3#H3\">",
"       \"Genetic disorders of the collecting tubule sodium channel: Liddle's syndrome and pseudohypoaldosteronism type 1\", section on 'Liddle's syndrome'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Pseudohypoaldosteronism type 2 (also called Gordon's syndrome or familial hyperkalemic hypertension), characterized by hypertension, hyperkalemia, normal renal function, and low or low-normal plasma renin activity and aldosterone concentrations. Mutations in WNK kinases 1 and 4 result in increased chloride reabsorption with sodium, thereby producing volume expansion, hypertension, and by having less sodium available to exchange for potassium, hyperkalemia. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?9/44/9930?source=see_link&amp;anchor=H13#H13\">",
"       \"Etiology, diagnosis, and treatment of hypoaldosteronism (type 4 RTA)\", section on 'Pseudohypoaldosteronism type 2 (Gordon's syndrome)'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Glucocorticoid-remediable aldosteronism, also known as familial hyperaldosteronism type I, is a disorder in which there is a chimeric gene formed from portions of the 11&szlig;-hydroxylase gene and the aldosterone synthase gene, that results in ACTH stimulating aldosterone synthesis [",
"      <a class=\"abstract\" href=\"UTD.htm?8/60/9159/abstract/8\">",
"       8",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?22/5/22615?source=see_link\">",
"       \"Familial hyperaldosteronism\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      In familial hyperaldosteronism type II, the hyperaldosteronism is not dependent upon ACTH and therefore is not suppressible by",
"      <a class=\"drug drug_general\" href=\"UTD.htm?33/4/33856?source=see_link\">",
"       dexamethasone",
"      </a>",
"      . The genetic defect appears to be on chromosome 7p22. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?5/13/5338?source=see_link&amp;anchor=H27#H27\">",
"       \"Approach to the patient with hypertension and hypokalemia\", section on 'Genetic testing'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Congenital adrenal hyperplasia due to 11&szlig;-hydroxylase deficiency, a disorder that has been associated with multiple mutations of the CYP11B1 gene. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?15/32/15878?source=see_link\">",
"       \"Congenital adrenal hyperplasia due to 11-beta-hydroxylase deficiency\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Syndrome of apparent mineralocorticoid excess, arising from mutations in the gene encoding the kidney enzyme 11-&szlig;-hydroxysteroid dehydrogenase; the defective enzyme allows normal circulating concentrations of cortisol (which are much higher than those of aldosterone) to activate the mineralocorticoid receptors. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?39/56/40838?source=see_link\">",
"       \"Apparent mineralocorticoid excess syndromes (including chronic licorice ingestion)\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Because of these observations, numerous studies have assessed any possible linkage between hypertension and other mutations in these same genes which may cause less severe phenotypes. Contradictory results have been published thus far. Among nearly 290 families in Australia, a link was found between chromosome 16p12, the location for the beta and gamma subunits of the epithelial sodium channel, and systolic blood pressure [",
"    <a class=\"abstract\" href=\"UTD.htm?8/60/9159/abstract/11\">",
"     11",
"    </a>",
"    ]. By comparison, in a study from Sweden, mutations in the sodium channel responsible for Liddle's syndrome did not appear to play a role in patients with essential hypertension [",
"    <a class=\"abstract\" href=\"UTD.htm?8/60/9159/abstract/12\">",
"     12",
"    </a>",
"    ]. Additional study in larger numbers of patients is required to determine whether mutations in these genes are associated with essential hypertension [",
"    <a class=\"abstract\" href=\"UTD.htm?8/60/9159/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Possible involvement of the angiotensinogen gene",
"    </span>",
"    &nbsp;&mdash;&nbsp;Increased plasma levels of angiotensinogen, the protein substrate acted upon by renin to generate angiotensin I, have been reported in hypertensive subjects and in children of hypertensive parents [",
"    <a class=\"abstract\" href=\"UTD.htm?8/60/9159/abstract/14\">",
"     14",
"    </a>",
"    ]. However, a review concluded that \"Neither the regulation of the expression of the angiotensinogen gene nor the physiological importance of its expression in various tissues is fully understood\" so that these polymorphisms remain only a hypothetical contributor to clinical hypertension [",
"    <a class=\"abstract\" href=\"UTD.htm?8/60/9159/abstract/15\">",
"     15",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A polymorphism of the aldosterone synthase gene may be associated with an increased risk of hypertension [",
"    <a class=\"abstract\" href=\"UTD.htm?8/60/9159/abstract/16\">",
"     16",
"    </a>",
"    ]. The genes for other parts of the renin-angiotensin system (eg, renin and angiotensin converting enzyme) do not appear to be associated with hypertension.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Possible involvement of adducin genes",
"    </span>",
"    &nbsp;&mdash;&nbsp;As noted above, cross-transplantation studies in experimental models of genetic hypertension have generally shown that the defect predisposing the hypertension resides in the kidney [",
"    <a class=\"abstract\" href=\"UTD.htm?8/60/9159/abstract/5\">",
"     5",
"    </a>",
"    ]. In at least one such model, there appears to be a mutation in the gene for the cytoskeletal protein adducin [",
"    <a class=\"abstract\" href=\"UTD.htm?8/60/9159/abstract/17\">",
"     17",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    There may be an association between polymorphisms in the alpha-adducin gene and hypertension and related adverse outcomes in humans [",
"    <a class=\"abstract\" href=\"UTD.htm?8/60/9159/abstract/18\">",
"     18",
"    </a>",
"    ]. The mechanism by which this might occur is not well understood. One possibility is alterations in actin polymerization, thereby leading to increased sodium reabsorption through the kidney [",
"    <a class=\"abstract\" href=\"UTD.htm?8/60/9159/abstract/19,20\">",
"     19,20",
"    </a>",
"    ]. Compatible with this hypothesis is the observation that certain mutations in the alpha-adducin gene lead to a greater antihypertensive response to salt restriction and diuretic therapy than is seen in patients who are homozygous for the wild-type allele [",
"    <a class=\"abstract\" href=\"UTD.htm?8/60/9159/abstract/21,22\">",
"     21,22",
"    </a>",
"    ]. In a study of 279 hypertensive patients, 19 percent had the 460Trp polymorphism in the alpha-adducin gene. The nine patients who were homozygous for this mutation had multiple defects in sodium excretion, were sodium sensitive, and had low plasma renin levels [",
"    <a class=\"abstract\" href=\"UTD.htm?8/60/9159/abstract/21\">",
"     21",
"    </a>",
"    ]. The 460Trp polymorphism is also associated with impaired endothelium-dependent vasodilation, which provides another possible mechanism for an association with hypertension [",
"    <a class=\"abstract\" href=\"UTD.htm?8/60/9159/abstract/23\">",
"     23",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The gamma-adducin gene may also be related to blood pressure through regulation of sodium reabsorption. Gamma-adducin increases the activity of thiazide-sensitive sodium chloride reabsorption in the distal convoluted tubule, possibly by interacting with the sodium chloride cotransporter and directing it to the apical membrane [",
"    <a class=\"abstract\" href=\"UTD.htm?8/60/9159/abstract/24\">",
"     24",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Possible involvement of the connexin40 gene",
"    </span>",
"    &nbsp;&mdash;&nbsp;Connexin40 is a gap junction protein expressed in afferent arteriole endothelial cells and in renin-secreting cells of the juxtaglomerular apparatus [",
"    <a class=\"abstract\" href=\"UTD.htm?8/60/9159/abstract/25\">",
"     25",
"    </a>",
"    ]. Defective expression of connexin40 may contribute to renin-mediated hypertension [",
"    <a class=\"abstract\" href=\"UTD.htm?8/60/9159/abstract/26,27\">",
"     26,27",
"    </a>",
"    ]. As an example, the connexin40-deficient mouse is characterized by hypertension, elevated plasma renin protein and mRNA levels and sensitivity to RAS inhibitors [",
"    <a class=\"abstract\" href=\"UTD.htm?8/60/9159/abstract/25,26,28\">",
"     25,26,28",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In addition, a stable polymorphism in the promoter region of the gene encoding connexin40 may be linked with clinical hypertension [",
"    <a class=\"abstract\" href=\"UTD.htm?8/60/9159/abstract/29\">",
"     29",
"    </a>",
"    ]. The mechanism by which connexin40 regulates renin is not known.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Other candidate genes",
"    </span>",
"    &nbsp;&mdash;&nbsp;A number of other genes have been studied by association and linkage techniques.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Genome scans for linkage with hypertension have been reported [",
"      <a class=\"abstract\" href=\"UTD.htm?8/60/9159/abstract/30-32\">",
"       30-32",
"      </a>",
"      ]. A combined analysis of the Global BPgen and CHARGE Consortiums consisting of 63,569 individuals found that a significant number of loci were associated with systolic blood pressure, diastolic blood pressure, and hypertension [",
"      <a class=\"abstract\" href=\"UTD.htm?8/60/9159/abstract/31,32\">",
"       31,32",
"      </a>",
"      ]. The presence of multiple risk alleles conferred an increase of several mmHg on blood pressure levels, which is associated with an increased cardiovascular risk [",
"      <a class=\"abstract\" href=\"UTD.htm?8/60/9159/abstract/32\">",
"       32",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Data from the Framingham Heart Study, using a genome-wide scan, found the strongest linkage for blood pressure variation in a locus on chromosome 17 [",
"      <a class=\"abstract\" href=\"UTD.htm?8/60/9159/abstract/33\">",
"       33",
"      </a>",
"      ]. This locus is very close to the WNK4 gene, mutations of which are responsible for hypertension due to one form of pseudohypoaldosteronism type 2 (also called Gordon's syndrome or familial hyperkalemic hypertension) [",
"      <a class=\"abstract\" href=\"UTD.htm?8/60/9159/abstract/34\">",
"       34",
"      </a>",
"      ]. Another report has noted an association between WNK1 gene polymorphisms with ambulatory blood pressures in the general population [",
"      <a class=\"abstract\" href=\"UTD.htm?8/60/9159/abstract/35\">",
"       35",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?9/44/9930?source=see_link&amp;anchor=H13#H13\">",
"       \"Etiology, diagnosis, and treatment of hypoaldosteronism (type 4 RTA)\", section on 'Pseudohypoaldosteronism type 2 (Gordon's syndrome)'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Two polymorphisms in the serine threonine kinase 39 (STK39) gene are associated with blood pressure [",
"      <a class=\"abstract\" href=\"UTD.htm?8/60/9159/abstract/36\">",
"       36",
"      </a>",
"      ]. STK39 interacts with WNK kinases (discussed above) to regulate sodium chloride transport. The physiologic importance of STK39 was demonstrated by the phenotype of SPAK knockout mice (SPAK is the murine equivalent of STK39), who develop hypotension and hypokalemia [",
"      <a class=\"abstract\" href=\"UTD.htm?8/60/9159/abstract/37\">",
"       37",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In a population based study of 4830 subjects, genetic variants of serum- and glucocorticoid- kinase-1 (SGK-1) were associated with blood pressure [",
"      <a class=\"abstract\" href=\"UTD.htm?8/60/9159/abstract/38\">",
"       38",
"      </a>",
"      ]. The relationship with blood pressure may be related to the influence of SGK-1 on expression of the epithelial sodium channel.",
"     </li>",
"     <li>",
"      Polymorphisms in the gene encoding the gamma subunit of the epithelial sodium channel have been associated with systolic blood pressure [",
"      <a class=\"abstract\" href=\"UTD.htm?8/60/9159/abstract/39-41\">",
"       39-41",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Among 66 pairs of dizygotic twins, a quantitative trait analysis of linkage among multiple suspect genes and blood pressure found that linkage was most consistent for the insulin-like growth factor-I gene and systolic blood pressure [",
"      <a class=\"abstract\" href=\"UTD.htm?8/60/9159/abstract/42\">",
"       42",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Four single nucleotide polymorphisms in chloride channel genes have been associated with increased salt sensitivity in a small number of individuals [",
"      <a class=\"abstract\" href=\"UTD.htm?8/60/9159/abstract/43\">",
"       43",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Polymorphisms in the gene encoding the G protein regulator, phosducin, have been associated with hypertension in a limited number of individuals [",
"      <a class=\"abstract\" href=\"UTD.htm?8/60/9159/abstract/44\">",
"       44",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      A polymorphism in the promoter region of the endothelial nitric oxide synthase gene was associated with hypertension in a population of 6246 European men and women [",
"      <a class=\"abstract\" href=\"UTD.htm?8/60/9159/abstract/45\">",
"       45",
"      </a>",
"      ]. &nbsp;",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Other rare forms of hereditary hypertension",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      An autosomal dominant gain-of-function mutation in the mineralocorticoid receptor causing hypertension that was exacerbated during pregnancy [",
"      <a class=\"abstract\" href=\"UTD.htm?8/60/9159/abstract/46\">",
"       46",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Autosomal-dominant hypertension with brachydactyly [",
"      <a class=\"abstract\" href=\"UTD.htm?8/60/9159/abstract/47\">",
"       47",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Hereditary pheochromocytomas [",
"      <a class=\"abstract\" href=\"UTD.htm?8/60/9159/abstract/48\">",
"       48",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Mutations in mitochondrial DNA [",
"      <a class=\"abstract\" href=\"UTD.htm?8/60/9159/abstract/49,50\">",
"       49,50",
"      </a>",
"      ]",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although multiple genes have been implicated, none have been clearly proven to be involved in the pathogenesis of primary hypertension. A plausible hypothesis is the interaction of multiple genes involved with renal sodium excretion, required for homeostasis during our ancestor's low sodium intake, are now disadvantageous with our current high sodium intake. The resultant volume expansion may initiate hypertension.",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/60/9159/abstract/1\">",
"      Rana BK, Insel PA, Payne SH, et al. Population-based sample reveals gene-gender interactions in blood pressure in White Americans. Hypertension 2007; 49:96.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/60/9159/abstract/2\">",
"      Taal HR, Verwoert GC, Demirkan A, et al. Genome-wide profiling of blood pressure in adults and children. Hypertension 2012; 59:241.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/60/9159/abstract/3\">",
"      Coggon DI, Martyn CN. Time and chance: the stochastic nature of disease causation. Lancet 2005; 365:1434.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/60/9159/abstract/4\">",
"      Kupper N, Willemsen G, Riese H, et al. Heritability of daytime ambulatory blood pressure in an extended twin design. Hypertension 2005; 45:80.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/60/9159/abstract/5\">",
"      Woolfson RG, de Wardener HE. Primary renal abnormalities in hereditary hypertension. Kidney Int 1996; 50:717.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/60/9159/abstract/6\">",
"      Curtis JJ, Luke RG, Dustan HP, et al. Remission of essential hypertension after renal transplantation. N Engl J Med 1983; 309:1009.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/60/9159/abstract/7\">",
"      Guidi E, Menghetti D, Milani S, et al. Hypertension may be transplanted with the kidney in humans: a long-term historical prospective follow-up of recipients grafted with kidneys coming from donors with or without hypertension in their families. J Am Soc Nephrol 1996; 7:1131.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/60/9159/abstract/8\">",
"      Lifton RP, Gharavi AG, Geller DS. Molecular mechanisms of human hypertension. Cell 2001; 104:545.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/60/9159/abstract/9\">",
"      Crowley SD, Gurley SB, Oliverio MI, et al. Distinct roles for the kidney and systemic tissues in blood pressure regulation by the renin-angiotensin system. J Clin Invest 2005; 115:1092.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/60/9159/abstract/10\">",
"      Kellenberger S, Gautschi I, Rossier BC, Schild L. Mutations causing Liddle syndrome reduce sodium-dependent downregulation of the epithelial sodium channel in the Xenopus oocyte expression system. J Clin Invest 1998; 101:2741.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/60/9159/abstract/11\">",
"      Wong ZY, Stebbing M, Ellis JA, et al. Genetic linkage of beta and gamma subunits of epithelial sodium channel to systolic blood pressure. Lancet 1999; 353:1222.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/60/9159/abstract/12\">",
"      Melander O, Orho M, Fagerudd J, et al. Mutations and variants of the epithelial sodium channel gene in Liddle's syndrome and primary hypertension. Hypertension 1998; 31:1118.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/60/9159/abstract/13\">",
"      Colhoun H. Confirmation needed for genes for hypertension. Lancet 1999; 353:1200.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/60/9159/abstract/14\">",
"      Watt GC, Harrap SB, Foy CJ, et al. Abnormalities of glucocorticoid metabolism and the renin-angiotensin system: a four-corners approach to the identification of genetic determinants of blood pressure. J Hypertens 1992; 10:473.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/60/9159/abstract/15\">",
"      Tamura K, Umemura S, Sumida Y, et al. Effect of genetic deficiency of angiotensinogen on the renin-angiotensin system. Hypertension 1998; 32:223.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/60/9159/abstract/16\">",
"      Sookoian S, Gianotti TF, Gonz&aacute;lez CD, Pirola CJ. Association of the C-344T aldosterone synthase gene variant with essential hypertension: a meta-analysis. J Hypertens 2007; 25:5.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/60/9159/abstract/17\">",
"      Cusi D, Bianchi G. Renal mechanisms of genetic hypertension: from the molecular level to the intact organism. Kidney Int 1996; 49:1754.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/60/9159/abstract/18\">",
"      Li Y, Thijs L, Kuznetsova T, et al. Cardiovascular risk in relation to alpha-adducin Gly460Trp polymorphism and systolic pressure: a prospective population study. Hypertension 2005; 46:527.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/60/9159/abstract/19\">",
"      Tripodi G, Valtorta F, Torielli L, et al. Hypertension-associated point mutations in the adducin alpha and beta subunits affect actin cytoskeleton and ion transport. J Clin Invest 1996; 97:2815.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/60/9159/abstract/20\">",
"      Beeks E, Kessels AG, Kroon AA, et al. Genetic predisposition to salt-sensitivity: a systematic review. J Hypertens 2004; 22:1243.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/60/9159/abstract/21\">",
"      Grant FD, Romero JR, Jeunemaitre X, et al. Low-renin hypertension, altered sodium homeostasis, and an alpha-adducin polymorphism. Hypertension 2002; 39:191.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/60/9159/abstract/22\">",
"      Cusi D, Barlassina C, Azzani T, et al. Polymorphisms of alpha-adducin and salt sensitivity in patients with essential hypertension. Lancet 1997; 349:1353.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/60/9159/abstract/23\">",
"      Perticone F, Sciacqua A, Barlassina C, et al. Gly460Trp alpha-adducin gene polymorphism and endothelial function in untreated hypertensive patients. J Hypertens 2007; 25:2234.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/60/9159/abstract/24\">",
"      Dimke H, San-Cristobal P, de Graaf M, et al. &gamma;-Adducin stimulates the thiazide-sensitive NaCl cotransporter. J Am Soc Nephrol 2011; 22:508.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/60/9159/abstract/25\">",
"      Krattinger N, Capponi A, Mazzolai L, et al. Connexin40 regulates renin production and blood pressure. Kidney Int 2007; 72:814.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/60/9159/abstract/26\">",
"      Kurtz L, Schweda F, de Wit C, et al. Lack of connexin 40 causes displacement of renin-producing cells from afferent arterioles to the extraglomerular mesangium. J Am Soc Nephrol 2007; 18:1103.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/60/9159/abstract/27\">",
"      Spray DC. Hypertension in connexin40-null mice: a renin disorder. Kidney Int 2007; 72:781.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/60/9159/abstract/28\">",
"      de Wit C, Roos F, Bolz SS, et al. Impaired conduction of vasodilation along arterioles in connexin40-deficient mice. Circ Res 2000; 86:649.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/60/9159/abstract/29\">",
"      Firouzi M, Kok B, Spiering W, et al. Polymorphisms in human connexin40 gene promoter are associated with increased risk of hypertension in men. J Hypertens 2006; 24:325.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/60/9159/abstract/30\">",
"      Zhu X, Luke A, Cooper RS, et al. Admixture mapping for hypertension loci with genome-scan markers. Nat Genet 2005; 37:177.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/60/9159/abstract/31\">",
"      Newton-Cheh, C, Johnson, T, Gateva, V, et al. Genome-wide association study identifies eight loci associated with blood pressure. Nat Gen 2009; 41:666.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/60/9159/abstract/32\">",
"      Levy, D, Ehret, GB, Rice, K, et al. Genome-wide association study of blood pressure and hypertension. Nat Gen 2009; 41:677.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/60/9159/abstract/33\">",
"      Levy D, DeStefano AL, Larson MG, et al. Evidence for a gene influencing blood pressure on chromosome 17. Genome scan linkage results for longitudinal blood pressure phenotypes in subjects from the framingham heart study. Hypertension 2000; 36:477.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/60/9159/abstract/34\">",
"      Wilson FH, Disse-Nicod&egrave;me S, Choate KA, et al. Human hypertension caused by mutations in WNK kinases. Science 2001; 293:1107.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/60/9159/abstract/35\">",
"      Tobin MD, Raleigh SM, Newhouse S, et al. Association of WNK1 gene polymorphisms and haplotypes with ambulatory blood pressure in the general population. Circulation 2005; 112:3423.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/60/9159/abstract/36\">",
"      Wang Y, O'Connell JR, McArdle PF, et al. From the Cover: Whole-genome association study identifies STK39 as a hypertension susceptibility gene. Proc Natl Acad Sci U S A 2009; 106:226.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/60/9159/abstract/37\">",
"      Yang SS, Lo YF, Wu CC, et al. SPAK-knockout mice manifest Gitelman syndrome and impaired vasoconstriction. J Am Soc Nephrol 2010; 21:1868.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/60/9159/abstract/38\">",
"      von Wowern F, Berglund G, Carlson J, et al. Genetic variance of SGK-1 is associated with blood pressure, blood pressure change over time and strength of the insulin-diastolic blood pressure relationship. Kidney Int 2005; 68:2164.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/60/9159/abstract/39\">",
"      Baker EH, Duggal A, Dong Y, et al. Amiloride, a specific drug for hypertension in black people with T594M variant? Hypertension 2002; 40:13.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/60/9159/abstract/40\">",
"      Iwai N, Baba S, Mannami T, et al. Association of sodium channel gamma-subunit promoter variant with blood pressure. Hypertension 2001; 38:86.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/60/9159/abstract/41\">",
"      B&uuml;sst CJ, Scurrah KJ, Ellis JA, Harrap SB. Selective genotyping reveals association between the epithelial sodium channel gamma-subunit and systolic blood pressure. Hypertension 2007; 50:672.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/60/9159/abstract/42\">",
"      Nagy Z, Busjahn A, B&auml;hring S, et al. Quantitative trait loci for blood pressure exist near the IGF-1, the Liddle syndrome, the angiotensin II-receptor gene and the renin loci in man. J Am Soc Nephrol 1999; 10:1709.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/60/9159/abstract/43\">",
"      Barlassina C, Dal Fiume C, Lanzani C, et al. Common genetic variants and haplotypes in renal CLCNKA gene are associated to salt-sensitive hypertension. Hum Mol Genet 2007; 16:1630.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/60/9159/abstract/44\">",
"      Beetz N, Harrison MD, Brede M, et al. Phosducin influences sympathetic activity and prevents stress-induced hypertension in humans and mice. J Clin Invest 2009; 119:3597.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/60/9159/abstract/45\">",
"      Salvi E, Kutalik Z, Glorioso N, et al. Genomewide association study using a high-density single nucleotide polymorphism array and case-control design identifies a novel essential hypertension susceptibility locus in the promoter region of endothelial NO synthase. Hypertension 2012; 59:248.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/60/9159/abstract/46\">",
"      Geller DS, Farhi A, Pinkerton N, et al. Activating mineralocorticoid receptor mutation in hypertension exacerbated by pregnancy. Science 2000; 289:119.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/60/9159/abstract/47\">",
"      Luft FC, Toka O, Toka HR, et al. Mendelian hypertension with brachydactyly as a molecular genetic lesson in regulatory physiology. Am J Physiol Regul Integr Comp Physiol 2003; 285:R709.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/60/9159/abstract/48\">",
"      Neumann HP, Hoegerle S, Manz T, et al. How many pathways to pheochromocytoma? Semin Nephrol 2002; 22:89.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/60/9159/abstract/49\">",
"      Liu C, Yang Q, Hwang SJ, et al. Association of genetic variation in the mitochondrial genome with blood pressure and metabolic traits. Hypertension 2012; 60:949.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/60/9159/abstract/50\">",
"      Wilson FH, Hariri A, Farhi A, et al. A cluster of metabolic defects caused by mutation in a mitochondrial tRNA. Science 2004; 306:1190.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 3847 Version 7.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1004-122.72.76.133-15E18CE5C3-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_60_9159=[""].join("\n");
var outline_f8_60_9159=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H10\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      GENETIC FACTORS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Importance of the kidney",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Identified prohypertensive genetic mutations",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Possible involvement of the angiotensinogen gene",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Possible involvement of adducin genes",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Possible involvement of the connexin40 gene",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Other candidate genes",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Other rare forms of hereditary hypertension",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/56/40838?source=related_link\">",
"      Apparent mineralocorticoid excess syndromes (including chronic licorice ingestion)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/13/5338?source=related_link\">",
"      Approach to the patient with hypertension and hypokalemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/43/23226?source=related_link\">",
"      Bartter and Gitelman syndromes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/32/15878?source=related_link\">",
"      Congenital adrenal hyperplasia due to 11-beta-hydroxylase deficiency",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/44/9930?source=related_link\">",
"      Etiology, diagnosis, and treatment of hypoaldosteronism (type 4 RTA)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/5/22615?source=related_link\">",
"      Familial hyperaldosteronism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/51/25399?source=related_link\">",
"      Genetic disorders of the collecting tubule sodium channel: Liddle's syndrome and pseudohypoaldosteronism type 1",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f8_60_9160="Maternal gastrointestinal tract adaptation to pregnancy";
var content_f8_60_9160=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Maternal gastrointestinal tract adaptation to pregnancy",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?8/60/9160/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?8/60/9160/contributors\">",
"     Angela Bianco, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?8/60/9160/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?8/60/9160/contributors\">",
"     Charles J Lockwood, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?8/60/9160/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?8/60/9160/contributors\">",
"     Vanessa A Barss, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?8/60/9160/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Nov 21, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pregnancy has little, if any, effect on gastrointestinal secretion or absorption, but it has a major effect on gastrointestinal motility. Pregnancy-related changes in motility are present throughout the gastrointestinal tract and are related to increased levels of female sex hormones. In addition, the enlarging uterus displaces bowel, which can affect the presentation of disorders such as appendicitis. Knowledge of the gastrointestinal adaptation to pregnancy is necessary for accurate interpretation of laboratory tests, as well as imaging studies in the gravid patient.",
"   </p>",
"   <p>",
"    Maternal gastrointestinal tract changes during pregnancy and common gastrointestinal disorders related to pregnancy will be reviewed here.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     OROPHARYNX",
"    </span>",
"    &nbsp;&mdash;&nbsp;The mucous membrane lining the oropharynx is responsive to the hormonal changes related to pregnancy. The gingiva is primarily affected, while the teeth, tongue, and salivary glands are spared, although excessive salivation during pregnancy has been described [",
"    <a class=\"abstract\" href=\"UTD.htm?8/60/9160/abstract/1\">",
"     1",
"    </a>",
"    ]. The effect of pregnancy on the initiation or progression of caries is not clear; pregnancy-related changes in the oral environment (salivary pH, oral flora) or in maternal diet and oral hygiene may increase the risk of caries [",
"    <a class=\"abstract\" href=\"UTD.htm?8/60/9160/abstract/2\">",
"     2",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/62/35816?source=see_link&amp;anchor=H17#H17\">",
"     \"The skin, hair, nails, and mucous membranes during pregnancy\", section on 'Mucous membranes'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Taste",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most studies suggest that taste perception changes during pregnancy [",
"    <a class=\"abstract\" href=\"UTD.htm?8/60/9160/abstract/3-6\">",
"     3-6",
"    </a>",
"    ]. The etiology is unknown and the direction of taste change varies among studies.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Gingiva",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h3\">",
"     Gingivitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Enlargement and blunting of the interdigital papillae of the gingiva may result in gingival bleeding, ulceration, and pain. Gingival inflammatory symptoms are frequently aggravated during pregnancy; prevalence rates of 40 to 100 percent have been reported [",
"    <a class=\"abstract\" href=\"UTD.htm?8/60/9160/abstract/7\">",
"     7",
"    </a>",
"    ]. The cause of pregnancy-induced gingivitis (",
"    <a class=\"graphic graphic_picture graphicRef82278 \" href=\"UTD.htm?27/6/27744\">",
"     picture 1",
"    </a>",
"    ) is likely multifactorial and includes pregnancy hormone-related vascular and inflammatory changes [",
"    <a class=\"abstract\" href=\"UTD.htm?8/60/9160/abstract/8-12\">",
"     8-12",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Optimal oral hygiene can reduce gingival swelling, erythema, and bleeding tendencies; therefore, frequent brushing and flossing are important. Women with moderate to severe symptoms should consult with a dental professional. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/21/18777?source=see_link\">",
"     \"Gingivitis and periodontitis in adults: Classification and dental treatment\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     Pregnancy epulis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pregnancy epulis (also called granuloma gravidarum, pregnancy granuloma) is a benign lesion of the gingiva, particularly the interdental papillae, that also occurs on the oral mucosa, lips, and tongue, as well as the skin of nonpregnant individuals, where it is termed a pyogenic granuloma. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/5/29785?source=see_link\">",
"     \"Pyogenic granuloma (Lobular capillary hemangioma)\"",
"    </a>",
"    .) It is a small, soft, pink or red, smooth or lobulated, exophytic growth on a pedunculated or sessile base that develops over a few days to weeks and bleeds easily due to its vascularity. It is thought to arise in response to local",
"    <span class=\"nowrap\">",
"     irritation/trauma",
"    </span>",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    hormonal factors [",
"    <a class=\"abstract\" href=\"UTD.htm?8/60/9160/abstract/13\">",
"     13",
"    </a>",
"    ]. Spontaneous resolution usually occurs postpartum so no intervention is necessary. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/62/35816?source=see_link&amp;anchor=H6#H6\">",
"     \"The skin, hair, nails, and mucous membranes during pregnancy\", section on 'Vascular changes'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7836902\">",
"    <span class=\"h2\">",
"     Ptyalism or sialorrhea gravidarum",
"    </span>",
"    &nbsp;&mdash;&nbsp;Sialorrhea is defined as an increase in salivary flow. It has been associated with pregnancy and may be caused by gastroesophageal reflux, pregnancy-related nausea and vomiting, some medications (eg,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/21/35161?source=see_link\">",
"     clozapine",
"    </a>",
"    ), or irritants (eg, smoking). Treatment or removal of the underlying cause reduces excessive salivation [",
"    <a class=\"abstract\" href=\"UTD.htm?8/60/9160/abstract/14-16\">",
"     14-16",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    &ldquo;Pseudo&rdquo;-sialorrhea is caused by failure to swallow saliva that is being secreted at a normal rate. It may be due to dysphagia, neurologic disease, cultural customs, or psychologic disorders.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     ESOPHAGUS AND STOMACH",
"    </span>",
"    &nbsp;&mdash;&nbsp;It is not clear whether gastric acid secretion is altered in pregnant women. Gastric emptying is not affected by pregnancy [",
"    <a class=\"abstract\" href=\"UTD.htm?8/60/9160/abstract/17-19\">",
"     17-19",
"    </a>",
"    ]. During labor, however, gastric emptying is prolonged if sedative or opiate drugs are administered. A combination of factors related to pregnancy, supine position, and analgesia and anesthesia put pregnant women at high risk of aspiration during labor and delivery. In contrast to the stomach, transit time is prolonged in the small and large intestine (see",
"    <a class=\"local\" href=\"#H15\">",
"     'Bloating and constipation'",
"    </a>",
"    below) .",
"   </p>",
"   <p>",
"    Women with diabetes may have gastroparesis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/25/24985?source=see_link\">",
"     \"Diabetic autonomic neuropathy of the gastrointestinal tract\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Gastroesophageal reflux disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;Gastroesophageal reflux (heartburn) occurs in 30 to 50 percent of pregnancies, with the prevalence approaching 80 percent in some patient groups [",
"    <a class=\"abstract\" href=\"UTD.htm?8/60/9160/abstract/20\">",
"     20",
"    </a>",
"    ]. Women with gastroesophageal reflux prior to pregnancy are likely to continue to have symptoms when they are pregnant. Most studies report an increasing prevalence of symptoms from the first to the third trimester, with relief postpartum [",
"    <a class=\"abstract\" href=\"UTD.htm?8/60/9160/abstract/21\">",
"     21",
"    </a>",
"    ]. Gastroesophageal reflux tends to recur in subsequent pregnancies, and similarly affects multiparous and nulliparous women [",
"    <a class=\"abstract\" href=\"UTD.htm?8/60/9160/abstract/22\">",
"     22",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The pathogenesis of gastroesophageal reflux during pregnancy involves both mechanical and intrinsic factors that adversely affect lower esophageal sphincter tone. Lower esophageal sphincter pressure is below the lower limits of normal in all trimesters, returning to normal in the postpartum period [",
"    <a class=\"abstract\" href=\"UTD.htm?8/60/9160/abstract/23-25\">",
"     23-25",
"    </a>",
"    ]. A study of women during early pregnancy and six weeks after pregnancy termination also demonstrated an inappropriate response of the sphincter to injections with pentagastrin,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/21/35156?source=see_link\">",
"     edrophonium",
"    </a>",
"    , and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?10/32/10756?source=see_link\">",
"     methacholine",
"    </a>",
"    , or a protein meal [",
"    <a class=\"abstract\" href=\"UTD.htm?8/60/9160/abstract/25\">",
"     25",
"    </a>",
"    ]. Thus, it appears that pregnancy is associated with both decreased lower esophageal sphincter pressure and inhibition of the adaptive responses of the sphincter.",
"   </p>",
"   <p>",
"    Animal and human experiments have helped elucidate the effects of female sex hormones on the lower esophageal sphincter. In vivo models (using the opossum) showed a substantial reduction of lower esophageal tone with the administration of both estradiol and progesterone [",
"    <a class=\"abstract\" href=\"UTD.htm?8/60/9160/abstract/26\">",
"     26",
"    </a>",
"    ]. Whether the decrease in tone was due to estrogen, progesterone, or both, is unclear. Some studies suggest that progesterone is the mediator of lower esophageal sphincter muscle relaxation; however, estrogen may be needed as a primer for this action to occur [",
"    <a class=\"abstract\" href=\"UTD.htm?8/60/9160/abstract/27\">",
"     27",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The clinical features of gastroesophageal reflux in pregnancy do not differ from those found in the general population. Dyspepsia and regurgitation are the predominant symptoms, worsening as pregnancy advances. Complications of reflux disease during pregnancy, such as dysphagia, are uncommon, and reflux symptoms are usually limited to pregnancy with no prolonged adverse effects [",
"    <a class=\"abstract\" href=\"UTD.htm?8/60/9160/abstract/28\">",
"     28",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/41/22168?source=see_link\">",
"     \"Clinical manifestations and diagnosis of gastroesophageal reflux in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The diagnostic evaluation of pregnant women with gastroesophageal reflux generally requires only a complete history.",
"    <a class=\"drug drug_general\" href=\"UTD.htm?12/17/12564?source=see_link\">",
"     Barium",
"    </a>",
"    studies should be avoided because of the potential risks of radiation. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/29/28120?source=see_link\">",
"     \"Diagnostic imaging procedures during pregnancy\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Endoscopy appears to be safe and has been performed with and without conscious sedation (using",
"    <a class=\"drug drug_general\" href=\"UTD.htm?11/44/11976?source=see_link\">",
"     meperidine",
"    </a>",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    <a class=\"drug drug_general\" href=\"UTD.htm?15/46/16105?source=see_link\">",
"     diazepam",
"    </a>",
"    ), but is typically only indicated if symptoms are unremitting despite medical therapy and lifestyle alterations, or if additional symptoms are present, such as hematemesis or dysphagia. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/44/42694?source=see_link\">",
"     \"Sedation-free gastrointestinal endoscopy\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/22/24936?source=see_link\">",
"     \"Overview of procedural sedation for gastrointestinal endoscopy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Management",
"    </span>",
"    &nbsp;&mdash;&nbsp;Minimal, but logical, therapy for gastrointestinal reflux consists of lifestyle modification including elevation of the head of the bed, dietary modification, antacids (as needed), and use of H2 receptor antagonists or proton pump inhibitors, as needed.",
"   </p>",
"   <p>",
"    Lifestyle modifications are aimed at enhancing esophageal acid clearance, minimizing the incidence of reflux events, or both. Women are instructed to elevate the head of the bed, eat small frequent meals, and refrain from eating at least three hours prior to bedtime. Lifestyle modifications, including dietary modifications, are described in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/53/42840?source=see_link&amp;anchor=H2#H2\">",
"     \"Medical management of gastroesophageal reflux disease in adults\", section on 'Lifestyle modifications'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Nonsystemic drug therapy with antacids should be the initial drug therapy when the woman does not respond to lifestyle modifications. Animal studies have not observed teratogenic effects from ingestion of antacids during pregnancy [",
"    <a class=\"abstract\" href=\"UTD.htm?8/60/9160/abstract/29\">",
"     29",
"    </a>",
"    ]. Adverse effects of antacids include interference with iron absorption and, if excessive",
"    <a class=\"drug drug_general\" href=\"UTD.htm?0/52/840?source=see_link\">",
"     sodium bicarbonate",
"    </a>",
"    is ingested, metabolic alkalosis and fluid overload in both fetus and mother [",
"    <a class=\"abstract\" href=\"UTD.htm?8/60/9160/abstract/30\">",
"     30",
"    </a>",
"    ].",
"    <a class=\"drug drug_general\" href=\"UTD.htm?28/29/29141?source=see_link\">",
"     Sucralfate",
"    </a>",
"    is likely safe because this drug is not absorbed [",
"    <a class=\"abstract\" href=\"UTD.htm?8/60/9160/abstract/31\">",
"     31",
"    </a>",
"    ]. A study comparing sucralfate (1 g orally three times daily) with lifestyle modifications found the sucralfate group had significant improvement in heartburn and regurgitation after 15 and 30 days [",
"    <a class=\"abstract\" href=\"UTD.htm?8/60/9160/abstract/32\">",
"     32",
"    </a>",
"    ]. There are theoretic concerns regarding chronic",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/29/35285?source=see_link\">",
"     bismuth",
"    </a>",
"    ingestion (eg, Pepto-Bismol) in late pregnancy, but human fetal toxicity from this preparation has not been demonstrated [",
"    <a class=\"abstract\" href=\"UTD.htm?8/60/9160/abstract/33\">",
"     33",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Use of systemic acid-inhibiting drugs (H2 receptor antagonists or proton pump inhibitors) during pregnancy is discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/53/42840?source=see_link&amp;anchor=H18#H18\">",
"     \"Medical management of gastroesophageal reflux disease in adults\", section on 'Pregnancy'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Aspiration of gastric contents",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pregnant women are predisposed to gastric aspiration due to increased intraabdominal pressure and relaxation of the lower esophageal sphincter associated with pregnancy. They are at highest risk of occurrence during labor or soon after delivery, presumably as a consequence of sedation and assumption of a recumbent position. Aspiration may also occur as a complication of general anesthesia and intubation for an emergent cesarean delivery. Aspiration pneumonia, acute bronchospasm, or the acute respiratory distress syndrome may ensue. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/18/31017?source=see_link\">",
"     \"Aspiration pneumonia in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/16/10505?source=see_link\">",
"     \"Acute respiratory distress syndrome: Clinical features and diagnosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     LIVER",
"    </span>",
"    &nbsp;&mdash;&nbsp;In late pregnancy, physical examination of the liver is difficult because of the expanding uterus. The enlarging uterus causes a progressive upward displacement of the diaphragm, to a maximum of 4 cm, and the liver is forced up further into the chest, as well. A palpable liver is an abnormal finding. On ultrasound examination, the biliary tract is usually normal. Because of hemodilution, serum albumin levels decrease during the first trimester, and this decrement becomes more accentuated with advancing gestation.",
"   </p>",
"   <p>",
"    Serum total cholesterol and triglyceride concentrations increase markedly during pregnancy [",
"    <a class=\"abstract\" href=\"UTD.htm?8/60/9160/abstract/34-36\">",
"     34-36",
"    </a>",
"    ]. Reported ranges vary among studies. In one large series, the 95th percentile of the distributions in the second and the third trimesters were: total triglyceride 254 and 415",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    (2.87 and 4.68",
"    <span class=\"nowrap\">",
"     mmol/L),",
"    </span>",
"    respectively; total cholesterol 319 and 380",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    (8.24 and 9.83",
"    <span class=\"nowrap\">",
"     mmol/L),",
"    </span>",
"    respectively; LDL-cholesterol 217 and 251",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    (5.61 and 6.48",
"    <span class=\"nowrap\">",
"     mmol/L),",
"    </span>",
"    respectively; and the fifth percentile of HDL-cholesterol distribution was 42 and 40",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    (1.09 and 1.04",
"    <span class=\"nowrap\">",
"     mmol/L),",
"    </span>",
"    respectively [",
"    <a class=\"abstract\" href=\"UTD.htm?8/60/9160/abstract/36\">",
"     36",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Serum alkaline phosphatase concentrations are significantly higher (up to two to four times normal) in the third trimester, primarily due to placental synthesis of alkaline phosphatase. Serum gammaglutamyl transpeptidase is significantly reduced and 5'-nucleotidase is slightly increased. The other liver biochemical tests are either normal or slightly increased or decreased, but remain within the normal range [",
"    <a class=\"abstract\" href=\"UTD.htm?8/60/9160/abstract/37\">",
"     37",
"    </a>",
"    ]. Thus, an increase in serum aminotransferase, bilirubin, or fasting total bile acid concentrations during pregnancy may be pathologic and should prompt further evaluation. The prothrombin time is unchanged during pregnancy, and serum fibrinogen increases in late pregnancy.",
"   </p>",
"   <p>",
"    Additional issues regarding the effect of pregnancy on the liver are discussed separately.",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?25/37/26198?source=see_link\">",
"       \"Approach to liver disease occurring during pregnancy\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?14/24/14726?source=see_link\">",
"       \"Intercurrent hepatobiliary disease during pregnancy\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?4/32/4617?source=see_link\">",
"       \"Intrahepatic cholestasis of pregnancy\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?22/15/22777?source=see_link\">",
"       \"Pregnancy in women with pre-existing chronic liver disease\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?23/38/24166?source=see_link\">",
"       \"Acute fatty liver of pregnancy\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     GALLBLADDER",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pregnancy decreases gallbladder motility and increases the lithogenicity of bile. On ultrasound examination, fasting gallbladder volume and residual volume after contraction may be increased, with no change in the size of the common hepatic duct [",
"    <a class=\"abstract\" href=\"UTD.htm?8/60/9160/abstract/38\">",
"     38",
"    </a>",
"    ]. Epidemiologic studies have shown that pregnancy is associated with an increased risk for gallstones. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/24/14726?source=see_link&amp;anchor=H9#H9\">",
"     \"Intercurrent hepatobiliary disease during pregnancy\", section on 'Gallstones'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h1\">",
"     PANCREAS",
"    </span>",
"    &nbsp;&mdash;&nbsp;There is a paucity of information on the effect of pregnancy and sex steroid hormones on pancreatic secretion. Amylase levels have been reported to remain in the normal range or be slightly elevated [",
"    <a class=\"abstract\" href=\"UTD.htm?8/60/9160/abstract/37,39-41\">",
"     37,39-41",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Acute pancreatitis during pregnancy is rare. Most cases are associated with gallstones and, like acute cholecystitis, the incidence increases with advancing gestational age [",
"    <a class=\"abstract\" href=\"UTD.htm?8/60/9160/abstract/42\">",
"     42",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/61/14297?source=see_link\">",
"     \"Etiology of acute pancreatitis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h1\">",
"     BOWEL, RECTUM, ANUS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Bowel and anorectal symptoms, such as constipation, incontinence, and hemorrhoids, are common during pregnancy and postpartum [",
"    <a class=\"abstract\" href=\"UTD.htm?8/60/9160/abstract/43\">",
"     43",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Bloating and constipation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pregnant women frequently complain of abdominal bloating and constipation. Prospective longitudinal studies of pregnant women using Rome II criteria to define constipation found the prevalence of constipation ranged from 16 to 39 percent in each trimester of pregnancy and 6 to 12 weeks postpartum [",
"    <a class=\"abstract\" href=\"UTD.htm?8/60/9160/abstract/44,45\">",
"     44,45",
"    </a>",
"    ]. This is higher than the baseline rate of constipation (7 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?8/60/9160/abstract/44\">",
"     44",
"    </a>",
"    ]) in nonpregnant women of similar age. Pregnant women become constipated for the same reasons as the general population; in addition, pregnancy-related factors can promote constipation. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/22/13673?source=see_link&amp;anchor=H2#H2\">",
"     \"Etiology and evaluation of chronic constipation in adults\", section on 'Definition of constipation'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Abdominal bloating and constipation during pregnancy are probably caused by hormonal changes that affect small bowel and colonic motility. Increased progesterone concentration probably plays the major role in decreasing the activity of colonic smooth muscle, but other hormones may be involved. Animal and human studies evaluating gastrointestinal transit during pregnancy and in relation to hormonal changes during the estrus cycle support this concept [",
"    <a class=\"abstract\" href=\"UTD.htm?8/60/9160/abstract/46-49\">",
"     46-49",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    For example, a study that measured gastrointestinal transit time and sex hormone concentrations in 15 women during their third trimester of pregnancy and four to six weeks postpartum found that small bowel transit time was significantly longer during pregnancy when progesterone and estradiol levels were increased compared to the postpartum period when the hormonal levels had fallen [",
"    <a class=\"abstract\" href=\"UTD.htm?8/60/9160/abstract/46\">",
"     46",
"    </a>",
"    ]. Another study noted that intestinal transit times were prolonged in both the second and third trimesters of pregnancy compared to the first trimester or the postpartum period [",
"    <a class=\"abstract\" href=\"UTD.htm?8/60/9160/abstract/47\">",
"     47",
"    </a>",
"    ]. A third study showed that progesterone inhibited both the amplitude and frequency of spontaneous colon muscle activity, while estrogen and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?31/49/32528?source=see_link\">",
"     hydrocortisone",
"    </a>",
"    had no effect [",
"    <a class=\"abstract\" href=\"UTD.htm?8/60/9160/abstract/49\">",
"     49",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    However, other factors may also contribute to the prolongation in transit time. The plasma concentration of motilin (a stimulatory gastrointestinal hormone) is reduced during pregnancy, possibly because progesterone may inhibit motilin release [",
"    <a class=\"abstract\" href=\"UTD.htm?8/60/9160/abstract/50\">",
"     50",
"    </a>",
"    ]. In addition, the gravid uterus can cause mechanical impedance to small bowel transit, particularly late in gestation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Incontinence of feces and flatus",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pregnancy appears to be a risk factor for fecal incontinence and increased flatus [",
"    <a class=\"abstract\" href=\"UTD.htm?8/60/9160/abstract/51\">",
"     51",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/56/9097?source=see_link\">",
"     \"Fecal incontinence related to pregnancy and vaginal delivery\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Hemorrhoids",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hemorrhoids are varicosities in the anal canal caused by local pressure. Hemorrhoidal disease is particularly frequent in the last trimester of pregnancy and immediately postpartum: approximately 30 to 40 percent of pregnant women are affected by hemorrhoidal discomfort. Symptoms include pruritus, discomfort,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    bleeding. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/14/5348?source=see_link\">",
"     \"Overview of hemorrhoids\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Constipation exacerbates these symptoms; therefore, adequate hydration and a diet replete with fiber are advisable. Treatment for relief of symptoms consists of conservative medical management using local application of antiinflammatory, antipruritic, and local anesthetic preparations. Recurrent and severe hemorrhoids usually require surgical treatment, typically hemorrhoidectomy, which can be performed safely during pregnancy if necessary [",
"    <a class=\"abstract\" href=\"UTD.htm?8/60/9160/abstract/52\">",
"     52",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/61/6105?source=see_link\">",
"     \"Treatment of hemorrhoids\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topic (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?23/42/24226?source=see_link\">",
"       \"Patient information: Acid reflux (gastroesophageal reflux disease) during pregnancy (The Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?22/55/23411?source=see_link\">",
"       \"Patient information: Pregnancy symptoms (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Oropharyngeal changes in pregnancy include pregnancy epulis, gingivitis, increased salivation, and changes in taste. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Oropharynx'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Gastrointestinal reflux is common in pregnancy because of decreased lower esophageal sphincter pressure and inhibition of the adaptive responses of the sphincter. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Gastroesophageal reflux disease'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Pregnant women are predisposed to gastric aspiration due to increased intraabdominal pressure and relaxation of the lower esophageal sphincter. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Aspiration of gastric contents'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Serum aminotransferase, bilirubin, and fasting total bile acid concentrations remain within the normal range during pregnancy. Serum albumin and gammaglutamyl transpeptidase levels are significantly reduced, whereas lipids and alkaline phosphatase levels are significantly increased. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Liver'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Gallbladder volume and the lithogenicity of bile are increased. (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Gallbladder'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Amylase levels appear to remain in the normal range or be slightly elevated. (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Pancreas'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Abdominal bloating and constipation during pregnancy are probably caused by hormonal changes (increased progesterone concentration) that reduce small bowel and colonic motility. (See",
"      <a class=\"local\" href=\"#H15\">",
"       'Bloating and constipation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Fecal incontinence and flatus are more common during pregnancy. (See",
"      <a class=\"local\" href=\"#H18\">",
"       'Incontinence of feces and flatus'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Hemorrhoids are common in pregnancy, due to increased local venous pressure and an increased prevalence of constipation. (See",
"      <a class=\"local\" href=\"#H19\">",
"       'Hemorrhoids'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/60/9160/abstract/1\">",
"      BERNSTINE RL, FRIEDMAN MH. Salivation in pregnant and nonpregnant women. Obstet Gynecol 1957; 10:184.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/60/9160/abstract/2\">",
"      Laine MA. Effect of pregnancy on periodontal and dental health. Acta Odontol Scand 2002; 60:257.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/60/9160/abstract/3\">",
"      Ochsenbein-K&ouml;lble N, von Mering R, Zimmermann R, Hummel T. Changes in gustatory function during the course of pregnancy and postpartum. BJOG 2005; 112:1636.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/60/9160/abstract/4\">",
"      Duffy VB, Bartoshuk LM, Striegel-Moore R, Rodin J. Taste changes across pregnancy. Ann N Y Acad Sci 1998; 855:805.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/60/9160/abstract/5\">",
"      Kuga M, Ikeda M, Suzuki K, Takeuchi S. Changes in gustatory sense during pregnancy. Acta Otolaryngol Suppl 2002; :146.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/60/9160/abstract/6\">",
"      K&ouml;lble N, Hummel T, von Mering R, et al. Gustatory and olfactory function in the first trimester of pregnancy. Eur J Obstet Gynecol Reprod Biol 2001; 99:179.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/60/9160/abstract/7\">",
"      Lee, H, Silness, J. Periodental disease in pregnancy. Acta Odontol Scan 1963; 21:533.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/60/9160/abstract/8\">",
"      Raber-Durlacher JE, van Steenbergen TJ, Van der Velden U, et al. Experimental gingivitis during pregnancy and post-partum: clinical, endocrinological, and microbiological aspects. J Clin Periodontol 1994; 21:549.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/60/9160/abstract/9\">",
"      GUSTAFSSON GT, NILSSON IM. Fibrinolytic activity in fluid from gingival crevice. Proc Soc Exp Biol Med 1961; 106:277.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/60/9160/abstract/10\">",
"      Kinnby, B, Lecander, I, Martinsson, G, Astedt, B. Tissue plasminogen activator and placental plasminogen activator inhibitor in human gingival fluid. Fibrinolysis 1991; 5:239.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/60/9160/abstract/11\">",
"      Kinnby, B, Astedt, B, Casslen, B. Reduction of PAI-2 production in cultured human peripheral blood monocytes by estradiol and progesterone on effect on t-PA, a-PA, and PAI-1. Fibrinolysis 1995; 9:152.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/60/9160/abstract/12\">",
"      Kinnby B, Matsson L, Astedt B. Aggravation of gingival inflammatory symptoms during pregnancy associated with the concentration of plasminogen activator inhibitor type 2 (PAI-2) in gingival fluid. J Periodontal Res 1996; 31:271.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/60/9160/abstract/13\">",
"      Jafarzadeh H, Sanatkhani M, Mohtasham N. Oral pyogenic granuloma: a review. J Oral Sci 2006; 48:167.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/60/9160/abstract/14\">",
"      Freeman JJ, Altieri RH, Baptiste HJ, et al. Evaluation and management of sialorrhea of pregnancy with concomitant hyperemesis. J Natl Med Assoc 1994; 86:704.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/60/9160/abstract/15\">",
"      Van Dinter MC. Ptyalism in pregnant women. J Obstet Gynecol Neonatal Nurs 1991; 20:206.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/60/9160/abstract/16\">",
"      Mandel L, Tamari K. Sialorrhea and gastroesophageal reflux. J Am Dent Assoc 1995; 126:1537.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/60/9160/abstract/17\">",
"      Chiloiro M, Darconza G, Piccioli E, et al. Gastric emptying and orocecal transit time in pregnancy. J Gastroenterol 2001; 36:538.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/60/9160/abstract/18\">",
"      Whitehead EM, Smith M, Dean Y, O'Sullivan G. An evaluation of gastric emptying times in pregnancy and the puerperium. Anaesthesia 1993; 48:53.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/60/9160/abstract/19\">",
"      Wong CA, Loffredi M, Ganchiff JN, et al. Gastric emptying of water in term pregnancy. Anesthesiology 2002; 96:1395.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/60/9160/abstract/20\">",
"      Bassey OO. Pregnancy heartburn in Nigerians and Caucasians with theories about aetiology based on manometric recordings from the oesophagus and stomach. Br J Obstet Gynaecol 1977; 84:439.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/60/9160/abstract/21\">",
"      Rey E, Rodriguez-Artalejo F, Herraiz MA, et al. Gastroesophageal reflux symptoms during and after pregnancy: a longitudinal study. Am J Gastroenterol 2007; 102:2395.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/60/9160/abstract/22\">",
"      Castro Lde P. Reflux esophagitis as the cause of heartburn in pregnancy. Am J Obstet Gynecol 1967; 98:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/60/9160/abstract/23\">",
"      Bainbridge ET, Temple JG, Nicholas SP, et al. Symptomatic gastro-oesophageal reflux in pregnancy. A comparative study of white Europeans and Asians in Birmingham. Br J Clin Pract 1983; 37:53.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/60/9160/abstract/24\">",
"      Van Thiel DH, Gavaler JS, Joshi SN, et al. Heartburn of pregnancy. Gastroenterology 1977; 72:666.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/60/9160/abstract/25\">",
"      Fisher RS, Roberts GS, Grabowski CJ, Cohen S. Altered lower esophageal sphincter function during early pregnancy. Gastroenterology 1978; 74:1233.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/60/9160/abstract/26\">",
"      Schulze K, Christensen J. Lower sphincter of the opossum esophagus in pseudopregnancy. Gastroenterology 1977; 73:1082.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/60/9160/abstract/27\">",
"      Van Thiel DH, Gavaler JS, Stremple J. Lower esophageal sphincter pressure in women using sequential oral contraceptives. Gastroenterology 1976; 71:232.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/60/9160/abstract/28\">",
"      Lewis JH, Weingold AB. The use of gastrointestinal drugs during pregnancy and lactation. Am J Gastroenterol 1985; 80:912.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/60/9160/abstract/29\">",
"      Hodgkinson R, Glassenberg R, Joyce TH 3rd, et al. Comparison of cimetidine (Tagamet) with antacid for safety and effectiveness in reducing gastric acidity before elective cesarean section. Anesthesiology 1983; 59:86.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/60/9160/abstract/30\">",
"      Witter FR, King TM, Blake DA. The effects of chronic gastrointestinal medication on the fetus and neonate. Obstet Gynecol 1981; 58:79S.",
"     </a>",
"    </li>",
"    <li>",
"     Physician's Desk Reference. 46th edition. Medical Economics Company Inc, Oradel, New Jersey 1992.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/60/9160/abstract/32\">",
"      Ranchet, G, Gangemi, O, Petrone, M. Sucralfate in the treatment of gravidic pyrosis. Giornia Italiano de Ostericia Ginecologia 1990; 12:1.",
"     </a>",
"    </li>",
"    <li>",
"     www.reprotox.org. (Accessed January 4, 2008).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/60/9160/abstract/34\">",
"      Wiznitzer A, Mayer A, Novack V, et al. Association of lipid levels during gestation with preeclampsia and gestational diabetes mellitus: a population-based study. Am J Obstet Gynecol 2009; 201:482.e1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/60/9160/abstract/35\">",
"      Brizzi P, Tonolo G, Esposito F, et al. Lipoprotein metabolism during normal pregnancy. Am J Obstet Gynecol 1999; 181:430.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/60/9160/abstract/36\">",
"      Piechota W, Staszewski A. Reference ranges of lipids and apolipoproteins in pregnancy. Eur J Obstet Gynecol Reprod Biol 1992; 45:27.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/60/9160/abstract/37\">",
"      Larsson A, Palm M, Hansson LO, Axelsson O. Reference values for clinical chemistry tests during normal pregnancy. BJOG 2008; 115:874.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/60/9160/abstract/38\">",
"      Mintz MC, Grumbach K, Arger PH, Coleman BG. Sonographic evaluation of bile duct size during pregnancy. AJR Am J Roentgenol 1985; 145:575.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/60/9160/abstract/39\">",
"      Kaiser R, Berk JE, Fridhandler L. Serum amylase changes during pregnancy. Am J Obstet Gynecol 1975; 122:283.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/60/9160/abstract/40\">",
"      Strickland DM, Hauth JC, Widish J, et al. Amylase and isoamylase activities in serum of pregnant women. Obstet Gynecol 1984; 63:389.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/60/9160/abstract/41\">",
"      Karsenti D, Bacq Y, Br&eacute;chot JF, et al. Serum amylase and lipase activities in normal pregnancy: a prospective case-control study. Am J Gastroenterol 2001; 96:697.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/60/9160/abstract/42\">",
"      Ramin KD, Ramin SM, Richey SD, Cunningham FG. Acute pancreatitis in pregnancy. Am J Obstet Gynecol 1995; 173:187.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/60/9160/abstract/43\">",
"      O'Boyle AL, O'Boyle JD, Magann EF, et al. Anorectal symptoms in pregnancy and the postpartum period. J Reprod Med 2008; 53:151.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/60/9160/abstract/44\">",
"      Bradley CS, Kennedy CM, Turcea AM, et al. Constipation in pregnancy: prevalence, symptoms, and risk factors. Obstet Gynecol 2007; 110:1351.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/60/9160/abstract/45\">",
"      Derbyshire E, Davies J, Costarelli V, Dettmar P. Diet, physical inactivity and the prevalence of constipation throughout and after pregnancy. Matern Child Nutr 2006; 2:127.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/60/9160/abstract/46\">",
"      Wald A, Van Thiel DH, Hoechstetter L, et al. Effect of pregnancy on gastrointestinal transit. Dig Dis Sci 1982; 27:1015.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/60/9160/abstract/47\">",
"      Lawson M, Kern F Jr, Everson GT. Gastrointestinal transit time in human pregnancy: prolongation in the second and third trimesters followed by postpartum normalization. Gastroenterology 1985; 89:996.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/60/9160/abstract/48\">",
"      Ryan JP, Bhojwani A. Colonic transit in rats: effect of ovariectomy, sex steroid hormones, and pregnancy. Am J Physiol 1986; 251:G46.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/60/9160/abstract/49\">",
"      Kumar, D. In vitro inhibitory effect of progesterone on extrauterine human smooth muscle. Obstet Gynecol 1962; 84:1300.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/60/9160/abstract/50\">",
"      Christofides ND, Ghatei MA, Bloom SR, et al. Decreased plasma motilin concentrations in pregnancy. Br Med J (Clin Res Ed) 1982; 285:1453.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/60/9160/abstract/51\">",
"      Chaliha C, Sultan AH, Bland JM, et al. Anal function: effect of pregnancy and delivery. Am J Obstet Gynecol 2001; 185:427.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/60/9160/abstract/52\">",
"      Saleeby RG Jr, Rosen L, Stasik JJ, et al. Hemorrhoidectomy during pregnancy: risk or relief? Dis Colon Rectum 1991; 34:260.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 407 Version 10.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-183.166.191.243-1D72A0B336-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_60_9160=[""].join("\n");
var outline_f8_60_9160=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H20\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      OROPHARYNX",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Taste",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Gingiva",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      - Gingivitis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - Pregnancy epulis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7836902\">",
"      Ptyalism or sialorrhea gravidarum",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      ESOPHAGUS AND STOMACH",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Gastroesophageal reflux disease",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Management",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Aspiration of gastric contents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      LIVER",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      GALLBLADDER",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      PANCREAS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      BOWEL, RECTUM, ANUS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Bloating and constipation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Incontinence of feces and flatus",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Hemorrhoids",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"OBGYN/407\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"OBGYN/407|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?27/6/27744\" title=\"picture 1\">",
"      Pregnancy gingivitis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/38/24166?source=related_link\">",
"      Acute fatty liver of pregnancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/16/10505?source=related_link\">",
"      Acute respiratory distress syndrome: Clinical features and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/37/26198?source=related_link\">",
"      Approach to liver disease occurring during pregnancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/18/31017?source=related_link\">",
"      Aspiration pneumonia in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/41/22168?source=related_link\">",
"      Clinical manifestations and diagnosis of gastroesophageal reflux in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/25/24985?source=related_link\">",
"      Diabetic autonomic neuropathy of the gastrointestinal tract",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/29/28120?source=related_link\">",
"      Diagnostic imaging procedures during pregnancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/22/13673?source=related_link\">",
"      Etiology and evaluation of chronic constipation in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/61/14297?source=related_link\">",
"      Etiology of acute pancreatitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/56/9097?source=related_link\">",
"      Fecal incontinence related to pregnancy and vaginal delivery",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/21/18777?source=related_link\">",
"      Gingivitis and periodontitis in adults: Classification and dental treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/24/14726?source=related_link\">",
"      Intercurrent hepatobiliary disease during pregnancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/32/4617?source=related_link\">",
"      Intrahepatic cholestasis of pregnancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/53/42840?source=related_link\">",
"      Medical management of gastroesophageal reflux disease in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/14/5348?source=related_link\">",
"      Overview of hemorrhoids",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/22/24936?source=related_link\">",
"      Overview of procedural sedation for gastrointestinal endoscopy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?23/42/24226?source=related_link\">",
"      Patient information: Acid reflux (gastroesophageal reflux disease) during pregnancy (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?22/55/23411?source=related_link\">",
"      Patient information: Pregnancy symptoms (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/15/22777?source=related_link\">",
"      Pregnancy in women with pre-existing chronic liver disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/5/29785?source=related_link\">",
"      Pyogenic granuloma (Lobular capillary hemangioma)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/44/42694?source=related_link\">",
"      Sedation-free gastrointestinal endoscopy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/62/35816?source=related_link\">",
"      The skin, hair, nails, and mucous membranes during pregnancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/61/6105?source=related_link\">",
"      Treatment of hemorrhoids",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f8_60_9161="Physical activity and exercise in older adults";
var content_f8_60_9161=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Physical activity and exercise in older adults",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?8/60/9161/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?8/60/9161/contributors\">",
"     Miriam C Morey, PhD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?8/60/9161/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?8/60/9161/contributors\">",
"     Kenneth E Schmader, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?8/60/9161/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?8/60/9161/contributors\">",
"     Fenny H Lin, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?8/60/9161/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jul 30, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H4894156\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;In western countries, the proportion of people over age 60 years is increasing faster than any other age group [",
"    <a class=\"abstract\" href=\"UTD.htm?8/60/9161/abstract/1\">",
"     1",
"    </a>",
"    ]. This is attributed to longer life expectancies, decreasing fertility rates, and aging of the baby boomer population. By the year 2050 over 80 million people in the United Stated will be over age 65 [",
"    <a class=\"abstract\" href=\"UTD.htm?8/60/9161/abstract/2\">",
"     2",
"    </a>",
"    ]. Numbers of adults over age 85 will also reach unprecedented levels. Individuals who are regularly physically active report better overall health, lower health care expenditures, and fewer mobility limitations than their sedentary counterparts [",
"    <a class=\"abstract\" href=\"UTD.htm?8/60/9161/abstract/3-5\">",
"     3-5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    This topic will review the benefits of physical activity in the geriatric population and make specific recommendations for how to engage older adults in appropriate exercise. Several other topics in UpToDate discuss the role of exercise in the general population. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/46/28394?source=see_link\">",
"     \"Overview of the benefits and risks of exercise\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/28/14793?source=see_link\">",
"     \"Exercise and fitness in the prevention of cardiovascular disease\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/35/25144?source=see_link\">",
"     \"Exercise physiology\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H96786655\">",
"    <span class=\"h1\">",
"     BENEFITS OF PHYSICAL ACTIVITY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Aerobic capacity, muscle mass, and strength decline with age. These changes can have considerable impact on the ability to perform daily activities. By age alone, a healthy 80-year-old woman might be very close to the strength threshold necessary to rise from an armless chair or toilet [",
"    <a class=\"abstract\" href=\"UTD.htm?8/60/9161/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Aerobic capacity declines at about 1 percent per year from mid-life forward and at one-half that rate among habitually active persons [",
"    <a class=\"abstract\" href=\"UTD.htm?8/60/9161/abstract/7\">",
"     7",
"    </a>",
"    ]. Loss of muscle mass and strength are also thought to accelerate after mid-life. In a study of 1880 older men and women, both men and women lost knee strength over a three year period [",
"    <a class=\"abstract\" href=\"UTD.htm?8/60/9161/abstract/8\">",
"     8",
"    </a>",
"    ]. The decline in strength was greater in men than women, and greater among African Americans than whites. Lean-mass loss was about 1 percent per year but was accompanied by losses in strength ranging from 2.6 percent among white women to 4.1 percent among African American men.",
"   </p>",
"   <p>",
"    Thus there is an imperative to encourage physical activity in the older population and to place emphasis on incorporating muscle-strengthening activities into an activity plan. Unfortunately, uptake of muscle-strengthening activities among older adults is low [",
"    <a class=\"abstract\" href=\"UTD.htm?8/60/9161/abstract/9\">",
"     9",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Physical activity benefits people of all ages and may decrease all-cause morbidity and increase lifespan (",
"    <a class=\"graphic graphic_table graphicRef59285 \" href=\"UTD.htm?19/51/20284\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?8/60/9161/abstract/10-12\">",
"     10-12",
"    </a>",
"    ]. All older adults can benefit from physical activity; in the presence of chronic conditions, some physical activity is better than none and participation in any amount of physical activity will result in some health benefit [",
"    <a class=\"abstract\" href=\"UTD.htm?8/60/9161/abstract/13\">",
"     13",
"    </a>",
"    ]. A more detailed discussion of the evidence supporting the benefits of regular physical activity is presented separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/46/28394?source=see_link&amp;anchor=H10#H10\">",
"     \"Overview of the benefits and risks of exercise\", section on 'Benefits of exercise'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    For older adults, the benefits of increasing physical activity include [",
"    <a class=\"abstract\" href=\"UTD.htm?8/60/9161/abstract/14\">",
"     14",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Improved conditioning, strength, flexibility, and overall physical fitness [",
"      <a class=\"abstract\" href=\"UTD.htm?8/60/9161/abstract/15\">",
"       15",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Improved mobility [",
"      <a class=\"abstract\" href=\"UTD.htm?8/60/9161/abstract/16\">",
"       16",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Reduced risk of cardiovascular disease, thromboembolic stroke, hypertension, type 2 diabetes mellitus, osteoporosis, obesity, colon cancer, breast cancer, anxiety, depression, and cognitive decline [",
"      <a class=\"abstract\" href=\"UTD.htm?8/60/9161/abstract/17,18\">",
"       17,18",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Reduced likelihood of falls and fall-related injuries [",
"      <a class=\"abstract\" href=\"UTD.htm?8/60/9161/abstract/19\">",
"       19",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Possible decreased incidence and severity of functional limitations [",
"      <a class=\"abstract\" href=\"UTD.htm?8/60/9161/abstract/20,21\">",
"       20,21",
"      </a>",
"      ]. The evidence for this association is mixed. Cohort studies have consistently found lower rates of functional limitations among active older adults compared to individuals who are sedentary [",
"      <a class=\"abstract\" href=\"UTD.htm?8/60/9161/abstract/4,22\">",
"       4,22",
"      </a>",
"      ]. However, the degree to which physical activity or exercise interventions improve physical function is not clear due to comparable numbers of studies reporting improved versus unchanged physical performance following an intervention [",
"      <a class=\"abstract\" href=\"UTD.htm?8/60/9161/abstract/23\">",
"       23",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Improved patient outcomes in several chronic conditions, including mood disorders, dementia, chronic pain, congestive heart failure, stroke, constipation, and sleep disorders [",
"      <a class=\"abstract\" href=\"UTD.htm?8/60/9161/abstract/14,24-26\">",
"       14,24-26",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    It is never too late to become physically active. For older adults, the benefits of physical activity, including lower mortality and functional independence, occur with initiation and maintenance of exercise. Even individuals who are previously sedentary but initiate exercise as late as age 85 demonstrate a significant survival benefit in three years in comparison to individuals who are sedentary [",
"    <a class=\"abstract\" href=\"UTD.htm?8/60/9161/abstract/27\">",
"     27",
"    </a>",
"    ]. Improved fitness with exercise has been noted even among institutionalized older adults [",
"    <a class=\"abstract\" href=\"UTD.htm?8/60/9161/abstract/28\">",
"     28",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4894177\">",
"    <span class=\"h1\">",
"     OVERVIEW OF SPECIFIC PHYSICAL ACTIVITY RECOMMENDATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The American Heart Association (AHA) and the American College of Sports Medicine (ACSM) provide recommendations for adults over age 65 years for various types of activity and guides for implementing such programs [",
"    <a class=\"abstract\" href=\"UTD.htm?8/60/9161/abstract/14\">",
"     14",
"    </a>",
"    ]. These recommendations are also intended for adults ages 50 to 64 with clinically-significant chronic conditions or functional limitations that limit mobility and activity. Prevention of new health problems and treatment for an individual&rsquo;s existing health conditions should be integrated into a physical activity plan, with appropriate arrangements for progression and reevaluation as needed.",
"   </p>",
"   <p>",
"    Specific recommendations for exercise fall into four categories:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Aerobic exercise",
"     </li>",
"     <li>",
"      Muscle strengthening",
"     </li>",
"     <li>",
"      Flexibility",
"     </li>",
"     <li>",
"      Balance",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In the United States, there is some public awareness of the physical activity guidelines recommending 30 minutes of aerobic exercise on five or more days of the week. However, it is not widely recognized by either the public or clinicians that this guideline is considered a minimum recommendation. Additional health benefits are gained by engaging in physical activity beyond the suggested 30 minutes and by avoiding inactivity [",
"    <a class=\"abstract\" href=\"UTD.htm?8/60/9161/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Even fewer older adults are knowledgeable about the other recommended components of the physical activity plan, and the prevalence of older adults performing activities to address muscle strengthening, flexibility, and balance is low. Approximately 11 percent of older adults engage in strengthening activities, and the prevalence of individuals performing strength training is lowest among older women and individuals who are obese, sedentary, or of low educational status [",
"    <a class=\"abstract\" href=\"UTD.htm?8/60/9161/abstract/29\">",
"     29",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4894184\">",
"    <span class=\"h2\">",
"     Aerobic exercise",
"    </span>",
"    &nbsp;&mdash;&nbsp;By definition, aerobic exercise involves the use of large muscle groups and must be sustained for a minimum of 10 minutes. Examples of aerobic activities include brisk walking, jogging, swimming, water aerobics, tennis, golf without use of a cart, aerobic exercise classes, dancing, bicycle riding, and use of &ldquo;cardio&rdquo; equipment (eg, elliptical machines, stair climbing machines, stationary bicycles, and treadmills).",
"   </p>",
"   <p>",
"    Guidelines from the AHA and the ACSM suggest a minimum of 30 minutes of moderate-intensity aerobic activity on five days each week, or a minimum of 20 minutes of vigorous-intensity activity on three days each week, or some combination of the two [",
"    <a class=\"abstract\" href=\"UTD.htm?8/60/9161/abstract/14\">",
"     14",
"    </a>",
"    ]. Exceeding the recommended minimum amount of physical activity will lead to greater health benefits. The recommended guidelines for aerobic activities are considered to be in addition to self-care activities normally conducted throughout the day such as cleaning, bathing, walking to the car, or doing errands.",
"   </p>",
"   <p>",
"    Definitions for moderate and vigorous activity depend on the person's baseline conditioning and are based on a perceived relative exertion of effort. (See",
"    <a class=\"local\" href=\"#H4894192\">",
"     'Assessing intensity of effort'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Some tips for implementing aerobic activity for older adults are as follows:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Activities do not have to be done at one time but can be spread throughout the day in shorter time allotments. For example, an individual can take 3 brisk 10-minute walks per day.",
"     </li>",
"     <li>",
"      The minimal 150 minutes of moderate-intensity physical activity per week may be insufficient for weight loss for overweight or obese individuals. Older adults who are overweight may need the equivalent of 300 minutes per week of moderate-intensity physical activity to adequately manage weight control, in conjunction with an appropriate diet [",
"      <a class=\"abstract\" href=\"UTD.htm?8/60/9161/abstract/13\">",
"       13",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Individuals with chronic disabling conditions may not be able to achieve the minimal recommended amount of physical activity, but should be as physically active as can be achieved without harm. Many months at levels below the recommended minimum guidelines may be appropriate for certain individuals.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4894192\">",
"    <span class=\"h3\">",
"     Assessing intensity of effort",
"    </span>",
"    &nbsp;&mdash;&nbsp;A major difference in the physical activity guidelines for aerobic activities between younger and older adults is in how intensity of effort is assessed [",
"    <a class=\"abstract\" href=\"UTD.htm?8/60/9161/abstract/14\">",
"     14",
"    </a>",
"    ]. For younger adults, intensity of effort is assessed in absolute terms by estimating the actual metabolic cost of a given activity and assigning intensity accordingly [",
"    <a class=\"abstract\" href=\"UTD.htm?8/60/9161/abstract/30\">",
"     30",
"    </a>",
"    ]. A metabolic equivalent (MET) is an estimate of oxygen consumed at rest. A three-MET activity would be an activity that utilizes roughly three times the amount of resting energy expenditure. Activities between three to six METs are considered moderate, and activities greater than six METs are considered vigorous. Typically, METs are determined by measurement of oxygen consumption during a given activity; METs levels for a wide range of physical and occupational activities are published, but these have largely been derived from measurement among younger adults [",
"    <a class=\"abstract\" href=\"UTD.htm?8/60/9161/abstract/30\">",
"     30",
"    </a>",
"    ]. In contrast, older adults have a reduced range of functional capacity and tremendous heterogeneity of fitness levels. Thus, the use of absolute MET values for estimating intensity of effort is inappropriate because an activity that requires four METS of energy expenditure may be low for one older adult but near maximum capacity for another. Thus for older adults, intensity of effort is best based on a relative scale.",
"   </p>",
"   <p>",
"    Estimates of exercise intensity for older adults may best be based upon a relative scale of required effort. Using a scale of 0 to 10, with 0 considered the amount of effort used while sitting and 10 considered the greatest effort possible, moderate-intensity activity would be defined between 5 and 6 and should produce a noticeable increase in breathing and heart rate, while 7 and 8 would indicate vigorous intensity and should produce a large increase in breathing and heart rate. A good rule of thumb for moderate to vigorous aerobic activity is that the individual should be able to carry on a conversation during activity; if the person cannot sustain a conversation, the effort is too high. In communicating to a patient the intensity of exercise they should aim to achieve, intensity effort should be scaled linearly to a physiologic response. Sensory input reflecting effort may be useful (",
"    <a class=\"graphic graphic_figure graphicRef65051 \" href=\"UTD.htm?40/3/41012\">",
"     figure 1",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H96786693\">",
"    <span class=\"h2\">",
"     Muscle strengthening",
"    </span>",
"    &nbsp;&mdash;&nbsp;Activities to maintain and increase muscle strength include weight training, weight-bearing calisthenics, or resistance training. Development of muscle strength and muscle endurance is progressive and requires gradual increases in strengthening activities over time.",
"   </p>",
"   <p>",
"    Muscle-strengthening activities should be done a minimum of two non-consecutive days of the week and should target 8 to 10 major muscle groups (abdomen, bilateral arms, legs, shoulders, and hips). There is no recommended time for muscle strengthening activities; individuals should strive to perform 10 to 15 repetitions of each exercise at a moderate to high level of intensity and gradually increase resistance over time. Sample exercises for strengthening are shown (",
"    <a class=\"graphic graphic_picture graphicRef53922 \" href=\"UTD.htm?0/42/687\">",
"     picture 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_picture graphicRef58676 \" href=\"UTD.htm?14/11/14513\">",
"     picture 2",
"    </a>",
"    and",
"    <a class=\"graphic graphic_picture graphicRef72489 \" href=\"UTD.htm?17/1/17426\">",
"     picture 3",
"    </a>",
"    and",
"    <a class=\"graphic graphic_picture graphicRef61047 \" href=\"UTD.htm?17/45/18143\">",
"     picture 4",
"    </a>",
"    and",
"    <a class=\"graphic graphic_picture graphicRef51521 \" href=\"UTD.htm?7/0/7169\">",
"     picture 5",
"    </a>",
"    and",
"    <a class=\"graphic graphic_picture graphicRef79809 \" href=\"UTD.htm?39/5/40016\">",
"     picture 6",
"    </a>",
"    and",
"    <a class=\"graphic graphic_picture graphicRef74052 \" href=\"UTD.htm?31/48/32513\">",
"     picture 7",
"    </a>",
"    and",
"    <a class=\"graphic graphic_picture graphicRef72859 \" href=\"UTD.htm?22/42/23215\">",
"     picture 8",
"    </a>",
"    and",
"    <a class=\"graphic graphic_movie graphicRef73796 \" href=\"UTD.htm?43/13/44254\">",
"     movie 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_movie graphicRef58435 \" href=\"UTD.htm?16/35/16959\">",
"     movie 2",
"    </a>",
"    and",
"    <a class=\"graphic graphic_movie graphicRef72241 \" href=\"UTD.htm?37/40/38528\">",
"     movie 3",
"    </a>",
"    and",
"    <a class=\"graphic graphic_movie graphicRef51229 \" href=\"UTD.htm?30/45/31441\">",
"     movie 4",
"    </a>",
"    and",
"    <a class=\"graphic graphic_movie graphicRef50656 \" href=\"UTD.htm?21/24/21903\">",
"     movie 5",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Some tips for counseling muscle strengthening for older adults are as follows:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The initial weight should be one that an individual can lift about eight times. This weight should be maintained until",
"      <span class=\"nowrap\">",
"       he/she",
"      </span>",
"      can easily lift the weight 10 to 15 times then increased to a weight that again",
"      <span class=\"nowrap\">",
"       he/she",
"      </span>",
"      can only lift eight times, continuing with this gradual approach to progression. If a weight cannot be lifted eight times, it is too heavy and should be dropped down.",
"     </li>",
"     <li>",
"      Breathing should be normal while lifting weights, exhaling as the weight is lifted.",
"     </li>",
"     <li>",
"      Movements should be slow through a repetition: two to three seconds to lift, hold for one second, and three to four seconds to return to the starting position.",
"     </li>",
"     <li>",
"      Avoid locking the joints in a tightened position.",
"     </li>",
"     <li>",
"      Patients should be advised that muscle soreness is normal at first and should subside in a few weeks. For individuals with painful chronic conditions, muscle-strengthening activities should not exacerbate pain. More gradual incremental strengthening is advised for patients with chronic pain to maximize tolerance and their long-term commitment to a strengthening program.",
"     </li>",
"     <li>",
"      Older adults often use structured exercise programs to meet muscle-strengthening guidelines. Muscle strengthening can also be performed at home, using exercise bands, dumbbells, or home-made weights such as soup cans, water bottles, or empty milk jugs filled with water or sand.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The National Institute on Aging has an exercise and physical activity guide that is free to individuals or can be ordered in bulk for selected purposes (",
"    <a class=\"external\" href=\"file://go4life.niapublications.org/\">",
"     go4life.niapublications.org/",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H96786700\">",
"    <span class=\"h2\">",
"     Flexibility",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although there is scant research devoted to examining the impact of flexibility on health outcomes, flexibility is considered paramount to overall good physical health. Flexibility is necessary to perform daily life activities such as putting on shoes, reaching for objects overhead, or turning around to back a car out of a driveway.",
"   </p>",
"   <p>",
"    Some tips for implementing a flexibility program for older adults are as follows:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Flexibility exercises should be performed twice a week for at least 10 minutes.",
"     </li>",
"     <li>",
"      Stretching is best performed after aerobic or strengthening activities when the body is warmed up.",
"     </li>",
"     <li>",
"      Patients should breathe normally while stretching and avoid bouncing into a stretch.",
"     </li>",
"     <li>",
"      It is best to slowly stretch into the desired position and hold each stretch for 10 to 30 seconds.",
"     </li>",
"     <li>",
"      Patients should feel a slight pull but should not stretch to the point of pain.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Examples of flexibility activities include shoulder and upper arm stretches, calf stretches, and yoga (",
"    <a class=\"graphic graphic_picture graphicRef50339 \" href=\"UTD.htm?35/60/36815\">",
"     picture 9",
"    </a>",
"    and",
"    <a class=\"graphic graphic_picture graphicRef65646 \" href=\"UTD.htm?42/30/43488\">",
"     picture 10",
"    </a>",
"    and",
"    <a class=\"graphic graphic_picture graphicRef64188 \" href=\"UTD.htm?25/44/26319\">",
"     picture 11",
"    </a>",
"    and",
"    <a class=\"graphic graphic_picture graphicRef56288 \" href=\"UTD.htm?30/30/31201\">",
"     picture 12",
"    </a>",
"    and",
"    <a class=\"graphic graphic_picture graphicRef75957 \" href=\"UTD.htm?35/35/36415\">",
"     picture 13",
"    </a>",
"    and",
"    <a class=\"graphic graphic_picture graphicRef75432 \" href=\"UTD.htm?22/23/22911\">",
"     picture 14",
"    </a>",
"    and",
"    <a class=\"graphic graphic_movie graphicRef61978 \" href=\"UTD.htm?29/26/30113\">",
"     movie 6",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H96786707\">",
"    <span class=\"h2\">",
"     Balance training",
"    </span>",
"    &nbsp;&mdash;&nbsp;Balance problems are common in older adults. In a data analysis from the 2008 US National Health Interview Survey, nearly 20 percent of 37 million older adults (mean age 74 years) reported dizziness or balance problems in the preceding 12 months [",
"    <a class=\"abstract\" href=\"UTD.htm?8/60/9161/abstract/31\">",
"     31",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Balance exercise improves stability and may prevent falls and reduce injuries related to falls [",
"    <a class=\"abstract\" href=\"UTD.htm?8/60/9161/abstract/32-35\">",
"     32-35",
"    </a>",
"    ]. Balance exercises are especially important for individuals who have a history of falling or who have mobility problems.",
"   </p>",
"   <p>",
"    Research has shown that participation in group classes such as tai chi improves balance and reduces falls risk [",
"    <a class=\"abstract\" href=\"UTD.htm?8/60/9161/abstract/36\">",
"     36",
"    </a>",
"    ]. A video of tai chi is available (",
"    <a class=\"external\" href=\"file://go4life.niapublications.org/try-these-exercises/balance/tai-chi\">",
"     tai chi video",
"    </a>",
"    ). In addition to tai chi, balance training may involve heel-to-toe walking or standing on one foot. Examples of balance exercises are shown (",
"    <a class=\"graphic graphic_picture graphicRef66423 \" href=\"UTD.htm?21/63/22512\">",
"     picture 15",
"    </a>",
"    and",
"    <a class=\"graphic graphic_picture graphicRef54690 \" href=\"UTD.htm?30/57/31646\">",
"     picture 16",
"    </a>",
"    and",
"    <a class=\"graphic graphic_picture graphicRef77740 \" href=\"UTD.htm?7/23/7551\">",
"     picture 17",
"    </a>",
"    and",
"    <a class=\"graphic graphic_movie graphicRef59269 \" href=\"UTD.htm?20/59/21424\">",
"     movie 7",
"    </a>",
"    and",
"    <a class=\"graphic graphic_movie graphicRef68978 \" href=\"UTD.htm?30/3/30782\">",
"     movie 8",
"    </a>",
"    and",
"    <a class=\"graphic graphic_movie graphicRef80218 \" href=\"UTD.htm?6/44/6863\">",
"     movie 9",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4894199\">",
"    <span class=\"h1\">",
"     ACTIVITY PLAN",
"    </span>",
"    &nbsp;&mdash;&nbsp;An activity plan is recommended for all older adults. This plan should be individualized, with recommended levels of physical activity and specific instructions for how the individual will meet each recommended type of activity. The plan should specify what, how, when, where, and how often each activity will be done. For adults who are not active at recommended levels, the plan should include a progressive and stepwise approach to increase physical activity.",
"   </p>",
"   <p>",
"    A single activity plan should integrate therapeutic and prevention activities for specific conditions. Developing an activity plan, particularly for older adults with chronic conditions, may warrant input from physical",
"    <span class=\"nowrap\">",
"     therapists/exercise",
"    </span>",
"    physiologists or referral to specialty programs (eg, cardiac or pulmonary rehabilitation) (",
"    <a class=\"graphic graphic_table graphicRef82111 \" href=\"UTD.htm?9/29/9694\">",
"     table 2",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4894206\">",
"    <span class=\"h2\">",
"     Initiating exercise",
"    </span>",
"    &nbsp;&mdash;&nbsp;The",
"    <span class=\"nowrap\">",
"     AHA/ACSM",
"    </span>",
"    guidelines emphasize a graduated or stepwise introduction of physical activity to improve safety and adherence. Routine testing by either electrocardiogram (ECG) or cardiac exercise testing is not indicated for asymptomatic adults who are preparing to undergo a physical activity program. While both the AHA and ACSM endorse the statement that &ldquo;exercise testing may be considered for previously sedentary older individuals who are planning to begin a vigorous exercise program,&rdquo; this is rarely relevant because sedentary older adults should not begin a vigorous exercise program. Sedentary adults should begin moderate exercise programs and gradually progress to vigorous activity if desired and as tolerated. Thus, exercise testing should not be a barrier to initiating an exercise program for most patients, but is indicated for individuals who have active symptoms, known coronary artery disease, or for those at high risk for coronary disease based on multiple risk factors, such as in patients with diabetes mellitus who also have macrovascular disease (eg, peripheral or carotid artery disease). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/50/26409?source=see_link&amp;anchor=H5#H5\">",
"     \"Screening for coronary heart disease\", section on 'Exercise ECG testing in asymptomatic individuals'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A thorough medical history and physical examination can serve to determine cardiac contraindications to physical activity and identify at-risk individuals. Individuals free from active cardiovascular symptoms should be able to initiate a low- to moderate-intensity physical activity program without risk [",
"    <a class=\"abstract\" href=\"UTD.htm?8/60/9161/abstract/37,38\">",
"     37,38",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/50/26409?source=see_link\">",
"     \"Screening for coronary heart disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The following conditions should be treated or discussed with the patient prior to initiating a physical activity program:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      An active infection",
"     </li>",
"     <li>",
"      Fever with muscle aches",
"     </li>",
"     <li>",
"      Deep vein thrombosis",
"     </li>",
"     <li>",
"      Unexplained weight loss",
"     </li>",
"     <li>",
"      Foot sores that won&rsquo;t heal",
"     </li>",
"     <li>",
"      Proliferative retinopathy, retinal bleeding, or detached retina",
"     </li>",
"     <li>",
"      Recent surgery",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4894213\">",
"    <span class=\"h2\">",
"     Special considerations",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H96786743\">",
"    <span class=\"h3\">",
"     Functionally limited or frail",
"    </span>",
"    &nbsp;&mdash;&nbsp;While functionally-limited or frail individuals may never be able to meet minimum recommended activity levels, even modest activity and muscle strengthening can impact the progression of functional limitations [",
"    <a class=\"abstract\" href=\"UTD.htm?8/60/9161/abstract/20,39\">",
"     20,39",
"    </a>",
"    ]. While all elements of the physical activity recommendations should be incorporated into an activity plan, the adage &ldquo;start low and go slow&rdquo; should be kept in mind. It is acceptable to begin a baseline physical activity recommendation of walking for five minutes twice a day as a starting point. The key is to identify a set of activities the patient feels capable of doing; thus incorporating the concept of self-efficacy into the physical activity recommendation [",
"    <a class=\"abstract\" href=\"UTD.htm?8/60/9161/abstract/40\">",
"     40",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/7/28792?source=see_link&amp;anchor=H11#H11\">",
"     \"Frailty\", section on 'Exercise and nutrition interventions'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Two concepts from exercise science should be considered for improved function in adults with frailty.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      &ldquo;Specificity of training&rdquo; alludes to training to an identified task that is challenging for an individual with functional limitations, to enhance performance. As an example, for an individual who has difficulty rising up from a chair, the exercise prescription might include chair stands initially using the arms for support, gradually building up repetitions until minimal arm support is needed, and then progressing to standing up without arm support. Single stair climbs can be incorporated into a program for an individual with difficulty climbing stairs, with graduation progression to multiple stairs. &nbsp;",
"     </li>",
"     <li>",
"      &ldquo;Dose response&rdquo; alludes to the association between dose or intensity and outcome; a higher dose of activity or a higher intensity of activity will yield better health outcomes. In a group of older institutionalized adults, high-intensity resistance training yielded more effective changes in knee strength and endurance, six minute walk distance, chair stands, and stair climbing than low-intensity resistance training [",
"      <a class=\"abstract\" href=\"UTD.htm?8/60/9161/abstract/41\">",
"       41",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4894220\">",
"    <span class=\"h3\">",
"     Multiple morbidities",
"    </span>",
"    &nbsp;&mdash;&nbsp;Physical activity is beneficial to most chronic conditions. Given the prevalence of chronic conditions that increase with age, it is likely 50 percent of patients with diabetes will also have arthritis and 30 percent will have coronary disease, or both. The American College of Sports Medicine&rsquo;s initiative, Exercise is Medicine, has prepared a library of patient handouts with specific exercise prescriptions for a wide variety of specific health problems (eg, Alzheimer disease, atrial fibrillation, peripheral arterial disease). These handouts are available at",
"    <a class=\"external\" href=\"file://exerciseismedicine.org/YourPrescription.htm\">",
"     file://exerciseismedicine.org/YourPrescription.htm",
"    </a>",
"    .",
"   </p>",
"   <p>",
"    Careful consideration should be given to symptoms that may become aggravated with initiation of physical activity. Thus, while it is easiest to recommend that a diabetic patient initiate a walking program, adherence is unlikely if walking exacerbates knee pain due to arthritis. Alternative activities, such as non-weight bearing activities (stationary cycling) or water walking, thus should be considered and discussed with the patient. Progression should be gradual over time.",
"   </p>",
"   <p>",
"    The most challenging comorbidity is cognitive impairment when it is concurrent with a disease requiring substantial self-management, such as diabetes. A partner or caregiver may be required as an activity buddy to monitor symptoms and manage activity progression over time.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4894227\">",
"    <span class=\"h3\">",
"     Arthritis",
"    </span>",
"    &nbsp;&mdash;&nbsp;For patients with arthritis, aerobic activities should be selected that minimize joint stress. Strengthening activities should start at a relatively low intensity and gradually progress as pain tolerates. Maintaining flexibility and full range of motion in affected joints should be encouraged. Recommendations for exercises for patients with arthritis are presented separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/28/7621?source=see_link\">",
"     \"Weight-resistance exercises in patients with osteoarthritis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Physical activity should be avoided during periods of acute flares. Patients should be advised that although they may experience discomfort during or following physical activity, further damage to the joint should not occur. Icing the affected area for 10 minutes following physical activity will provide symptom relief and can prevent inflammation.",
"   </p>",
"   <p>",
"    Activity should be moderated if pain persists. Consideration should be given to timing physical activities to the optimal timing of prescribed pain medications [",
"    <a class=\"abstract\" href=\"UTD.htm?8/60/9161/abstract/37\">",
"     37",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4894234\">",
"    <span class=\"h3\">",
"     Cognitive impairment",
"    </span>",
"    &nbsp;&mdash;&nbsp;The standard recommendations for physical activity apply to individuals with cognitive impairment, with an emphasis on gradual progression. In some instances it might be useful to have a partner or caregiver monitor and provide ongoing support for activities performed.",
"   </p>",
"   <p>",
"    If the physical activity program involves the use of equipment with electronic display boards, it should be recognized that it may be difficult for someone with impaired cognition to appropriately set the correct speed, grade, or resistance of such devices.",
"   </p>",
"   <p>",
"    Activity logs to track physical activities over time may present difficulties for individuals with advanced cognitive impairment and may actually become a barrier to exercise compliance for such individuals, rather than a facilitating tool as intended. Such logs may be helpful, however, for individuals with mild cognitive impairment if their use in not too demanding.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4894241\">",
"    <span class=\"h3\">",
"     Osteoporosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The standard activity recommendations apply for individuals with osteoporosis but greater emphasis should be placed on weight-bearing and strengthening activities. Strengthening programs should be gradual, because excessive weight bearing with the initiation of exercise may increase the risk of fractures. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/52/39754?source=see_link&amp;anchor=H5#H5\">",
"     \"Overview of the management of osteoporosis in postmenopausal women\", section on 'Exercise'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Fall avoidance is important, so individuals with osteoporosis should consider fall prevention activities or balance training, such as tai chi. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/12/8393?source=see_link&amp;anchor=H4#H4\">",
"     \"Prevention of falls and complications of falls in community-dwelling older persons\", section on 'Exercise'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/59/31673?source=see_link&amp;anchor=H17787010#H17787010\">",
"     \"Prevention of falls in nursing care facilities and the hospital setting\", section on 'Exercise'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Individuals who have had osteoporotic fractures should avoid sudden movements, jarring or twisting movements, abdominal crunches or curls, and heavy lifting. It is best to consult a professional therapist for activity after a fracture to relieve pain and regain mobility.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4894248\">",
"    <span class=\"h1\">",
"     THE ROLE OF THE PROVIDER",
"    </span>",
"    &nbsp;&mdash;&nbsp;Health care providers are perceived as respected sources of health information and should thus take an active role in promoting physical activity. The primary care setting would appear to be a good venue for health promotion because most older adults visit their primary care provider more than once a year. However, most observational studies and randomized trials have found conflicting results on whether usual counseling in a primary care setting is sufficient to effect behavioral change [",
"    <a class=\"abstract\" href=\"UTD.htm?8/60/9161/abstract/42,43\">",
"     42,43",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The United States Preventive Task Force (USPSTF) found insufficient evidence to determine whether provider counseling for physical activity is effective [",
"    <a class=\"abstract\" href=\"UTD.htm?8/60/9161/abstract/44\">",
"     44",
"    </a>",
"    ], although an updated systematic review for the USPSTF found that moderate to intensive counseling by a trained health educator was associated with small improvements in secondary outcomes (weight, blood pressure, lipids) and self-reported physical activity [",
"    <a class=\"abstract\" href=\"UTD.htm?8/60/9161/abstract/45\">",
"     45",
"    </a>",
"    ]. These data may lead to revision of the USPSTF recommendations undergoing current review. The American Heart Association (AHA) and the American College of Preventive Medicine have endorsed counseling by health care providers [",
"    <a class=\"abstract\" href=\"UTD.htm?8/60/9161/abstract/46,47\">",
"     46,47",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/46/28394?source=see_link&amp;anchor=H36#H36\">",
"     \"Overview of the benefits and risks of exercise\", section on 'Efficacy of exercise counseling'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H96786550\">",
"    <span class=\"h2\">",
"     Behavioral counseling and patient motivation",
"    </span>",
"    &nbsp;&mdash;&nbsp;The literature is mixed relative to what approach providers should use for behavioral counseling. The AHA prepared a listing (not constrained to older adults) of the most effective strategies to promote exercise, as well as healthy diet, based on a systematic review of studies published between 1999 and 2009 (",
"    <a class=\"graphic graphic_table graphicRef59899 \" href=\"UTD.htm?20/23/20861\">",
"     table 3",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?8/60/9161/abstract/48\">",
"     48",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Modifications of stage of change, the 5 A&rsquo;s, and written prescriptions have shown some success [",
"    <a class=\"abstract\" href=\"UTD.htm?8/60/9161/abstract/47\">",
"     47",
"    </a>",
"    ]. The 5 A&rsquo;s include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       A",
"      </strong>",
"      ssess physical activity. Ask patients what about their current physical activity. Determine their specific physical activity (type, frequency, duration, and intensity) for each physical activity component.",
"     </li>",
"     <li>",
"      <strong>",
"       A",
"      </strong>",
"      dvise patients that physical activity is beneficial to their health and directly state what recommended guidelines should be modified to patient history, health, and current activity status.",
"     </li>",
"     <li>",
"      <strong>",
"       A",
"      </strong>",
"      gree with patient willingness to be physically active based upon their readiness to change, and counsel accordingly. For patients not interested in changing sedentary behaviors (precontemplators), the focus should be on emphasizing the benefits of physical activity and seeking agreement to discuss in the future. For patients thinking about changing behavior (contemplation), the focus should be on discussing what the next steps and encouraging actual behavior change. For patients intending to begin becoming more physically active (preparation), the focus should be on assisting in developing a specific activity plan with a specific start date. Patients already engaged in physical activity (active) should be congratulated and assessed as to whether they are meeting recommended guidelines. Patients appropriately active for over six months (maintenance) should be congratulated and encouraged.",
"     </li>",
"     <li>",
"      <strong>",
"       A",
"      </strong>",
"      ssist the patient in developing a specific physical activity plan that incorporates all of the physical activity components, addresses potential barriers and how to overcome them, elicits a source of social support, and links physical activity plan into a comprehensive plan that integrates heath. Written prescriptions have been effective [",
"      <a class=\"abstract\" href=\"UTD.htm?8/60/9161/abstract/49\">",
"       49",
"      </a>",
"      ]. Providers should also be aware of local resources that patients can be referred to.",
"     </li>",
"     <li>",
"      <strong>",
"       A",
"      </strong>",
"      rrange for a method to follow-up on activity or referral to a specialist if needed.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Initial motivational strategies should focus on personally-meaningful benefits. The clinician should emphasize immediate benefits such as feeling better, sleeping better, getting stronger, maintaining weight, increasing energy to do desired activities with family and friends, etc. The physical activity plan should incorporate these immediate goals.",
"   </p>",
"   <p>",
"    Motivational strategies should be ongoing, with attention at each usual care visit to transition from initiation of physical activity to long-term adherence. Long-terms goals such as maintaining independence or reducing risk of cognitive decline can be discussed to facilitate adherence.",
"   </p>",
"   <p>",
"    Clinicians should acknowledge that older adults may experience interruptions in physical activity due to illness, caregiving, or other obligations. Patients should be made aware that interruptions in physical activity are normal and should be encouraged return to physical activity as soon as possible.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1648690\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Physical activity benefits people of all ages and may decrease all-cause morbidity and increase lifespan. In the presence of chronic conditions, some physical activity is better than none, and participation in any amount of physical activity will result in some health benefit. It is never too late to become physically active. (See",
"      <a class=\"local\" href=\"#H96786655\">",
"       'Benefits of physical activity'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Guidelines from the American Heart Association (AHA) and the American College of Sports Medicine (ACSM) identify four categories for specific recommendations for exercises: aerobic exercise, muscle strengthening, flexibility, and balance. (See",
"      <a class=\"local\" href=\"#H4894177\">",
"       'Overview of specific physical activity recommendations'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Aerobic exercise involves the use of large muscle groups and must be sustained for a minimum of 10 minutes. Minimal recommendations advise moderate intensity aerobic activity for 30 minutes on five days each week or vigorous activity on three days each week. Moderate or vigorous intensity is based upon a person&rsquo;s baseline conditioning and is determined by an individual&rsquo;s perceived relative exertion of effort. (See",
"      <a class=\"local\" href=\"#H4894184\">",
"       'Aerobic exercise'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Activities to maintain and increase muscle strength include weight training, weight-bearing calisthenics, or resistance training. Muscle-strengthening activities should be done a minimum of two non-consecutive days of the week and should target 8 to 10 major muscle groups. The initial weight should be one that an individual can lift about eight times, and repetitions and weight load are gradually increased over time. (See",
"      <a class=\"local\" href=\"#H96786693\">",
"       'Muscle strengthening'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Flexibility is necessary to perform daily life activities, and exercises to increase or maintain flexibility should be performed twice a week for at least 10 minutes. Stretching is best performed after aerobic or strengthening activities when the body is warmed up. (See",
"      <a class=\"local\" href=\"#H96786700\">",
"       'Flexibility'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Balance exercise, such as tai chi, improves stability and may prevent falls and reduce injuries related to falls. (See",
"      <a class=\"local\" href=\"#H96786707\">",
"       'Balance training'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      An individualized activity plan is recommended for all older adults to include specific physical activity instructions, advice for progression of activity, and should integrate both prevention and therapeutic activities. Routine testing by electrocardiogram or cardiac exercise testing is not indicated for most asymptomatic adults prior to initiating moderate physical activity, unless they are at high risk for coronary disease on the basis of multiple risk factors. (See",
"      <a class=\"local\" href=\"#H4894199\">",
"       'Activity plan'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Physical activity, even if at limited intensity with slow increments and adapted to specific functional limitations, is helpful for frail older adults and those with multiple morbidities. Maintaining flexibility and range of motion in affected joints is important for patients with arthritis. A caregiver may need to be involved in supporting physical activity for patients with cognitive impairment. Increased emphasis on weight-bearing and strengthening exercise is advised for patients with osteoporosis. (See",
"      <a class=\"local\" href=\"#H4894213\">",
"       'Special considerations'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Data conflict on the effectiveness and most-effective strategies for physician counseling to promote physical activity. Initial motivational strategies should focus on personally-meaningful benefits and immediate goals should be incorporated into the physical activity plan. (See",
"      <a class=\"local\" href=\"#H96786550\">",
"       'Behavioral counseling and patient motivation'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     file://www.who.int/topics/ageing/en/ (Accessed on November 02, 2011).",
"    </li>",
"    <li>",
"     Federal Interagency Forum on Aging-Related Statistics. Older Americans Update 2010: Key indicators of well-being. U.S. Government Printing Office; Washington, DC 2010.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/60/9161/abstract/3\">",
"      Brach JS, FitzGerald S, Newman AB, et al. Physical activity and functional status in community-dwelling older women: a 14-year prospective study. Arch Intern Med 2003; 163:2565.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/60/9161/abstract/4\">",
"      Brach JS, Simonsick EM, Kritchevsky S, et al. The association between physical function and lifestyle activity and exercise in the health, aging and body composition study. J Am Geriatr Soc 2004; 52:502.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/60/9161/abstract/5\">",
"      Nguyen HQ, Ackermann RT, Maciejewski M, et al. Managed-Medicare health club benefit and reduced health care costs among older adults. Prev Chronic Dis 2008; 5:A14.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/60/9161/abstract/6\">",
"      Young A. Exercise physiology in geriatric practice. Acta Med Scand Suppl 1986; 711:227.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/60/9161/abstract/7\">",
"      Dehn MM, Bruce RA. Longitudinal variations in maximal oxygen intake with age and activity. J Appl Physiol 1972; 33:805.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/60/9161/abstract/8\">",
"      Goodpaster BH, Park SW, Harris TB, et al. The loss of skeletal muscle strength, mass, and quality in older adults: the health, aging and body composition study. J Gerontol A Biol Sci Med Sci 2006; 61:1059.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/60/9161/abstract/9\">",
"      Peterson MD, Gordon PM. Resistance exercise for the aging adult: clinical implications and prescription guidelines. Am J Med 2011; 124:194.",
"     </a>",
"    </li>",
"    <li>",
"     US Department of Health and Human Services. Healthy People 2010, conference edition. US Department of Health and Human Services; Washington, DC 2000. Available at: www.healthypeople.gov (Accessed on December 21, 2007).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/60/9161/abstract/11\">",
"      King AC, Guralnik JM. Maximizing the potential of an aging population. JAMA 2010; 304:1944.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/60/9161/abstract/12\">",
"      Nicklett EJ, Semba RD, Xue QL, et al. Fruit and vegetable intake, physical activity, and mortality in older community-dwelling women. J Am Geriatr Soc 2012; 60:862.",
"     </a>",
"    </li>",
"    <li>",
"     Department of Health and Human Services. Physical Activity Guidelines for Americans, 2008. Department of Health and Human Services, 2008.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/60/9161/abstract/14\">",
"      Nelson ME, Rejeski WJ, Blair SN, et al. Physical activity and public health in older adults: recommendation from the American College of Sports Medicine and the American Heart Association. Circulation 2007; 116:1094.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/60/9161/abstract/15\">",
"      Cress ME, Buchner DM, Questad KA, et al. Exercise: effects on physical functional performance in independent older adults. J Gerontol A Biol Sci Med Sci 1999; 54:M242.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/60/9161/abstract/16\">",
"      M&auml;nty M, Heinonen A, Leinonen R, et al. Long-term effect of physical activity counseling on mobility limitation among older people: a randomized controlled study. J Gerontol A Biol Sci Med Sci 2009; 64:83.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/60/9161/abstract/17\">",
"      Sattelmair JR, Pertman JH, Forman DE. Effects of physical activity on cardiovascular and noncardiovascular outcomes in older adults. Clin Geriatr Med 2009; 25:677.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/60/9161/abstract/18\">",
"      De Vries HA. Physiological effects of an exercise training regimen upon men aged 52 to 88. J Gerontol 1970; 25:325.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/60/9161/abstract/19\">",
"      Campbell AJ, Robertson MC, Gardner MM, et al. Falls prevention over 2 years: a randomized controlled trial in women 80 years and older. Age Ageing 1999; 28:513.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/60/9161/abstract/20\">",
"      Miller ME, Rejeski WJ, Reboussin BA, et al. Physical activity, functional limitations, and disability in older adults. J Am Geriatr Soc 2000; 48:1264.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/60/9161/abstract/21\">",
"      Villareal DT, Chode S, Parimi N, et al. Weight loss, exercise, or both and physical function in obese older adults. N Engl J Med 2011; 364:1218.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/60/9161/abstract/22\">",
"      Morey MC, Sloane R, Pieper CF, et al. Effect of physical activity guidelines on physical function in older adults. J Am Geriatr Soc 2008; 56:1873.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/60/9161/abstract/23\">",
"      American College of Sports Medicine, Chodzko-Zajko WJ, Proctor DN, et al. American College of Sports Medicine position stand. Exercise and physical activity for older adults. Med Sci Sports Exerc 2009; 41:1510.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/60/9161/abstract/24\">",
"      Guideline for the prevention of falls in older persons. American Geriatrics Society, British Geriatrics Society, and American Academy of Orthopaedic Surgeons Panel on Falls Prevention. J Am Geriatr Soc 2001; 49:664.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/60/9161/abstract/25\">",
"      Keysor JJ. Does late-life physical activity or exercise prevent or minimize disablement? A critical review of the scientific evidence. Am J Prev Med 2003; 25:129.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/60/9161/abstract/26\">",
"      LIFE Study Investigators, Pahor M, Blair SN, et al. Effects of a physical activity intervention on measures of physical performance: Results of the lifestyle interventions and independence for Elders Pilot (LIFE-P) study. J Gerontol A Biol Sci Med Sci 2006; 61:1157.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/60/9161/abstract/27\">",
"      Stessman J, Hammerman-Rozenberg R, Cohen A, et al. Physical activity, function, and longevity among the very old. Arch Intern Med 2009; 169:1476.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/60/9161/abstract/28\">",
"      Lobo A, Carvalho J, Santos P. Comparison of functional fitness in elderlies with reference values by Rikli and Jones and after one-year of health intervention programs. J Sports Med Phys Fitness 2011; 51:111.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/60/9161/abstract/29\">",
"      Centers for Disease Control and Prevention (CDC). Strength training among adults aged &gt;/=65 years--United States, 2001. MMWR Morb Mortal Wkly Rep 2004; 53:25.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/60/9161/abstract/30\">",
"      Ainsworth BE, Haskell WL, Whitt MC, et al. Compendium of physical activities: an update of activity codes and MET intensities. Med Sci Sports Exerc 2000; 32:S498.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/60/9161/abstract/31\">",
"      Lin HW, Bhattacharyya N. Balance disorders in the elderly: epidemiology and functional impact. Laryngoscope 2012; 122:1858.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/60/9161/abstract/32\">",
"      Sherrington C, Lord SR, Finch CF. Physical activity interventions to prevent falls among older people: update of the evidence. J Sci Med Sport 2004; 7:43.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/60/9161/abstract/33\">",
"      Province MA, Hadley EC, Hornbrook MC, et al. The effects of exercise on falls in elderly patients. A preplanned meta-analysis of the FICSIT Trials. Frailty and Injuries: Cooperative Studies of Intervention Techniques. JAMA 1995; 273:1341.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/60/9161/abstract/34\">",
"      Wolfson L, Whipple R, Derby C, et al. Balance and strength training in older adults: intervention gains and Tai Chi maintenance. J Am Geriatr Soc 1996; 44:498.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/60/9161/abstract/35\">",
"      Wolf SL, Barnhart HX, Kutner NG, et al. Reducing frailty and falls in older persons: an investigation of Tai Chi and computerized balance training. Atlanta FICSIT Group. Frailty and Injuries: Cooperative Studies of Intervention Techniques. J Am Geriatr Soc 1996; 44:489.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/60/9161/abstract/36\">",
"      Li F, Harmer P, Fisher KJ, et al. Tai Chi and fall reductions in older adults: a randomized controlled trial. J Gerontol A Biol Sci Med Sci 2005; 60:187.",
"     </a>",
"    </li>",
"    <li>",
"     American College of Sports Medicine. ACSM's Guidelines for Exercise Testing and Prescription, 8th ed, Lippincott Williams and Willkins, Philadelphia 2010. p.380.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/60/9161/abstract/38\">",
"      Gill TM, DiPietro L, Krumholz HM. Role of exercise stress testing and safety monitoring for older persons starting an exercise program. JAMA 2000; 284:342.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/60/9161/abstract/39\">",
"      Fiatarone MA, O'Neill EF, Ryan ND, et al. Exercise training and nutritional supplementation for physical frailty in very elderly people. N Engl J Med 1994; 330:1769.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/60/9161/abstract/40\">",
"      McAuley E, Konopack JF, Morris KS, et al. Physical activity and functional limitations in older women: influence of self-efficacy. J Gerontol B Psychol Sci Soc Sci 2006; 61:P270.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/60/9161/abstract/41\">",
"      Seynnes O, Fiatarone Singh MA, Hue O, et al. Physiological and functional responses to low-moderate versus high-intensity progressive resistance training in frail elders. J Gerontol A Biol Sci Med Sci 2004; 59:503.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/60/9161/abstract/42\">",
"      Kinmonth AL, Wareham NJ, Hardeman W, et al. Efficacy of a theory-based behavioural intervention to increase physical activity in an at-risk group in primary care (ProActive UK): a randomised trial. Lancet 2008; 371:41.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/60/9161/abstract/43\">",
"      Dubbert PM, Morey MC, Kirchner KA, et al. Counseling for home-based walking and strength exercise in older primary care patients. Arch Intern Med 2008; 168:979.",
"     </a>",
"    </li>",
"    <li>",
"     U.S. Preventive Services Task Force. Behavioral counseling in primary care to promote physical activity: recommendations and rationale, 2002. U.S. Preventive Services Task Force, 2002.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/60/9161/abstract/45\">",
"      Lin JS, O'Connor E, Whitlock EP, Beil TL. Behavioral counseling to promote physical activity and a healthful diet to prevent cardiovascular disease in adults: a systematic review for the U.S. Preventive Services Task Force. Ann Intern Med 2010; 153:736.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/60/9161/abstract/46\">",
"      Thompson PD, Buchner D, Pina IL, et al. Exercise and physical activity in the prevention and treatment of atherosclerotic cardiovascular disease: a statement from the Council on Clinical Cardiology (Subcommittee on Exercise, Rehabilitation, and Prevention) and the Council on Nutrition, Physical Activity, and Metabolism (Subcommittee on Physical Activity). Circulation 2003; 107:3109.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/60/9161/abstract/47\">",
"      Jacobson DM, Strohecker L, Compton MT, Katz DL. Physical activity counseling in the adult primary care setting: position statement of the American College of Preventive Medicine. Am J Prev Med 2005; 29:158.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/60/9161/abstract/48\">",
"      Artinian NT, Fletcher GF, Mozaffarian D, et al. Interventions to promote physical activity and dietary lifestyle changes for cardiovascular risk factor reduction in adults: a scientific statement from the American Heart Association. Circulation 2010; 122:406.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/60/9161/abstract/49\">",
"      Kerse N, Elley CR, Robinson E, Arroll B. Is physical activity counseling effective for older people? A cluster randomized, controlled trial in primary care. J Am Geriatr Soc 2005; 53:1951.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 16524 Version 5.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1004-61.234.146.186-FF4A722CD6-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_60_9161=[""].join("\n");
var outline_f8_60_9161=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H1648690\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4894156\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H96786655\">",
"      BENEFITS OF PHYSICAL ACTIVITY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4894177\">",
"      OVERVIEW OF SPECIFIC PHYSICAL ACTIVITY RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4894184\">",
"      Aerobic exercise",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H4894192\">",
"      - Assessing intensity of effort",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H96786693\">",
"      Muscle strengthening",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H96786700\">",
"      Flexibility",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H96786707\">",
"      Balance training",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4894199\">",
"      ACTIVITY PLAN",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4894206\">",
"      Initiating exercise",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4894213\">",
"      Special considerations",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H96786743\">",
"      - Functionally limited or frail",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H4894220\">",
"      - Multiple morbidities",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H4894227\">",
"      - Arthritis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H4894234\">",
"      - Cognitive impairment",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H4894241\">",
"      - Osteoporosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4894248\">",
"      THE ROLE OF THE PROVIDER",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H96786550\">",
"      Behavioral counseling and patient motivation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1648690\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PC/16524\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PC/16524|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?40/3/41012\" title=\"figure 1\">",
"      10-point perceived exertion scale",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PC/16524|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?0/42/687\" title=\"picture 1\">",
"      Toe stand exercise",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?14/11/14513\" title=\"picture 2\">",
"      Arm curl exercise",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?17/1/17426\" title=\"picture 3\">",
"      Chair dip exercise",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?17/45/18143\" title=\"picture 4\">",
"      Back leg raise exercise",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?7/0/7169\" title=\"picture 5\">",
"      Chair stand exercise",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?39/5/40016\" title=\"picture 6\">",
"      Wall push-up exercise",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?31/48/32513\" title=\"picture 7\">",
"      Overhead arm raise exercise",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?22/42/23215\" title=\"picture 8\">",
"      Side leg raise exercise",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?35/60/36815\" title=\"picture 9\">",
"      Back stretch",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?42/30/43488\" title=\"picture 10\">",
"      Calf stretch",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?25/44/26319\" title=\"picture 11\">",
"      Chest stretch",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?30/30/31201\" title=\"picture 12\">",
"      Shoulder and upper arm stretch",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?35/35/36415\" title=\"picture 13\">",
"      Shoulder stretch",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?22/23/22911\" title=\"picture 14\">",
"      Standing thigh stretch",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?21/63/22512\" title=\"picture 15\">",
"      Balance walk",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?30/57/31646\" title=\"picture 16\">",
"      Heel to toe walk",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?7/23/7551\" title=\"picture 17\">",
"      Stand on one foot",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PC/16524|MOV\">",
"      <a href=\"#\" title=\"MOVIES\">",
"       MOVIES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_movie\" href=\"UTD.htm?43/13/44254\" title=\"movie 1\">",
"      Toe stand video",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_movie\" href=\"UTD.htm?16/35/16959\" title=\"movie 2\">",
"      Back leg raise video",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_movie\" href=\"UTD.htm?37/40/38528\" title=\"movie 3\">",
"      Wall push-up exercise video",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_movie\" href=\"UTD.htm?30/45/31441\" title=\"movie 4\">",
"      Overhead arm raise exercise video",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_movie\" href=\"UTD.htm?21/24/21903\" title=\"movie 5\">",
"      Side leg raise video",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_movie\" href=\"UTD.htm?29/26/30113\" title=\"movie 6\">",
"      Shoulder and upper arm stretch video",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_movie\" href=\"UTD.htm?20/59/21424\" title=\"movie 7\">",
"      Balance walk video",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_movie\" href=\"UTD.htm?30/3/30782\" title=\"movie 8\">",
"      Heel to toe walk video",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_movie\" href=\"UTD.htm?6/44/6863\" title=\"movie 9\">",
"      Stand on one foot video",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PC/16524|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?19/51/20284\" title=\"table 1\">",
"      Evidence health benefits",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?9/29/9694\" title=\"table 2\">",
"      Older adult activity counseling",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?20/23/20861\" title=\"table 3\">",
"      AHA recs for exercise and diet counseling",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/28/14793?source=related_link\">",
"      Exercise and fitness in the prevention of cardiovascular disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/35/25144?source=related_link\">",
"      Exercise physiology",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/7/28792?source=related_link\">",
"      Frailty",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/46/28394?source=related_link\">",
"      Overview of the benefits and risks of exercise",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/52/39754?source=related_link\">",
"      Overview of the management of osteoporosis in postmenopausal women",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/12/8393?source=related_link\">",
"      Prevention of falls and complications of falls in community-dwelling older persons",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/59/31673?source=related_link\">",
"      Prevention of falls in nursing care facilities and the hospital setting",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/50/26409?source=related_link\">",
"      Screening for coronary heart disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/28/7621?source=related_link\">",
"      Weight-resistance exercises in patients with osteoarthritis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f8_60_9162="Liver in sideroblastic anemia";
var content_f8_60_9162=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=HEME%2F60882&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=HEME%2F60882&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Iron overload in the liver in sideroblastic anemia",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 390px; height: 527px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Liver biopsy sections from a 26-year-old man with autosomal recessive&nbsp;congenital sideroblastic anemia and moderate iron overload.",
"    <br>",
"     (Top panel) Hematoxylin and eosin stain.",
"     <br>",
"      (Bottom panel) Prussian blue (iron) stain.",
"      <div class=\"footnotes\">",
"      </div>",
"      <div class=\"reference\">",
"       Courtesy of Sylvia Bottomley, MD.",
"      </div>",
"     </br>",
"    </br>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_60_9162=[""].join("\n");
var outline_f8_60_9162=null;
var title_f8_60_9163="CGG repeats mutation status";
var content_f8_60_9163=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F64429&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F64429&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    How CGG repeats influence mutation status",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Maternal repeats",
"       </td>",
"       <td class=\"subtitle1\">",
"        Percent of offspring with expansion to full mutation (&gt;200 repeats)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        55-59",
"       </td>",
"       <td>",
"        4",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        60-69",
"       </td>",
"       <td>",
"        5",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        70-79",
"       </td>",
"       <td>",
"        31",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        80-89",
"       </td>",
"       <td>",
"        58",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        90-99",
"       </td>",
"       <td>",
"        80",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        100-200",
"       </td>",
"       <td>",
"        Approximately 100",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from: Nolin, SL, et al. Expansion of the fragile X CGG repeat in females with premutation or intermediate alleles. Am J Hum Genet 2003; 72:454.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_60_9163=[""].join("\n");
var outline_f8_60_9163=null;
var title_f8_60_9164="Vulvar lesion immunocompromise";
var content_f8_60_9164=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F57626&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=11\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F57626&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=11\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Vulvar lesions in immunocompromised patient populations",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Diagnosis",
"       </td>",
"       <td class=\"subtitle1\">",
"        Important characteristics in immunocompromised women",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        HIV",
"       </td>",
"       <td>",
"        Shallow, sharply demarcated painful ulcers. Diagnosis is made by serology or measurement of viral load. Biopsy is not useful as it will show only nonspecific changes.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        HSV",
"       </td>",
"       <td>",
"        Common cause for chronic, non-healing ulcers; super infection with CMV; culture or biopsy for diagnosis.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        CMV",
"       </td>",
"       <td>",
"        Large deep necrotic ulcers; rare; biopsy for diagnosis.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Condyloma",
"       </td>",
"       <td>",
"        Numerous, larger, more difficult to treat and more likely to recur; size and number may cause obstruction in perineum; clinical diagnosis may be augmented with biopsy.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Molluscum contagiosum (pox virus)",
"       </td>",
"       <td>",
"        Numerous, larger, not self-limited, distribution over entire body; form plaques as typical umbilicated papules coalesce; biopsy for diagnosis.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Tinea cruris",
"       </td>",
"       <td>",
"        Uncommon in women; atypical&nbsp;patches with uniform scale extending to legs, buttocks, abdomen; hair follicles involvement with pustules; microscopy of scale sample with KOH.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Scabies",
"       </td>",
"       <td>",
"        Severe variant - Norwegian scabies - vast increase in quantity of mites; hyperkeratotic papules/plaques over entire body;nails thickened with crusting; microscopy of scale sample.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Psoriasis",
"       </td>",
"       <td>",
"        Typical appearance with more numerous sites and \"inverse\" distribution affecting the anogenital skin more commonly; more difficult to treat; diagnose clinically &plusmn; biopsy and by exclusion.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Giant aphthae",
"       </td>",
"       <td>",
"        Large (1-2 cm), deep, painful erosions/ulcers; biopsy/culture to exclude HSV.",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     HIV: human immunodeficiency virus; HSV: herpes simplex virus; CMV: cytomegalovirus.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_60_9164=[""].join("\n");
var outline_f8_60_9164=null;
var title_f8_60_9165="Infectious arthritis child";
var content_f8_60_9165=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F75773&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F75773&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Infectious causes of arthritis/arthralgia in children",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        &nbsp;",
"       </td>",
"       <td class=\"subtitle1\">",
"        Comment",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Viruses",
"       </td>",
"       <td>",
"        Viral arthritis usually involves multiple small joints",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Varicella zoster virus (VZV)",
"       </td>",
"       <td class=\"sublist_other\">",
"        VZV may cause primary arthritis within several days of the onset of rash; monoarticular knee involvement is most common; varicella also may cause secondary bacterial arthritis by providing a portal of entry for Staphylococci or Streptococci",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Hepatitis B virus (HBV)",
"       </td>",
"       <td class=\"sublist_other\">",
"        10 to 25 percent of patients with HBV develop arthritis, usually during the prodromal stage; joints of hands and knees most often affected; may be associated with urticarial and maculopapular eruption",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Hepatitis C virus (HCV)",
"       </td>",
"       <td class=\"sublist_other\">",
"        2 to 20 percent of patients with HCV develop arthritis (evanescent or oligoarthritis)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Parvovirus",
"       </td>",
"       <td class=\"sublist_other\">",
"        Arthralgia or arthritis may accompany or follow the skin eruption; the knee is most commonly affected joint",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Rubella",
"       </td>",
"       <td class=\"sublist_other\">",
"        Joint symptoms develop within one week before or after the rash",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Rubella vaccine virus",
"       </td>",
"       <td class=\"sublist_other\">",
"        Joint symptoms develop approximately two weeks after vaccination",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Mumps virus",
"       </td>",
"       <td class=\"sublist_other\">",
"        Joint symptoms usually develop after the onset of parotitis",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td class=\"sublist1_start\" colspan=\"2\">",
"        Fungi",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        <em>",
"         Candida",
"        </em>",
"       </td>",
"       <td class=\"sublist_other\">",
"        May occur in neonates or immunocompromised children",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        <em>",
"         Histoplasma",
"        </em>",
"       </td>",
"       <td class=\"sublist_other\">",
"        Endemic to the eastern and central United States and Canada; exposure to bird droppings, bat guano",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        <em>",
"         Coccidiodes",
"        </em>",
"       </td>",
"       <td class=\"sublist_other\">",
"        Endemic to the southwestern United States, northern Mexico, parts of Central and South America",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        <em>",
"         Sporothrix schenckii",
"        </em>",
"       </td>",
"       <td class=\"sublist_other\">",
"        Present in soil, moss, and other organic material; may be inoculated into the skin or inhaled",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        <em>",
"         Blastomyces dermatitidis",
"        </em>",
"       </td>",
"       <td class=\"sublist_other\">",
"        Endemic in the southeastern and central states and Midwestern states bordering the Great Lakes",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        Post-infectious arthritis or reactive arthritis",
"       </td>",
"       <td>",
"        Preceding episode of respiratory (group A streptococcus,",
"        <em>",
"         Neisseria meningitidis",
"        </em>",
"        ), gastrointestinal (eg,",
"        <em>",
"         Shigella",
"        </em>",
"        ,",
"        <em>",
"         Salmonella",
"        </em>",
"        ,",
"        <em>",
"         Campylobacter",
"        </em>",
"        ), or genitourinary infection (",
"        <em>",
"         Chlamydia trachomatis",
"        </em>",
"        ); may be associated conjunctivitis, uveitis, or rash; onset of joint inflammation &ge;7 days after acute infection; resolves without sequelae in 97 to 99 percent of cases; if obtained, synovial fluid WBC count&nbsp;usually is &lt;50,000 cells/microL",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        Rheumatic fever",
"       </td>",
"       <td>",
"        Evanescent and migratory arthritis; extreme pain and limited range of motion, but minimal effusion or swelling",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <p>",
"     &nbsp;",
"    </p>",
"    <div class=\"footnotes\">",
"     WBC: white blood cell.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_60_9165=[""].join("\n");
var outline_f8_60_9165=null;
var title_f8_60_9166="T3 resin test TBG excess";
var content_f8_60_9166=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ENDO%2F72712&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ENDO%2F72712&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    T3-resin test in TBG excess",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 285px; height: 386px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The radiolabeled T3 (*T3) is able to bind to the excess binding sites on TBG; as a result, the amount left over to bind to the resin is lower than normal. The serum total T4 is high; the T3-resin uptake and THBR are low, and the serum free T4 index is normal.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_60_9166=[""].join("\n");
var outline_f8_60_9166=null;
var title_f8_60_9167="Erythema nodosum PI";
var content_f8_60_9167=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PI%2F83950&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PI%2F83950&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Erythema nodosum",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 238px; height: 360px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Erythema nodosum causes painful red bumps on the legs that can look like bruises.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Lee T Nesbitt, Jr. The Skin and Infection: A Color Atlas and Text, Sanders CV, Nesbitt LT Jr (Eds), Williams &amp; Wilkins, Baltimore. 1995.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_60_9167=[""].join("\n");
var outline_f8_60_9167=null;
